data_2lji_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lji _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 tpp . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.813 0.34 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.32 149.36 23.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.82 140.01 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.51 113.54 11.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG22 ' CG1' ' A' ' 59' ' ' VAL . 27.6 m -117.43 137.27 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.672 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.46 115.24 21.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.01 134.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.56 120.38 30.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.15 17.91 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.042 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.64 163.71 16.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.771 0.285 . . . . 0.0 110.825 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -168.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.467 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -99.69 122.84 43.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.046 0.45 . . . . 0.0 111.195 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m -123.24 162.94 21.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.265 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.79 139.57 40.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.29 143.66 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.33 128.64 34.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.18 161.11 15.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.92 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.73 -34.33 21.25 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -31.02 64.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.223 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -46.83 71.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.83 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.7 26.06 54.83 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 179.09 5.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -58.11 -34.22 69.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.171 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.7 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.091 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.97 -42.72 90.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.78 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -46.47 87.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.771 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.99 -50.44 79.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -58.89 -37.37 76.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.18 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.54 -27.46 49.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.834 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 t -94.26 23.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.289 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.05 48.35 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.09 0.471 . . . . 0.0 111.033 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.9 52.33 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.581 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . 52.6 p -90.2 120.48 69.16 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.64 -32.97 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.627 2.218 . . . . 0.0 112.916 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -39.68 31.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.402 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 39.52 62.1 1.25 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.869 0.468 . . . . 0.0 111.883 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.77 153.72 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.68 137.17 33.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.34 134.87 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.33 147.21 26.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.663 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.72 117.81 47.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.87 120.25 12.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.301 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 CA-C-N 115.009 -0.996 . . . . 0.0 114.739 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.615 0.245 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.16 161.86 26.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -149.22 153.97 38.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -95.38 124.96 39.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.875 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.83 166.63 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.46 136.03 44.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.54 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 5' ' ' VAL . 3.2 m -106.69 141.23 22.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.842 0.354 . . . . 0.0 111.426 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 119.04 38.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.69 0.281 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -84.91 146.71 27.13 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.37 140.13 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.709 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -74.6 113.24 11.62 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.7 136.43 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.36 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.49 114.85 20.49 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.447 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.67 133.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.86 120.61 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.89 -57.42 5.01 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.449 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.76 163.51 26.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.37 -172.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.521 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -99.52 121.05 40.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.951 0.405 . . . . 0.0 111.035 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.5 t -120.96 161.71 21.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.55 140.83 33.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -128.24 150.75 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 124.67 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.93 164.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.707 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -88.53 -29.54 19.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.55 -37.61 63.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 32.5 p30 -50.72 -30.39 13.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.54 25.62 75.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.983 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -103.07 179.14 4.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -57.02 -32.8 66.52 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.33 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.46 -36.96 69.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.207 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.74 -44.75 93.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.632 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -36.29 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.049 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 t -70.88 -51.08 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.888 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -35.89 76.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.185 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.2 65.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.577 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 t -94.53 20.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.276 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.36 47.85 3.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.991 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.97 49.63 1.95 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 p -93.28 120.43 66.69 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 14.1 Cg_exo -68.99 -32.95 20.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.705 2.27 . . . . 0.0 112.583 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.77 23.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.377 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.17 55.23 6.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.082 0.468 . . . . 0.0 110.952 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.04 148.83 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.298 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.2 m -84.68 133.46 34.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 33.5 m -109.42 131.2 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.493 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.98 141.67 40.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.695 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.81 139.27 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -74.43 120.69 20.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.253 0.549 . . . . 0.0 109.643 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.884 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.154 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.7 pt-20 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.435 0.16 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.83 162.17 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.28 155.86 41.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.745 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -94.72 127.66 40.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.715 0.293 . . . . 0.0 110.347 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 13.2 m -131.64 167.23 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.903 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -102.78 140.75 36.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.49 141.94 35.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.12 115.29 29.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.779 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -85.61 142.46 29.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.22 139.91 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -75.0 113.62 12.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.436 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -118.04 137.56 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.363 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.87 115.04 20.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -88.88 134.12 29.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.75 120.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.27 -57.19 5.04 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.397 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 163.57 26.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.63 -170.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.48 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -99.73 122.53 42.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 111.014 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -121.34 162.56 20.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.083 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -100.47 138.44 37.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.5 150.56 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.339 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.58 127.02 33.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.819 0.342 . . . . 0.0 111.398 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG1' HG13 ' A' ' 39' ' ' VAL . 3.4 m -121.94 139.55 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.5 -21.93 64.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -35.16 47.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.59 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.16 -48.3 80.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.447 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.11 26.55 52.41 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.429 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -88.06 176.4 7.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.206 0.503 . . . . 0.0 111.46 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -60.44 -38.95 85.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.75 76.17 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.174 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.65 -37.18 83.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.78 -35.46 66.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.543 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 -49.27 73.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.936 0.398 . . . . 0.0 110.831 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.9 -35.79 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.9 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.854 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 11.3 t -87.45 23.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 63.53 48.08 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 2.6 mt -133.57 48.24 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m -97.49 123.03 53.8 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.934 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.28 -27.76 6.3 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.734 2.289 . . . . 0.0 112.718 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -73.31 -43.07 61.55 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.326 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 46.55 60.05 3.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.19 148.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.376 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.98 137.27 33.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.457 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.403 HG13 ' CG1' ' A' ' 17' ' ' VAL . 25.9 m -107.33 129.8 60.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 111.634 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.45 138.22 51.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.593 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.82 135.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -62.94 120.56 11.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.391 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.891 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -154.31 162.06 2.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.108 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.49 29.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.406 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -94.76 125.37 39.37 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.829 0.347 . . . . 0.0 110.316 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.16 167.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.649 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.36 136.47 42.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -106.39 139.16 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.836 0.351 . . . . 0.0 111.549 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 121.22 40.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.909 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 . . . . . 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.254 -179.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -85.92 143.39 28.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.783 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 54' ' ' VAL . 30.9 m -102.35 139.79 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.731 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -74.66 115.87 14.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.237 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.452 HG21 ' CG1' ' A' ' 59' ' ' VAL . 17.7 m -115.57 137.33 49.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.183 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.28 117.27 21.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.538 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -89.46 133.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.422 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.03 120.65 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.36 -117.13 4.59 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.081 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -120.8 159.93 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.544 0.211 . . . . 0.0 111.249 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 72.61 147.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.928 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -116.99 135.11 53.95 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -114.24 162.84 16.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.206 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -125.96 133.97 51.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.65 147.18 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.64 133.56 34.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.71 161.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.98 -38.32 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.63 -31.65 16.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.036 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -68.07 -51.54 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.89 25.73 31.23 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.158 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.09 179.18 6.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -57.46 -36.14 71.05 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.61 74.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.95 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.84 -44.42 97.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.61 -44.66 93.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.45 -50.53 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.972 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -59.1 -36.77 75.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.288 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -27.72 65.34 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.607 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -93.44 23.59 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.215 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 60.34 48.15 8.25 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.54 44.88 2.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.776 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -83.82 120.3 74.86 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.696 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.51 -31.18 3.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.765 2.31 . . . . 0.0 112.801 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -77.05 -42.81 36.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.819 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 48.41 61.98 2.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.233 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.56 146.1 29.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -85.72 119.57 26.2 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 m -88.89 134.76 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 7.4 mp -107.05 144.44 33.71 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 t -101.59 139.38 22.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.13 121.64 15.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.309 0.575 . . . . 0.0 110.344 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.42 179.719 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.63 0.252 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' HG11 ' A' ' 3' ' ' VAL . 24.6 m -109.06 163.83 6.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.485 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.41 150.35 34.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.851 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -95.33 126.11 40.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.74 167.08 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.416 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 1.6 mttt -103.43 138.4 40.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.452 ' CG1' HG21 ' A' ' 5' ' ' VAL . 2.6 m -112.77 139.3 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 111.476 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tp -108.22 119.61 39.98 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 CA--C 1.529 0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.085 179.784 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.693 0.283 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 3.2 m120 -87.0 143.4 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.04 140.16 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -75.0 115.2 14.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.58 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 59' ' ' VAL . 30.5 m -115.97 137.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.49 114.83 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.69 133.93 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.633 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.37 120.69 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.28 -117.06 3.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.162 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.74 159.83 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 111.175 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 68.61 162.32 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -126.6 135.11 50.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.605 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 m -111.9 163.42 14.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.243 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 52.3 mt-10 -124.61 137.81 54.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.419 HG21 ' CD2' ' A' ' 35' ' ' HIS . 9.3 p -125.53 143.96 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.86 131.61 34.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.839 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.77 133.3 63.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.671 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.98 -28.29 67.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.528 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.58 -33.87 61.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.276 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.55 -54.92 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 26.75 16.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 170.4 9.28 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.909 0.355 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -62.62 -38.74 91.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.416 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -38.55 74.29 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -64.73 -38.07 89.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.964 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 -42.12 82.63 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.569 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.2 t -65.55 -49.68 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.972 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -60.22 -35.81 76.28 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.14 64.28 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.644 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.93 23.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.187 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.83 46.46 2.97 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.099 0.476 . . . . 0.0 111.167 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.36 34.43 5.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 p -91.22 120.58 68.44 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.499 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.05 -31.48 9.68 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.53 2.153 . . . . 0.0 112.484 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.419 ' CD2' HG21 ' A' ' 15' ' ' VAL . 8.7 p-80 -79.38 -41.61 27.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.33 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 43.97 73.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.228 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.28 148.81 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.308 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -85.23 137.62 32.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.77 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.3 126.96 48.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.392 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.42 141.74 41.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.63 117.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' GLY . 8.3 t70 -63.73 120.49 11.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 C--N 1.335 0.527 0 O-C-N 124.597 1.185 . . . . 0.0 115.002 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.59 161.44 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 111.531 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.63 157.22 44.91 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.574 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -94.74 125.46 39.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 110.497 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.9 167.86 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.36 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 139.53 47.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.399 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' CG1' HG21 ' A' ' 5' ' ' VAL . 3.7 m -104.89 141.25 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.603 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -105.22 135.84 45.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.237 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.897 0.379 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.69 136.78 32.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.517 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -102.35 139.69 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.026 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 m -74.88 117.58 16.89 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.03 137.51 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 114.67 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.13 133.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.69 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.08 120.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.88 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.92 -114.24 3.06 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.234 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.03 158.97 26.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 111.651 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 66.73 163.6 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.923 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -126.88 134.39 50.49 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.494 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 m -110.63 162.92 14.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.79 135.0 52.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.577 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -130.04 149.23 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.875 0.369 . . . . 0.0 111.406 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.18 35.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.75 163.83 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.95 -14.85 58.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.546 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.15 -35.44 62.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.25 -44.97 20.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.33 27.02 34.36 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.618 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.78 175.68 7.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -57.15 -32.9 66.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.544 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.22 74.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.14 -40.92 97.2 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -39.95 75.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.42 -51.01 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -35.9 77.87 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.092 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -30.0 67.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.534 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.7 23.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.53 48.5 9.62 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.68 42.54 3.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 t -99.24 132.23 23.76 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.61 -32.89 4.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.535 2.157 . . . . 0.0 112.59 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -80.21 -42.75 22.72 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 46.89 61.67 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.455 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.04 146.0 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.212 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 134.97 33.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.046 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.2 m -91.28 135.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.0 152.57 20.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.51 119.92 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.612 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.18 120.03 7.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 CA-C-N 114.801 -1.091 . . . . 0.0 114.76 -179.624 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.457 0.17 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.21 161.91 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -146.09 156.97 43.82 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -95.32 126.33 40.56 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.492 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -134.42 167.52 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.22 135.94 42.92 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.14 140.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 111.523 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.35 119.41 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.843 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.757 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -85.01 145.75 27.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 t -127.96 139.66 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.62 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.95 113.51 12.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.964 0.411 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.93 137.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.385 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -81.87 115.01 20.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 133.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.41 120.78 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.719 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.41 -56.98 5.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.443 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.58 163.64 26.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.618 0.246 . . . . 0.0 110.95 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -58.77 -174.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.407 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -99.63 131.69 45.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.151 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.22 162.06 34.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -94.79 139.35 31.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.693 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.58 148.27 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.39 129.05 34.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.76 150.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.814 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.6 p30 -70.79 -20.67 62.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.044 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.2 -41.35 62.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.786 0.327 . . . . 0.0 111.015 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -54.78 -45.49 74.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.51 26.51 46.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.996 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.48 170.53 9.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 111.465 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.76 75.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.18 67.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.058 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.5 m-20 -68.5 -42.64 78.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -43.52 98.7 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.94 -39.87 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.258 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -66.9 -35.94 81.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.985 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.56 -25.03 23.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.0 t -89.31 23.35 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.706 0.289 . . . . 0.0 111.392 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 62.84 48.28 4.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 32.57 5.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.93 140.61 25.02 Favored Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.064 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 -32.86 7.22 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.66 -42.75 27.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.132 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.79 72.19 0.34 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 111.024 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.74 146.85 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.343 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 137.85 35.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.746 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.84 131.7 34.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.12 147.46 37.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.223 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.37 117.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.404 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.04 120.09 6.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.335 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 O-C-N 124.447 1.092 . . . . 0.0 115.048 -179.858 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.39 162.31 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.047 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -149.07 154.45 39.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -94.95 125.2 39.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 110.046 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.86 167.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.265 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.11 140.92 40.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.517 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -101.27 140.88 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 125.81 54.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.689 0.28 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.52 148.96 22.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.466 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.43 139.91 22.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.844 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -74.88 113.34 12.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.11 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.7 135.69 57.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.228 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 114.89 23.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.6 t -83.74 130.96 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.38 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.62 120.43 16.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.19 -57.41 4.77 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.161 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 163.53 26.07 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.683 0.278 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.55 -177.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -99.65 134.25 42.8 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.959 0.409 . . . . 0.0 111.07 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 m -137.19 160.45 38.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.228 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.34 137.39 32.41 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.77 145.69 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.48 125.83 32.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -119.76 161.42 19.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.672 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.94 -36.94 64.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.052 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -31.37 65.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.48 -48.05 72.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.85 26.06 63.37 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.606 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 178.89 4.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.015 0.408 . . . . 0.0 111.03 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -59.09 -34.63 72.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -36.1 72.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.78 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -59.25 -38.7 80.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.21 -45.22 91.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.686 0.279 . . . . 0.0 110.779 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.05 -47.73 59.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.97 81.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.673 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.12 53.51 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 t -90.57 23.48 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.988 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.29 48.36 10.31 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.009 0.433 . . . . 0.0 111.042 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.12 45.24 2.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.71 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -84.65 129.11 58.36 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -33.09 10.61 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.95 -40.97 26.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.189 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.27 59.14 2.78 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.44 146.01 33.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 m -86.13 123.3 31.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 32.6 m -91.52 127.65 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.38 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -116.76 133.28 56.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.48 117.79 47.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' GLY . 13.4 t70 -56.23 120.66 7.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.902 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 C--N 1.339 0.746 0 O-C-N 124.843 1.34 . . . . 0.0 115.679 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.519 0.2 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.51 162.29 30.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.707 0.289 . . . . 0.0 111.34 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.94 154.69 39.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -95.56 129.93 42.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 4.2 m -135.23 167.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.261 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.37 138.2 50.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.477 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 m -103.1 138.4 27.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.46 117.17 33.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.176 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.066 179.86 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.457 0.17 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -86.16 148.96 25.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -102.19 139.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.466 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.13 113.57 11.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.286 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.45 ' CG2' HG13 ' A' ' 59' ' ' VAL . 2.1 p -114.39 135.12 55.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.268 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.5 114.94 22.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.7 t -85.93 133.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -77.33 120.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -23.68 11.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.111 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.64 164.11 15.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.573 0.349 . . . . 0.0 110.826 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.91 -173.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.39 129.34 45.58 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -126.29 163.09 23.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.22 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.9 137.67 42.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.89 146.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.38 31.01 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.228 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.53 157.89 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -80.59 -18.23 48.93 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -41.02 73.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.556 0.217 . . . . 0.0 111.315 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -51.64 -35.94 44.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.792 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.31 26.07 69.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.588 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -93.34 166.75 12.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.215 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -34.58 74.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.44 70.22 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.278 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.9 m-20 -58.98 -38.12 78.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.993 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -34.25 70.74 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.622 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -70.45 -51.57 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 25' ' ' ASP . 1.4 ptm180 -65.18 -35.43 81.05 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.171 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -25.32 39.97 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 t -87.48 23.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.615 0.245 . . . . 0.0 111.156 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 65.47 47.5 2.26 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.18 37.18 4.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.728 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -77.61 124.71 86.58 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.77 -32.78 2.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.697 2.265 . . . . 0.0 112.913 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -42.9 32.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.2 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.02 72.1 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.216 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.68 157.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.413 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 m -84.76 116.92 23.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.554 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -94.3 137.07 23.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 6.7 mt -81.99 157.81 24.09 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.45 139.68 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.58 130.33 13.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.718 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 -179.431 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.08 171.57 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.355 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -146.22 157.39 43.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.214 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 133.99 38.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.602 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.47 167.38 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 23.0 mmtp -115.75 133.47 56.0 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.45 HG13 ' CG2' ' A' ' 5' ' ' VAL . 19.0 m -100.76 131.69 47.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.902 0.382 . . . . 0.0 111.307 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 111.24 23.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.647 0.26 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -84.9 146.61 27.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 111.002 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.24 140.02 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.907 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.81 113.41 12.06 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.104 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.59 136.19 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.246 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -81.51 114.72 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -90.15 130.48 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.2 120.68 23.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.717 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.52 -51.37 3.0 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.395 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 163.39 14.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.658 0.266 . . . . 0.0 111.037 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.44 -177.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -99.62 127.02 45.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.193 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -131.12 162.64 29.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.267 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -92.89 137.77 32.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -129.87 150.47 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.202 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.49 126.85 33.65 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 m -116.51 160.7 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.765 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -84.71 -31.86 23.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.307 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.51 -31.63 24.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.078 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -40.99 61.66 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.515 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.52 26.16 70.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -95.06 179.09 5.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 111.155 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.13 -32.88 66.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.238 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.6 67.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.366 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -58.48 -43.92 89.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.556 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -45.02 85.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.27 -45.65 78.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -35.88 73.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.028 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.73 34.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.26 23.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.675 0.274 . . . . 0.0 111.464 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 64.62 48.2 2.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.056 0.455 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.22 48.9 1.41 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.5 t -99.01 120.37 58.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.54 -33.02 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.571 2.181 . . . . 0.0 113.224 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -79.89 -42.66 23.7 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.264 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 50.42 66.37 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.076 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -123.81 151.31 28.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 121.33 33.85 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.92 132.47 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 4.3 mm? -102.17 134.93 44.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 130.65 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -63.58 119.77 10.47 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.573 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.88 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.408 0.147 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.0 161.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.387 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -147.92 154.11 39.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -94.93 125.94 39.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.203 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.18 167.37 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.62 141.1 36.0 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -112.49 131.83 62.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 111.318 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.06 122.38 44.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.602 0.239 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -92.67 146.98 23.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.76 139.57 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.931 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.21 113.42 12.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.4 HG11 HG23 ' A' ' 15' ' ' VAL . 17.4 m -118.44 137.22 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -81.8 114.81 20.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 59' ' ' VAL . 5.5 t -86.86 133.23 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.72 120.66 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.638 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.82 -57.58 5.05 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.418 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.53 163.78 25.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -58.22 -175.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.249 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -99.64 130.44 45.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.928 0.394 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -127.48 162.72 25.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.55 130.89 42.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 5' ' ' VAL . 26.8 m -129.77 144.3 38.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.25 126.61 33.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.041 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.11 161.98 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.135 0.493 . . . . 0.0 112.254 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.72 -41.94 78.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.335 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.69 -41.57 56.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.962 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -47.19 -40.94 17.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.387 0.429 . . . . 0.0 111.582 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.94 26.38 69.14 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.931 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.55 178.47 4.85 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.87 0.367 . . . . 0.0 111.111 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -32.75 66.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.219 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.82 70.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.17 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.42 -44.03 95.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.869 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.68 -46.43 89.08 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.69 0.281 . . . . 0.0 110.8 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.5 t -67.53 -44.88 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.52 -36.15 81.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.23 -26.87 42.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.84 23.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.562 0.22 . . . . 0.0 111.331 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.3 42.0 9.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.059 0.457 . . . . 0.0 110.964 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mt -121.1 39.43 3.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.529 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.08 120.67 72.65 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.22 -33.15 7.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.505 2.136 . . . . 0.0 112.494 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -79.89 -42.07 24.92 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 51.67 70.26 0.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.68 147.29 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.414 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.18 136.97 32.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.796 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 m -93.34 133.96 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.399 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.83 148.01 31.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 t -106.65 117.72 52.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.01 120.18 11.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.149 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.684 0 O-C-N 124.411 1.069 . . . . 0.0 114.786 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 . . . . . 0 N--CA 1.464 0.246 0 CA-C-O 120.435 0.159 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.65 161.66 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 110.546 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.3 145.72 28.28 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -95.0 125.24 39.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.288 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.1 m -136.21 167.17 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -102.24 141.67 34.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' CG2' HG23 ' A' ' 7' ' ' VAL . 4.4 m -106.07 137.61 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.838 0.352 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.75 128.49 56.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.174 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.353 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.86 0.362 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -89.3 142.16 27.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.31 140.0 21.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -74.67 113.2 11.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 110.485 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.87 137.6 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.378 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.15 114.95 21.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.66 133.98 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.419 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.22 120.62 4.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.6 -49.44 3.15 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.55 163.3 26.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.626 0.251 . . . . 0.0 110.972 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.41 -100.0 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -127.96 135.06 49.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 111.349 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 t -132.07 162.89 29.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.245 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -123.47 138.54 54.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.98 147.88 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 125.79 32.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.148 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.17 161.05 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.47 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.6 -26.98 37.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.725 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.54 -34.87 67.46 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.599 0.238 . . . . 0.0 110.929 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -61.09 2.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.18 57.11 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.709 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.73 178.91 5.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 111.141 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -57.17 -38.93 74.32 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.15 82.76 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.932 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -60.38 -37.51 80.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -41.73 78.52 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.809 0.338 . . . . 0.0 110.555 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.96 -50.71 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -59.34 -36.16 75.18 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.213 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.31 36.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.99 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.14 23.46 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.702 0.287 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.61 47.32 4.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.134 0.492 . . . . 0.0 111.454 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 33.16 4.99 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.8 120.27 68.81 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.863 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.82 -32.47 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.951 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.93 -41.12 75.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.97 69.37 0.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.036 0.446 . . . . 0.0 111.176 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 m -124.02 145.8 30.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.8 m -96.77 119.43 35.22 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.831 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.2 m -84.18 131.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.1 mt -105.51 147.64 28.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 t -102.15 136.68 33.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.864 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.85 120.83 14.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.65 0.262 . . . . 0.0 110.333 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 CA-C-N 115.191 -0.913 . . . . 0.0 114.625 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.516 0.198 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.41 162.22 11.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.797 0.332 . . . . 0.0 111.214 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -147.97 152.3 37.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -97.13 125.12 41.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.41 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.26 167.13 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -110.64 128.71 55.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.86 141.62 17.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.975 0.417 . . . . 0.0 111.337 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tt -97.64 128.53 44.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.959 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.507 0.194 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -91.59 148.78 22.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.76 0.315 . . . . 0.0 110.648 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 17' ' ' VAL . 20.4 m -102.15 139.96 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.727 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -74.48 114.3 12.72 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.431 HG23 ' CG1' ' A' ' 59' ' ' VAL . 30.3 m -116.48 137.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.303 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 114.76 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.22 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.96 120.26 3.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.475 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.38 -118.14 4.19 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.246 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -120.73 159.04 26.19 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 70.19 155.19 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.05 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.1 m -116.23 134.9 54.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.393 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 t -108.51 161.98 14.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.298 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.01 131.93 52.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.92 144.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.778 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.19 134.97 34.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.241 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 3' ' ' VAL . 15.7 m -121.58 159.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 111.88 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.85 -33.78 45.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.299 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -56.73 -35.82 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -55.18 -48.54 73.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.779 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.21 42.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.15 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 179.17 5.55 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -57.31 -32.65 66.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.181 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.76 74.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.06 -44.4 91.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.559 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -41.1 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.12 -50.08 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -60.39 -36.05 77.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.359 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.596 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -95.58 23.15 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.717 0.294 . . . . 0.0 111.221 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 59.27 46.94 12.14 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.47 46.02 2.31 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.64 120.46 72.96 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-O 120.598 0.237 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.674 2.25 . . . . 0.0 113.008 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.75 23.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 111.175 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.24 61.97 2.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.089 0.471 . . . . 0.0 111.173 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.51 146.08 29.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 m -85.49 132.21 34.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.71 131.42 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.61 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 3.9 mm? -107.29 147.71 29.9 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.19 117.79 52.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.86 120.12 11.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.419 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 CA-C-N 114.827 -1.078 . . . . 0.0 115.153 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 120.424 0.154 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.96 161.63 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 111.498 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 152.63 40.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -95.63 125.23 40.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.525 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.69 167.09 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 6.2 mmtt -107.65 140.11 41.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' CG1' HG23 ' A' ' 5' ' ' VAL . 3.9 m -102.2 136.12 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.315 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.2 112.41 23.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.604 0.24 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -89.81 144.21 26.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.98 139.91 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.521 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -74.7 113.49 12.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.98 135.55 53.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.398 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.71 114.65 20.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.27 133.9 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.393 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.03 120.45 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.91 -45.09 2.32 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.53 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.41 164.01 12.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.458 0.303 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.31 -176.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -99.25 132.5 44.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -134.69 163.01 30.73 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -94.91 138.12 33.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.217 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.33 147.61 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 127.85 34.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.65 160.6 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -76.05 -34.52 59.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.897 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -52.77 -35.56 56.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.794 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.29 -51.18 70.42 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.85 26.19 46.49 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.799 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -88.28 162.25 16.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.378 . . . . 0.0 111.265 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -57.57 -35.62 70.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.056 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.76 73.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.246 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.39 -37.31 77.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.373 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.23 -40.01 73.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.794 0.331 . . . . 0.0 110.577 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.07 -48.05 57.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.841 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -61.89 -35.7 79.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.27 -25.14 32.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 t -88.8 23.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.6 0.238 . . . . 0.0 111.218 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 64.34 47.5 3.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.58 34.9 5.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 4.1 p -94.68 120.51 64.72 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 23.7 Cg_exo -64.04 -32.78 64.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.678 2.252 . . . . 0.0 112.56 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -43.04 23.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.341 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 48.53 67.2 0.89 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.069 0.462 . . . . 0.0 111.04 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.39 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 m -91.37 135.66 33.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.3 130.05 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 149.1 33.29 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -116.4 119.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.623 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' GLY . 17.8 t0 -52.47 120.59 5.77 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.53 0 O-C-N 124.481 1.113 . . . . 0.0 114.904 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.541 0.21 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.09 165.99 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.952 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.99 154.9 42.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -94.64 125.45 39.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 110.539 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -134.53 167.78 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.952 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 42' ' ' ASP . 6.7 ptpp? -109.72 139.9 44.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -106.1 141.66 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 111.443 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.62 118.48 36.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.785 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.3 p30 -89.41 147.9 23.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.896 0.379 . . . . 0.0 110.613 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.35 139.95 22.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.43 113.42 11.64 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 m -118.4 135.43 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.694 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.98 115.02 22.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.569 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.69 134.14 27.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.53 120.62 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.555 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.3 -55.55 5.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.431 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 163.93 25.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.358 0.263 . . . . 0.0 110.989 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -167.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.473 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -99.34 128.04 45.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.936 0.398 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -126.65 162.82 24.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.063 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 2' ' ' ASN . 6.6 mp0 -105.69 145.26 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.97 147.06 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 123.64 30.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 111.065 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 t -121.97 152.25 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.718 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.75 -44.77 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.301 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -28.67 46.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.118 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 18.1 t70 -50.53 -29.53 10.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.7 25.95 61.75 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.732 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -107.49 179.05 4.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.887 0.375 . . . . 0.0 111.294 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.34 -32.35 66.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.074 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.78 -35.67 66.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.946 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.76 -44.71 90.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.511 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.975 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 t -70.53 -47.25 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.2 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.42 63.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.648 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t -92.61 20.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.602 0.239 . . . . 0.0 111.275 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.76 45.12 2.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.2 88.57 2.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -115.81 120.5 35.66 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.96 -33.13 2.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.659 2.239 . . . . 0.0 112.8 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -79.54 -42.28 25.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.198 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.98 57.5 6.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.62 152.17 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -84.75 134.17 34.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.88 132.18 53.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.918 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 14.2 mt -101.55 151.52 21.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.25 139.35 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -47.61 124.0 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.74 0 O-C-N 124.204 0.94 . . . . 0.0 114.547 -178.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 1.5 pt-20 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.687 0.279 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.13 161.36 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.419 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.43 146.1 27.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -95.42 125.08 39.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.221 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.63 167.16 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.619 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.1 mttt -104.22 140.24 38.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.57 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.01 140.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.727 0.299 . . . . 0.0 111.329 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.51 131.05 54.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.946 0.403 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 18.6 m120 -89.12 138.16 31.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.496 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -102.53 140.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 113.5 12.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.215 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.74 137.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.489 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.96 114.8 21.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.741 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -88.32 134.36 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.977 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.22 120.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.482 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.93 -33.01 5.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.784 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.01 163.95 14.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.416 0.286 . . . . 0.0 110.757 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -169.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.44 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -99.68 132.87 44.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.057 0.455 . . . . 0.0 111.236 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m -132.73 160.16 37.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HB3' ' CB ' ' A' ' 2' ' ' ASN . 3.1 mp0 -89.2 132.83 34.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.22 145.95 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.304 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.21 125.94 32.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 111.361 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.0 137.76 51.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.941 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -27.59 47.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.681 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -40.81 63.31 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.949 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.24 -45.94 45.3 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.368 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.26 71.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.621 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.42 174.18 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -57.44 -38.51 74.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.205 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.1 78.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.407 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -59.35 -37.02 76.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.46 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.2 -42.71 77.6 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.28 -44.57 72.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -59.57 -36.03 75.43 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.289 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.31 -25.07 58.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.918 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.47 23.37 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.618 0.247 . . . . 0.0 111.255 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.93 48.23 2.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.101 0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.22 37.48 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -92.9 120.74 66.94 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.703 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 16.0 Cg_exo -67.68 -33.16 28.73 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.8 2.333 . . . . 0.0 112.54 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -79.57 -42.92 23.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 51.38 65.29 1.53 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.48 145.99 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.518 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 m -88.03 136.6 32.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.648 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 34.0 m -98.82 134.64 36.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.44 140.36 48.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.77 137.56 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -66.61 120.16 12.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.346 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 CA-C-N 115.126 -0.943 . . . . 0.0 114.528 -179.865 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.409 0.147 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 m -130.89 161.85 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.298 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.27 156.67 42.47 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -95.12 124.63 39.27 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 16.0 m -134.92 167.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.16 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.88 130.78 55.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.572 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 m -103.3 141.74 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.06 127.52 53.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.021 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.751 0.31 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.55 146.01 24.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.071 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.6 t -120.83 139.79 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.675 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -75.01 114.94 14.08 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.411 HG21 ' CG1' ' A' ' 59' ' ' VAL . 10.0 m -118.15 137.66 51.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.264 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.33 114.79 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.565 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.46 134.14 32.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.03 120.35 3.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.87 -118.36 3.43 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.183 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -120.93 152.88 37.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.55 165.09 0.22 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.123 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -117.99 135.43 54.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.679 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.15 159.98 15.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.394 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.73 127.27 45.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.222 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.18 149.26 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 127.05 34.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.356 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -116.98 148.77 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -23.38 67.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.758 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -54.24 -37.94 65.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.785 0.326 . . . . 0.0 110.808 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.97 -43.83 86.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.255 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.36 26.32 40.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.226 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 163.98 12.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.959 0.379 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -60.08 -38.4 82.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.365 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.46 71.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.259 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.09 -41.86 98.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.17 77.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.28 -44.33 94.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.664 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -35.89 82.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.89 -25.08 41.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.698 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 12.6 t -88.71 23.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.5 48.34 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 111.135 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.415 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 1.4 mt -130.65 44.81 2.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -99.18 136.53 20.47 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 -33.18 6.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.466 2.111 . . . . 0.0 112.529 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -42.35 23.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.203 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 54.59 59.35 4.18 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.4 146.32 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.268 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -90.49 138.48 31.52 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 34.5 m -96.59 132.0 42.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 140.21 45.34 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.67 135.49 38.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.96 120.46 13.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 110.231 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.612 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.57 -179.815 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.596 0.236 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.9 161.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.741 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -148.17 151.21 35.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.716 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -95.21 125.48 39.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.948 0.404 . . . . 0.0 110.663 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 15.5 m -132.25 167.35 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.17 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -108.49 136.7 47.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.679 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' CG1' HG21 ' A' ' 5' ' ' VAL . 15.0 m -102.18 140.81 19.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.311 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.31 132.2 56.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 . . . . . 0 CA--C 1.532 0.262 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.998 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -85.26 133.16 34.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.725 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.08 140.45 21.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.922 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -74.73 113.19 11.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.313 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.75 138.05 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.249 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.76 115.0 20.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.406 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.24 133.94 40.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.06 120.77 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.2 -55.82 0.69 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.468 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 163.39 22.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.587 0.232 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.66 -82.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.99 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -127.95 135.01 49.36 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.037 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 p -120.62 147.91 44.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.73 128.97 55.83 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.35 145.86 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.416 ' CB ' ' HG3' ' A' ' 28' ' ' ARG . . . -84.19 138.28 33.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.64 160.09 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.265 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 5.5 t70 -99.05 -22.84 15.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.004 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -24.99 65.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -62.2 -60.55 3.43 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.42 35.74 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.859 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -89.97 178.61 6.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.912 0.356 . . . . 0.0 111.312 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -40.14 83.58 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.56 81.54 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.621 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 21.0 t0 -59.86 -37.92 80.67 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.61 -40.56 72.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.54 0.209 . . . . 0.0 110.687 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 t -71.26 -50.68 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HG3' ' CB ' ' A' ' 16' ' ' ALA . 8.3 mmt85 -63.06 -35.67 81.01 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.557 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.1 26.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 t -85.74 22.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.592 0.234 . . . . 0.0 111.441 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.35 47.98 2.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 110.983 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -116.09 38.05 3.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.959 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.15 121.52 71.42 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 120.727 0.298 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.34 -29.52 9.35 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 113.06 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -77.71 -42.62 33.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.097 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.09 70.49 0.4 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 111.402 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.45 155.61 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.489 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 t -85.32 138.32 32.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 28.7 m -110.36 129.73 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.456 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.8 139.99 45.61 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.72 135.11 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -47.75 122.06 4.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 O-C-N 124.414 1.071 . . . . 0.0 115.014 -178.532 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.6 0.238 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 161.84 22.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.786 0.327 . . . . 0.0 111.186 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.3 157.08 43.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -94.35 125.09 38.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.051 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 13.9 m -133.63 167.49 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.681 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 141.35 35.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -116.54 141.32 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.794 0.33 . . . . 0.0 111.346 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mt -114.65 129.08 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.674 0.273 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -85.02 135.62 33.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.34 140.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.562 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.47 118.65 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.511 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG23 ' CG1' ' A' ' 59' ' ' VAL . 18.0 m -117.2 137.45 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.068 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.41 114.66 20.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -87.75 134.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.64 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 t -57.31 120.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.89 -117.59 4.33 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.04 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -120.7 159.86 24.48 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.604 0.24 . . . . 0.0 111.251 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 69.49 145.71 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.016 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 135.03 54.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.408 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -118.58 163.35 16.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.7 144.12 44.39 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.032 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' CD2' ' A' ' 35' ' ' HIS . 11.8 p -120.13 139.63 46.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.65 130.24 34.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.868 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.54 160.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.901 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.42 -21.36 15.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.895 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -34.91 50.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.514 0.197 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -68.56 -51.63 40.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.61 26.02 18.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.468 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.95 178.72 6.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.05 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.41 -32.82 67.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.467 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.76 70.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.651 0.262 . . . . 0.0 110.92 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.72 -40.53 95.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.753 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -37.42 69.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.861 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.69 -51.2 48.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.979 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -36.27 79.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -28.44 61.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.71 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -93.55 21.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.672 0.272 . . . . 0.0 111.203 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 62.77 46.82 4.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.06 50.95 2.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.6 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.51 119.69 67.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.31 -27.35 2.87 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.388 . . . . 0.0 112.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.446 ' CD2' HG23 ' A' ' 15' ' ' VAL . 10.4 p-80 -65.04 -43.39 92.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.96 45.52 8.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.985 0.421 . . . . 0.0 111.575 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 35' ' ' HIS . 18.6 m -126.88 160.52 35.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.91 122.99 44.44 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.0 135.17 25.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.96 145.27 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -101.68 126.07 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.17 120.0 12.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.771 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.947 179.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.47 0.176 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.24 162.18 39.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.59 154.81 40.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -94.83 125.26 39.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -133.62 167.88 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.582 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.18 136.48 41.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.082 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.465 ' CG1' HG23 ' A' ' 5' ' ' VAL . 2.3 m -108.41 140.24 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.855 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -99.35 131.77 45.14 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.389 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 -179.589 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.743 0.306 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -93.1 147.3 22.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.026 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.12 139.6 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.844 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m -74.88 113.59 12.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.03 136.29 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.443 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -81.65 114.7 20.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -89.03 133.29 31.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.65 120.4 33.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.546 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.09 -24.92 13.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.973 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.7 163.97 15.68 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 110.796 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -169.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.795 0.331 . . . . 0.0 111.709 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 131.2 45.38 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.35 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -133.1 162.99 30.26 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.043 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.16 140.23 39.45 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.49 146.96 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 125.83 32.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.999 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 m -116.32 161.63 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.909 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.3 -33.86 59.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -39.2 58.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.863 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.01 -47.33 33.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.802 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.97 26.5 70.92 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.191 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.48 174.49 6.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.952 0.376 . . . . 0.0 111.143 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.86 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.313 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.42 -36.03 70.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.183 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 27.9 t0 -58.95 -39.33 81.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.892 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -35.66 81.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.693 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.56 -51.34 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.067 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -63.28 -35.43 80.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.044 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.68 -25.05 37.75 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 2.5 t -85.72 23.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.93 48.28 2.39 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.247 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.508 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 2.1 mt -132.32 52.78 2.05 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.3 130.4 22.9 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.739 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.36 -32.93 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.615 2.21 . . . . 0.0 113.23 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.8 -43.0 23.24 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 48.37 67.45 0.85 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.345 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.06 149.59 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.502 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -85.2 138.66 32.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.31 131.62 46.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.296 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.9 151.26 23.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.9 t -118.25 139.27 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.814 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -47.55 124.45 7.03 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.775 0 O-C-N 124.083 0.864 . . . . 0.0 114.356 -178.626 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.534 0.207 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.43 161.86 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 149.97 34.54 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.853 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 129.77 42.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.345 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.23 167.15 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.394 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -105.39 136.29 45.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.487 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.82 136.52 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.3 113.01 25.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.267 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.651 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 tpp . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.813 0.34 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.32 149.36 23.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.82 140.01 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.51 113.54 11.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG22 ' CG1' ' A' ' 59' ' ' VAL . 27.6 m -117.43 137.27 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.672 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.46 115.24 21.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 t -90.01 134.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.56 120.38 30.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.15 17.91 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.042 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.64 163.71 16.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.771 0.285 . . . . 0.0 110.825 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -168.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.467 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -99.69 122.84 43.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.046 0.45 . . . . 0.0 111.195 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m -123.24 162.94 21.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.265 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.79 139.57 40.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.29 143.66 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.33 128.64 34.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.18 161.11 15.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.92 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.73 -34.33 21.25 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -31.02 64.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.223 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.02 -46.83 71.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.83 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.7 26.06 54.83 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.74 179.09 5.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -58.11 -34.22 69.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.171 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.7 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.091 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.97 -42.72 90.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.78 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -46.47 87.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.771 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.99 -50.44 79.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -58.89 -37.37 76.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.18 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.54 -27.46 49.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.834 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 t -94.26 23.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.289 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.05 48.35 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.09 0.471 . . . . 0.0 111.033 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.9 52.33 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.581 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . 52.6 p -90.2 120.48 69.16 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.64 -32.97 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.627 2.218 . . . . 0.0 112.916 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -39.68 31.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.402 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 39.52 62.1 1.25 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.869 0.468 . . . . 0.0 111.883 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.77 153.72 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.68 137.17 33.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.34 134.87 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.33 147.21 26.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.663 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 2.0 t -101.72 117.81 47.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.87 120.25 12.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.301 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 32.79 36.54 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.009 -0.996 . . . . 0.0 114.739 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.464 ' HB2' ' CG1' ' A' ' 41' ' ' VAL . 16.6 mtt85 -132.61 120.51 16.74 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 117.151 0.475 . . . . 0.0 111.531 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.32 -40.18 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 112.771 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.04 103.59 11.77 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-O 120.794 0.33 . . . . 0.0 111.306 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.55 -17.64 42.65 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.956 2.437 . . . . 0.0 112.685 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.35 -21.28 59.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.386 0.274 . . . . 0.0 111.48 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.47 -13.69 60.09 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.49 0.186 . . . . 0.0 111.247 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -107.5 166.54 10.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.1 t -146.95 92.9 2.19 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 t -145.73 141.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.45 -46.08 76.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.082 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.16 161.86 26.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -149.22 153.97 38.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -95.38 124.96 39.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.875 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.83 166.63 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -104.46 136.03 44.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.54 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 5' ' ' VAL . 3.2 m -106.69 141.23 22.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.842 0.354 . . . . 0.0 111.426 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 119.04 38.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -35.37 79.03 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 tp -149.28 110.97 4.52 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.76 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.7 pp -67.72 156.9 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.537 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.01 -43.54 13.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.81 -49.77 0.2 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.651 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.555 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.69 0.281 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -84.91 146.71 27.13 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.1 p -117.37 140.13 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.709 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -74.6 113.24 11.62 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.1 m -118.7 136.43 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.36 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.49 114.85 20.49 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.447 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.67 133.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.805 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.86 120.61 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.89 -57.42 5.01 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.449 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.76 163.51 26.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.37 -172.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.521 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.5 m -99.52 121.05 40.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.951 0.405 . . . . 0.0 111.035 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.5 t -120.96 161.71 21.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.55 140.83 33.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -128.24 150.75 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 124.67 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.93 164.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.707 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -88.53 -29.54 19.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.55 -37.61 63.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 32.5 p30 -50.72 -30.39 13.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.54 25.62 75.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.983 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -103.07 179.14 4.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -57.02 -32.8 66.52 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.33 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.46 -36.96 69.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.207 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.74 -44.75 93.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.632 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -36.29 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.049 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 t -70.88 -51.08 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.888 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -35.89 76.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.185 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.2 65.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.577 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.8 t -94.53 20.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.276 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.36 47.85 3.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.991 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.97 49.63 1.95 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 p -93.28 120.43 66.69 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 14.1 Cg_exo -68.99 -32.95 20.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.705 2.27 . . . . 0.0 112.583 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.77 23.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.377 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.17 55.23 6.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.082 0.468 . . . . 0.0 110.952 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.04 148.83 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.298 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.2 m -84.68 133.46 34.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 33.5 m -109.42 131.2 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.493 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.98 141.67 40.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.695 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.81 139.27 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -74.43 120.69 20.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.253 0.549 . . . . 0.0 109.643 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.94 -54.54 0.56 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.154 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.17 163.6 36.98 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.634 0.254 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.34 -49.93 4.09 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.657 2.238 . . . . 0.0 112.589 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.92 152.61 74.39 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.923 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -60.94 95.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.863 2.375 . . . . 0.0 112.239 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.06 -35.35 78.07 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.5 -18.23 13.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.711 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 59.61 54.27 4.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -63.8 131.44 47.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.145 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t 69.22 153.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.111 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.7 pt-20 -58.83 -48.43 81.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.86 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.5 m -117.83 162.17 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -148.28 155.86 41.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.745 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -94.72 127.66 40.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.715 0.293 . . . . 0.0 110.347 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 13.2 m -131.64 167.23 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.903 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -102.78 140.75 36.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.49 141.94 35.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.12 115.29 29.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -45.14 68.62 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tp -175.99 98.99 0.07 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.622 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.2 tp -95.31 141.98 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.305 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -166.69 35.16 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.83 123.28 0.12 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.655 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.674 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.779 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -85.61 142.46 29.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.22 139.91 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.83 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -75.0 113.62 12.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.436 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.7 m -118.04 137.56 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.363 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.87 115.04 20.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 t -88.88 134.12 29.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.75 120.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.27 -57.19 5.04 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.397 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 163.57 26.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.63 -170.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.48 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -99.73 122.53 42.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 111.014 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -121.34 162.56 20.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.083 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -100.47 138.44 37.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.5 150.56 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.339 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.58 127.02 33.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.819 0.342 . . . . 0.0 111.398 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.403 ' CG1' HG13 ' A' ' 39' ' ' VAL . 3.4 m -121.94 139.55 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.5 -21.93 64.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -35.16 47.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.59 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.16 -48.3 80.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.447 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.11 26.55 52.41 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.429 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -88.06 176.4 7.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.206 0.503 . . . . 0.0 111.46 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -60.44 -38.95 85.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.75 76.17 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.174 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.65 -37.18 83.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.78 -35.46 66.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.543 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 -49.27 73.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.936 0.398 . . . . 0.0 110.831 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.9 -35.79 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.9 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.854 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 11.3 t -87.45 23.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 63.53 48.08 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.416 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 2.6 mt -133.57 48.24 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m -97.49 123.03 53.8 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.934 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.28 -27.76 6.3 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.734 2.289 . . . . 0.0 112.718 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -73.31 -43.07 61.55 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.326 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 46.55 60.05 3.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.0 m -124.19 148.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.376 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.98 137.27 33.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.457 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.403 HG13 ' CG1' ' A' ' 17' ' ' VAL . 25.9 m -107.33 129.8 60.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 111.634 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.45 138.22 51.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.593 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 44' ' ' ARG . 4.6 t -101.82 135.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -62.94 120.56 11.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.391 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 27.98 42.39 0.02 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.891 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.444 ' HB2' ' CG1' ' A' ' 41' ' ' VAL . 18.2 mmt85 -132.37 128.6 21.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 117.195 0.497 . . . . 0.0 111.375 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.41 -42.71 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.648 2.232 . . . . 0.0 113.077 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.74 96.66 25.99 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.716 0.293 . . . . 0.0 111.197 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.95 -18.11 17.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.752 2.302 . . . . 0.0 112.806 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.86 -23.18 64.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.626 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -86.5 18.9 3.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -104.03 158.23 16.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.901 0.381 . . . . 0.0 110.981 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 t -74.73 177.72 5.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.674 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.4 t 71.81 154.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.763 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.83 21.83 4.6 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.521 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -154.31 162.06 2.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.108 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.48 147.49 29.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.406 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -94.76 125.37 39.37 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.829 0.347 . . . . 0.0 110.316 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.9 m -130.16 167.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.649 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.36 136.47 42.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -106.39 139.16 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.836 0.351 . . . . 0.0 111.549 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 121.22 40.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.909 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -133.94 -61.48 0.79 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mp -96.26 113.52 25.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.105 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 19.3 tt -79.57 150.65 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 3.6 mtmp? 70.19 151.95 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.372 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.79 66.51 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.469 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.302 -1.277 . . . . 0.0 112.549 -179.773 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -85.92 143.39 28.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.783 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.43 HG11 ' HB ' ' A' ' 54' ' ' VAL . 30.9 m -102.35 139.79 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.731 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -74.66 115.87 14.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.237 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG21 ' CG1' ' A' ' 59' ' ' VAL . 17.7 m -115.57 137.33 49.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.183 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.28 117.27 21.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.538 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.1 t -89.46 133.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.422 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.03 120.65 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.36 -117.13 4.59 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.081 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -120.8 159.93 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.544 0.211 . . . . 0.0 111.249 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 72.61 147.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.928 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -116.99 135.11 53.95 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.8 m -114.24 162.84 16.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.206 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -125.96 133.97 51.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.65 147.18 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.64 133.56 34.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.71 161.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.98 -38.32 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.63 -31.65 16.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.036 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -68.07 -51.54 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.89 25.73 31.23 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.158 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.09 179.18 6.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -57.46 -36.14 71.05 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.61 74.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.95 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.84 -44.42 97.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.61 -44.66 93.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.45 -50.53 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.972 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -59.1 -36.77 75.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.288 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -27.72 65.34 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.607 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 t -93.44 23.59 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.215 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 60.34 48.15 8.25 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.54 44.88 2.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.776 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -83.82 120.3 74.86 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.696 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.51 -31.18 3.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.765 2.31 . . . . 0.0 112.801 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -77.05 -42.81 36.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.819 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 48.41 61.98 2.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.233 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.56 146.1 29.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -85.72 119.57 26.2 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.6 m -88.89 134.76 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 7.4 mp -107.05 144.44 33.71 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 45' ' ' PRO . 13.7 t -101.59 139.38 22.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.13 121.64 15.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.309 0.575 . . . . 0.0 110.344 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.77 -71.7 2.92 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.42 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 61.3 mtt180 -131.96 145.94 59.57 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 71.8 Cg_endo -75.61 48.27 2.11 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.821 2.347 . . . . 0.0 113.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.5 t -151.3 114.33 3.08 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.11 57.17 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.897 2.398 . . . . 0.0 112.319 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.68 -35.59 77.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.223 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -18.87 55.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.69 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.41 174.1 0.14 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.173 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.95 -167.92 0.8 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.15 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.02 -175.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.696 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -49.24 -36.74 21.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.274 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.43 ' HB ' HG11 ' A' ' 3' ' ' VAL . 24.6 m -109.06 163.83 6.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.485 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.41 150.35 34.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.851 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -95.33 126.11 40.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.2 m -134.74 167.08 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.416 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 1.6 mttt -103.43 138.4 40.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' CG1' HG21 ' A' ' 5' ' ' VAL . 2.6 m -112.77 139.3 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 111.476 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tp -108.22 119.61 39.98 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -73.52 -40.31 64.14 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.085 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 88.17 3.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -81.96 157.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.187 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.45 102.52 4.98 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 48.98 4.19 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.703 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.551 179.895 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.693 0.283 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 3.2 m120 -87.0 143.4 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 p -102.04 140.16 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.678 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -75.0 115.2 14.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.58 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG21 ' CG1' ' A' ' 59' ' ' VAL . 30.5 m -115.97 137.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.49 114.83 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 t -88.69 133.93 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.633 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.37 120.69 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.28 -117.06 3.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.162 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.74 159.83 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 111.175 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 68.61 162.32 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -126.6 135.11 50.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.605 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 m -111.9 163.42 14.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.243 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 52.3 mt-10 -124.61 137.81 54.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.419 HG21 ' CD2' ' A' ' 35' ' ' HIS . 9.3 p -125.53 143.96 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.86 131.61 34.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.839 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.77 133.3 63.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.671 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.98 -28.29 67.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.528 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.58 -33.87 61.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.276 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.55 -54.92 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 26.75 16.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 170.4 9.28 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.909 0.355 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -62.62 -38.74 91.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.416 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -38.55 74.29 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -64.73 -38.07 89.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.964 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 tp -57.61 -42.12 82.63 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.569 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.2 t -65.55 -49.68 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.972 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -60.22 -35.81 76.28 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.14 64.28 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.644 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.93 23.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.187 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.83 46.46 2.97 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.099 0.476 . . . . 0.0 111.167 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.36 34.43 5.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 p -91.22 120.58 68.44 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.499 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.05 -31.48 9.68 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.53 2.153 . . . . 0.0 112.484 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.419 ' CD2' HG21 ' A' ' 15' ' ' VAL . 8.7 p-80 -79.38 -41.61 27.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.33 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 43.97 73.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.228 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.28 148.81 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.308 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -85.23 137.62 32.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.77 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.0 m -96.3 126.96 48.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.392 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.42 141.74 41.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.63 117.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' GLY . 8.3 t70 -63.73 120.49 11.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 16.56 54.62 0.01 OUTLIER Glycine 0 C--N 1.335 0.527 0 O-C-N 124.597 1.185 . . . . 0.0 115.002 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.05 120.38 17.24 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.53 0.205 . . . . 0.0 111.389 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.67 53.51 4.16 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.018 2.478 . . . . 0.0 112.294 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t 61.92 90.6 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.03 94.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.113 2.542 . . . . 0.0 112.858 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -29.79 70.4 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.31 18.26 5.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -115.47 99.68 7.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.767 0.318 . . . . 0.0 110.725 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.74 34.82 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -80.28 178.17 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.377 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.4 -31.43 11.32 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.273 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.59 161.44 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 111.531 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -142.63 157.22 44.91 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.574 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -94.74 125.46 39.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 110.497 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.9 167.86 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.36 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 139.53 47.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.399 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' CG1' HG21 ' A' ' 5' ' ' VAL . 3.7 m -104.89 141.25 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.603 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -105.22 135.84 45.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -73.83 0.22 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.237 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -92.63 149.75 21.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.115 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.64 143.89 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.288 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -128.66 -48.5 1.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.981 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.02 -62.0 0.11 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.179 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.07 -179.918 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.897 0.379 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.69 136.78 32.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.517 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -102.35 139.69 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.026 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 m -74.88 117.58 16.89 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.03 137.51 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.022 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 114.67 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 t -86.13 133.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.69 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.08 120.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.88 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.92 -114.24 3.06 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.234 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.03 158.97 26.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 111.651 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 66.73 163.6 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.923 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -126.88 134.39 50.49 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.494 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 m -110.63 162.92 14.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.79 135.0 52.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.577 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -130.04 149.23 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.875 0.369 . . . . 0.0 111.406 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.18 35.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.75 163.83 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.95 -14.85 58.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.546 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.15 -35.44 62.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.25 -44.97 20.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.33 27.02 34.36 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.618 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.78 175.68 7.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -57.15 -32.9 66.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.544 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.22 74.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.14 -40.92 97.2 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -39.95 75.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.42 -51.01 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -35.9 77.87 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.092 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -30.0 67.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.534 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 t -94.7 23.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.53 48.5 9.62 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.68 42.54 3.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 t -99.24 132.23 23.76 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.61 -32.89 4.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.535 2.157 . . . . 0.0 112.59 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -80.21 -42.75 22.72 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 46.89 61.67 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.455 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.04 146.0 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.212 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 134.97 33.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.046 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.2 m -91.28 135.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.0 152.57 20.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.51 119.92 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.612 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.18 120.03 7.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 33.97 32.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.801 -1.091 . . . . 0.0 114.76 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 148.32 69.02 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 117.289 0.544 . . . . 0.0 111.613 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.89 -48.09 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.429 2.086 . . . . 0.0 112.125 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -161.3 126.21 2.14 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.09 51.79 4.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.571 2.181 . . . . 0.0 112.702 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.57 -35.8 77.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.34 19.44 15.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.582 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -75.64 140.71 42.74 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.72 167.39 20.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.961 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 22.1 t 74.04 135.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.67 70.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.2 m -111.21 161.91 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -146.09 156.97 43.82 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -95.32 126.33 40.56 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.492 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.5 m -134.42 167.52 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.22 135.94 42.92 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.14 140.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 111.523 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.35 119.41 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.843 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -60.19 -33.2 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.6 mt -116.51 146.12 42.83 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 tt -155.42 147.6 12.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.019 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttm 62.52 38.72 12.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.41 -96.25 1.0 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.382 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.483 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -85.01 145.75 27.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.6 t -127.96 139.66 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.62 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.95 113.51 12.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.964 0.411 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.93 137.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.385 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -81.87 115.01 20.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -89.98 133.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.41 120.78 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.719 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.41 -56.98 5.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.443 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.58 163.64 26.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.618 0.246 . . . . 0.0 110.95 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -58.77 -174.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.407 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -99.63 131.69 45.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.151 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.22 162.06 34.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -94.79 139.35 31.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.693 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 35.2 m -132.58 148.27 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.386 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.39 129.05 34.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -116.76 150.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.814 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.6 p30 -70.79 -20.67 62.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.044 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.2 -41.35 62.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.786 0.327 . . . . 0.0 111.015 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -54.78 -45.49 74.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.51 26.51 46.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.996 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.48 170.53 9.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 111.465 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.76 75.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.56 -35.18 67.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.058 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.448 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.5 m-20 -68.5 -42.64 78.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -43.52 98.7 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.94 -39.87 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.258 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -66.9 -35.94 81.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.985 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.56 -25.03 23.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.0 t -89.31 23.35 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.706 0.289 . . . . 0.0 111.392 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 62.84 48.28 4.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 32.57 5.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.93 140.61 25.02 Favored Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.064 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 -32.86 7.22 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.66 -42.75 27.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.132 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.79 72.19 0.34 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 111.024 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.8 m -123.74 146.85 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.343 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 137.85 35.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.746 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.8 m -86.84 131.7 34.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.12 147.46 37.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.223 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 44' ' ' ARG . 2.0 t -113.37 117.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.404 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 44' ' ' ARG . 10.6 t70 -56.04 120.09 6.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.335 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 24.44 43.47 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 124.447 1.092 . . . . 0.0 115.048 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.413 ' HB3' ' CG1' ' A' ' 41' ' ' VAL . 10.0 tpp180 -132.91 124.79 18.84 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.964 0.382 . . . . 0.0 111.153 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.87 -47.21 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.445 2.097 . . . . 0.0 112.091 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 m -155.88 153.6 26.18 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.03 74.98 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.98 2.453 . . . . 0.0 112.121 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.59 -22.2 64.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.593 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.66 5.73 30.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 66.22 96.74 0.05 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.921 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -94.37 154.68 17.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.124 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.08 -175.05 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -51.82 -42.62 62.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.357 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -111.39 162.31 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.047 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -149.07 154.45 39.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.976 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -94.95 125.2 39.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 110.046 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.1 m -135.86 167.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.265 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.11 140.92 40.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.517 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -101.27 140.88 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 125.81 54.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 48.7 1.83 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.87 -48.97 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.221 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 tt -131.07 154.03 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.826 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt 62.05 37.68 14.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.957 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.23 145.9 19.34 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.391 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.427 179.872 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.689 0.28 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.52 148.96 22.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.466 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.43 139.91 22.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.844 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -74.88 113.34 12.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.11 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.7 135.69 57.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.228 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 114.89 23.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.6 t -83.74 130.96 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.38 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.62 120.43 16.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.19 -57.41 4.77 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.161 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 163.53 26.07 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.683 0.278 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.55 -177.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -99.65 134.25 42.8 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.959 0.409 . . . . 0.0 111.07 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 m -137.19 160.45 38.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.228 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.34 137.39 32.41 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -130.77 145.69 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.48 125.83 32.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.2 m -119.76 161.42 19.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.672 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.94 -36.94 64.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.052 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -31.37 65.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.48 -48.05 72.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.85 26.06 63.37 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.606 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.62 178.89 4.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.015 0.408 . . . . 0.0 111.03 179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -59.09 -34.63 72.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -36.1 72.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.78 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -59.25 -38.7 80.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.21 -45.22 91.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.686 0.279 . . . . 0.0 110.779 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.05 -47.73 59.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.97 81.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.673 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.12 53.51 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.4 t -90.57 23.48 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.988 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.29 48.36 10.31 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.009 0.433 . . . . 0.0 111.042 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.12 45.24 2.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.71 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -84.65 129.11 58.36 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -33.09 10.61 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.95 -40.97 26.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.189 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.27 59.14 2.78 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.6 m -126.44 146.01 33.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 m -86.13 123.3 31.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 32.6 m -91.52 127.65 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.38 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -116.76 133.28 56.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.2 t -101.48 117.79 47.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 44' ' ' ARG . 13.4 t70 -56.23 120.66 7.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.902 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 3.78 61.11 0.0 OUTLIER Glycine 0 C--N 1.339 0.746 0 O-C-N 124.843 1.34 . . . . 0.0 115.679 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASP . 26.5 mtm180 -132.09 120.48 17.26 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 12.7 Cg_exo -68.81 -58.5 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.921 2.414 . . . . 0.0 111.982 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.7 t -140.72 140.51 22.21 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.247 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.05 90.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.81 2.34 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.8 -33.74 74.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.223 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.81 -18.85 58.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.599 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.05 158.82 0.13 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.056 0.455 . . . . 0.0 111.407 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -167.79 -172.8 1.95 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.7 t -82.4 60.68 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.272 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 55.81 23.86 6.83 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.436 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.51 162.29 30.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.707 0.289 . . . . 0.0 111.34 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.94 154.69 39.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -95.56 129.93 42.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 4.2 m -135.23 167.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.261 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.37 138.2 50.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.477 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.7 m -103.1 138.4 27.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.46 117.17 33.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.176 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -111.36 -47.06 3.22 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.066 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.98 157.85 17.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.1 tt -163.44 150.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -130.5 84.13 2.17 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.11 -84.77 1.07 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.186 -1.341 . . . . 0.0 112.953 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.457 0.17 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -86.16 148.96 25.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -102.19 139.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.466 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.13 113.57 11.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.286 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.45 ' CG2' HG13 ' A' ' 59' ' ' VAL . 2.1 p -114.39 135.12 55.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.268 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.5 114.94 22.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.7 t -85.93 133.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -77.33 120.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -23.68 11.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.111 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.64 164.11 15.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.573 0.349 . . . . 0.0 110.826 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.91 -173.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.39 129.34 45.58 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -126.29 163.09 23.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.22 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.9 137.67 42.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.89 146.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.38 31.01 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.228 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.53 157.89 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -80.59 -18.23 48.93 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -41.02 73.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.556 0.217 . . . . 0.0 111.315 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -51.64 -35.94 44.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.792 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.31 26.07 69.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.588 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -93.34 166.75 12.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.215 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -34.58 74.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.44 70.22 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.278 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.9 m-20 -58.98 -38.12 78.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.993 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -34.25 70.74 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.622 179.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -70.45 -51.57 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 25' ' ' ASP . 1.4 ptm180 -65.18 -35.43 81.05 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.171 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -25.32 39.97 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.2 t -87.48 23.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.615 0.245 . . . . 0.0 111.156 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 65.47 47.5 2.26 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.18 37.18 4.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.728 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -77.61 124.71 86.58 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.77 -32.78 2.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.697 2.265 . . . . 0.0 112.913 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -42.9 32.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.2 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.02 72.1 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.216 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.1 m -123.68 157.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.413 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 m -84.76 116.92 23.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.554 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -94.3 137.07 23.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 58' ' ' LYS . 6.7 mt -81.99 157.81 24.09 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.45 139.68 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.58 130.33 13.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.718 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.93 -30.49 0.18 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -95.46 165.35 16.91 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.67 86.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.942 2.428 . . . . 0.0 112.734 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -149.8 137.09 11.32 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.755 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.51 37.1 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 112.624 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -68.5 -16.77 64.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.656 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.78 -7.83 56.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -120.14 99.34 6.54 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.69 0.281 . . . . 0.0 111.414 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.96 39.54 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.6 t 62.49 -85.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.162 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -123.42 -10.16 7.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.08 171.57 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.355 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -146.22 157.39 43.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.214 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 133.99 38.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.602 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.3 m -129.47 167.38 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HB2' ' CD1' ' A' ' 40' ' ' LEU . 23.0 mmtp -115.75 133.47 56.0 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.45 HG13 ' CG2' ' A' ' 5' ' ' VAL . 19.0 m -100.76 131.69 47.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.902 0.382 . . . . 0.0 111.307 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 111.24 23.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 30.91 5.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -173.71 150.01 1.67 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.5 tt -160.0 151.99 5.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -45.66 1.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.381 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.83 -46.09 0.12 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.518 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.541 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.647 0.26 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -84.9 146.61 27.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 111.002 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.24 140.02 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.907 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.81 113.41 12.06 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.104 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.3 m -118.59 136.19 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.246 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -81.51 114.72 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -90.15 130.48 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.2 120.68 23.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.717 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.52 -51.37 3.0 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.395 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 163.39 14.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.658 0.266 . . . . 0.0 111.037 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.44 -177.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -99.62 127.02 45.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.193 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -131.12 162.64 29.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.267 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -92.89 137.77 32.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -129.87 150.47 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.202 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.49 126.85 33.65 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 m -116.51 160.7 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.765 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -84.71 -31.86 23.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.307 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.51 -31.63 24.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.078 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -40.99 61.66 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.515 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.52 26.16 70.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -95.06 179.09 5.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 111.155 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.13 -32.88 66.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.238 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.6 67.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.366 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -58.48 -43.92 89.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.556 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -45.02 85.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.27 -45.65 78.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -35.88 73.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.028 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.73 34.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.4 t -91.26 23.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.675 0.274 . . . . 0.0 111.464 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 64.62 48.2 2.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.056 0.455 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.22 48.9 1.41 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.5 t -99.01 120.37 58.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.54 -33.02 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.571 2.181 . . . . 0.0 113.224 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -79.89 -42.66 23.7 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.264 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 50.42 66.37 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.076 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -123.81 151.31 28.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 121.33 33.85 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.8 m -90.92 132.47 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 4.3 mm? -102.17 134.93 44.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 130.65 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' ARG . 19.7 p-10 -63.58 119.77 10.47 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.573 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 28.07 35.64 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.5 mmm180 -133.22 120.77 16.24 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 117.684 0.742 . . . . 0.0 111.107 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.2 -54.85 3.41 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.34 2.026 . . . . 0.0 112.092 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.87 148.44 17.86 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.61 78.7 1.62 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.826 2.351 . . . . 0.0 112.332 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.34 -35.41 77.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.02 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.671 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.0 64.89 1.41 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.143 0.497 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.43 112.27 11.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 t 68.33 154.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.344 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.39 -44.1 84.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -108.0 161.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.387 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -147.92 154.11 39.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.667 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -94.93 125.94 39.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.203 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.18 167.37 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.62 141.1 36.0 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -112.49 131.83 62.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 111.318 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.06 122.38 44.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.83 -53.83 2.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.3 90.93 3.44 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.869 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 tp -82.42 145.63 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.186 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -135.22 154.82 51.46 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.38 -65.18 0.26 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.405 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.51 179.797 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.602 0.239 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -92.67 146.98 23.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 t -121.76 139.57 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.931 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.21 113.42 12.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.4 HG11 HG23 ' A' ' 15' ' ' VAL . 17.4 m -118.44 137.22 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -81.8 114.81 20.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG23 ' CG2' ' A' ' 59' ' ' VAL . 5.5 t -86.86 133.23 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.72 120.66 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.638 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.82 -57.58 5.05 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.418 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.53 163.78 25.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -58.22 -175.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.249 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.1 m -99.64 130.44 45.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.928 0.394 . . . . 0.0 111.187 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -127.48 162.72 25.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.55 130.89 42.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG23 HG11 ' A' ' 5' ' ' VAL . 26.8 m -129.77 144.3 38.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.25 126.61 33.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.041 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.11 161.98 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.135 0.493 . . . . 0.0 112.254 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.72 -41.94 78.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.335 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.69 -41.57 56.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.962 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -47.19 -40.94 17.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.387 0.429 . . . . 0.0 111.582 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.94 26.38 69.14 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.931 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.55 178.47 4.85 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.87 0.367 . . . . 0.0 111.111 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -32.75 66.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.219 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.82 70.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.17 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.42 -44.03 95.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.869 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.68 -46.43 89.08 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.69 0.281 . . . . 0.0 110.8 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.5 t -67.53 -44.88 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.52 -36.15 81.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.23 -26.87 42.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.84 23.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.562 0.22 . . . . 0.0 111.331 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.3 42.0 9.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.059 0.457 . . . . 0.0 110.964 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 mt -121.1 39.43 3.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.529 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.08 120.67 72.65 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.22 -33.15 7.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.505 2.136 . . . . 0.0 112.494 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -79.89 -42.07 24.92 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 51.67 70.26 0.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.68 147.29 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.414 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.18 136.97 32.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.796 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.2 m -93.34 133.96 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.399 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.83 148.01 31.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 t -106.65 117.72 52.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.01 120.18 11.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.149 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 23.1 47.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 124.411 1.069 . . . . 0.0 114.786 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 121.03 16.81 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.874 0.337 . . . . 0.0 111.366 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.05 -51.8 6.15 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.528 2.152 . . . . 0.0 112.118 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 27.7 t -150.61 144.09 17.02 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 46' ' ' VAL . 4.8 Cg_exo -78.73 47.28 2.4 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.836 2.357 . . . . 0.0 112.469 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.59 -31.83 71.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.82 19.28 6.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.664 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -98.32 119.0 36.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.059 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.1 m -120.29 33.71 5.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.987 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 t -121.66 138.47 51.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.722 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.77 -35.98 71.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.231 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -110.65 161.66 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 110.546 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.3 145.72 28.28 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -95.0 125.24 39.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.288 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.1 m -136.21 167.17 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -102.24 141.67 34.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' CG2' HG23 ' A' ' 7' ' ' VAL . 4.4 m -106.07 137.61 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.838 0.352 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.75 128.49 56.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.174 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -95.08 -55.23 3.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.353 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -92.06 102.45 14.99 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 tp -101.43 146.21 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.281 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.83 114.71 14.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.65 131.01 7.89 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.558 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.348 -1.251 . . . . 0.0 112.518 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.86 0.362 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -89.3 142.16 27.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.31 140.0 21.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -74.67 113.2 11.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 110.485 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.9 m -118.87 137.6 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.378 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.15 114.95 21.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.66 133.98 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.419 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.22 120.62 4.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.6 -49.44 3.15 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.55 163.3 26.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.626 0.251 . . . . 0.0 110.972 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.41 -100.0 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -127.96 135.06 49.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 111.349 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 t -132.07 162.89 29.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.245 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -123.47 138.54 54.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 p -131.98 147.88 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.257 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 125.79 32.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.148 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.17 161.05 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.47 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.6 -26.98 37.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.725 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.54 -34.87 67.46 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.599 0.238 . . . . 0.0 110.929 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.73 -61.09 2.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.18 57.11 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.709 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.73 178.91 5.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 111.141 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -57.17 -38.93 74.32 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.15 82.76 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.932 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -60.38 -37.51 80.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -41.73 78.52 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.809 0.338 . . . . 0.0 110.555 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.96 -50.71 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -59.34 -36.16 75.18 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.213 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.31 36.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.99 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.4 t -92.14 23.46 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.702 0.287 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.61 47.32 4.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.134 0.492 . . . . 0.0 111.454 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 33.16 4.99 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.8 120.27 68.81 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.863 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.82 -32.47 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.951 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.93 -41.12 75.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.97 69.37 0.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.036 0.446 . . . . 0.0 111.176 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.4 m -124.02 145.8 30.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.239 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.8 m -96.77 119.43 35.22 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.831 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.2 m -84.18 131.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.519 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.1 mt -105.51 147.64 28.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 t -102.15 136.68 33.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.864 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.85 120.83 14.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.65 0.262 . . . . 0.0 110.333 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 26.24 47.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.191 -0.913 . . . . 0.0 114.625 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.31 120.36 16.97 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.943 0.371 . . . . 0.0 111.0 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.81 -61.03 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.752 2.301 . . . . 0.0 112.834 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.65 161.5 43.56 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.25 53.07 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 0.0 112.44 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -68.51 -32.94 73.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.498 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.96 19.69 5.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.872 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.05 94.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.83 159.7 39.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.75 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t 72.21 146.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -59.1 -45.07 91.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.186 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.4 m -113.41 162.22 11.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.797 0.332 . . . . 0.0 111.214 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -147.97 152.3 37.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -97.13 125.12 41.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.41 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 10.4 m -136.26 167.13 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -110.64 128.71 55.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 m -100.86 141.62 17.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.975 0.417 . . . . 0.0 111.337 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.3 tt -97.64 128.53 44.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.959 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.27 -56.39 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.36 -72.6 0.67 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 pt -147.05 171.76 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.259 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -171.06 93.97 0.18 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.6 -178.02 28.3 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.896 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.094 179.801 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.507 0.194 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -91.59 148.78 22.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.76 0.315 . . . . 0.0 110.648 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 17' ' ' VAL . 20.4 m -102.15 139.96 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.727 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -74.48 114.3 12.72 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.431 HG23 ' CG1' ' A' ' 59' ' ' VAL . 30.3 m -116.48 137.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.303 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 114.76 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.22 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.96 120.26 3.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.475 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.38 -118.14 4.19 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.246 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -120.73 159.04 26.19 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 70.19 155.19 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.05 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.1 m -116.23 134.9 54.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.393 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.6 t -108.51 161.98 14.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.298 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.01 131.93 52.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.92 144.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.778 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.19 134.97 34.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.241 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 3' ' ' VAL . 15.7 m -121.58 159.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 111.88 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.85 -33.78 45.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.299 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -56.73 -35.82 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -55.18 -48.54 73.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.779 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.21 42.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.15 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 179.17 5.55 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -57.31 -32.65 66.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.181 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.76 74.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.06 -44.4 91.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.559 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -41.1 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.12 -50.08 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -60.39 -36.05 77.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.359 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.596 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -95.58 23.15 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.717 0.294 . . . . 0.0 111.221 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 59.27 46.94 12.14 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.47 46.02 2.31 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.64 120.46 72.96 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-O 120.598 0.237 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.674 2.25 . . . . 0.0 113.008 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.75 23.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 111.175 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.24 61.97 2.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.089 0.471 . . . . 0.0 111.173 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.51 146.08 29.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 m -85.49 132.21 34.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.71 131.42 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.61 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 3.9 mm? -107.29 147.71 29.9 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.19 117.79 52.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.86 120.12 11.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.419 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 31.94 35.72 0.02 OUTLIER Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.827 -1.078 . . . . 0.0 115.153 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.07 143.94 50.62 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 117.349 0.574 . . . . 0.0 111.555 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.87 -47.53 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.417 2.078 . . . . 0.0 112.165 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 m -154.15 110.11 2.46 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.953 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -81.24 6.22 5.74 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.534 2.156 . . . . 0.0 113.1 179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -15.61 59.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.6 -10.92 59.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.56 150.54 31.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.588 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -96.88 45.93 1.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 m -139.46 166.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.293 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -85.68 -37.48 19.37 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.3 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.96 161.63 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 111.498 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 152.63 40.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -95.63 125.23 40.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.525 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.69 167.09 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.4 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 6.2 mmtt -107.65 140.11 41.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' CG1' HG23 ' A' ' 5' ' ' VAL . 3.9 m -102.2 136.12 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.315 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.2 112.41 23.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -141.19 34.04 1.71 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -171.26 98.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.6 tt -110.2 147.52 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.278 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -89.92 -54.15 4.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.44 123.41 0.7 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.25 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.269 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.102 179.914 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.604 0.24 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -89.81 144.21 26.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.98 139.91 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.521 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -74.7 113.49 12.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.98 135.55 53.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.398 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.71 114.65 20.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.27 133.9 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.393 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.03 120.45 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.91 -45.09 2.32 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.53 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.41 164.01 12.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.458 0.303 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.31 -176.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -99.25 132.5 44.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -134.69 163.01 30.73 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -94.91 138.12 33.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.217 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.33 147.61 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 127.85 34.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.65 160.6 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -76.05 -34.52 59.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.897 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -52.77 -35.56 56.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.794 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.29 -51.18 70.42 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.85 26.19 46.49 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.799 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -88.28 162.25 16.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.378 . . . . 0.0 111.265 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -57.57 -35.62 70.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.056 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.76 73.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.246 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.39 -37.31 77.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.373 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.23 -40.01 73.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.794 0.331 . . . . 0.0 110.577 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.07 -48.05 57.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.841 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -61.89 -35.7 79.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.27 -25.14 32.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.1 t -88.8 23.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.6 0.238 . . . . 0.0 111.218 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 64.34 47.5 3.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.58 34.9 5.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 4.1 p -94.68 120.51 64.72 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 23.7 Cg_exo -64.04 -32.78 64.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.678 2.252 . . . . 0.0 112.56 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -43.04 23.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.341 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 48.53 67.2 0.89 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.069 0.462 . . . . 0.0 111.04 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.1 m -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.39 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 m -91.37 135.66 33.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -88.3 130.05 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 149.1 33.29 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -116.4 119.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.623 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' GLY . 17.8 t0 -52.47 120.59 5.77 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 18.88 54.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.53 0 O-C-N 124.481 1.113 . . . . 0.0 114.904 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 26.6 mtt-85 -131.82 119.72 17.17 Favored Pre-proline 0 C--O 1.232 0.163 0 CA-C-N 116.759 0.279 . . . . 0.0 111.304 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.91 -45.81 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.664 2.242 . . . . 0.0 112.566 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -150.57 93.3 3.8 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.07 78.57 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.01 2.473 . . . . 0.0 112.588 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.58 -29.94 70.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.33 19.36 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.13 136.06 57.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.703 0.287 . . . . 0.0 111.149 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -129.85 158.81 38.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.1 t 72.89 146.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.23 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -34.68 68.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.995 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.09 165.99 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.952 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.99 154.9 42.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -94.64 125.45 39.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 110.539 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.9 m -134.53 167.78 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.952 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' NZ ' ' HB2' ' A' ' 42' ' ' ASP . 6.7 ptpp? -109.72 139.9 44.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.4 m -106.1 141.66 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 111.443 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -110.62 118.48 36.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.785 -179.802 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -118.94 -58.29 1.96 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.56 -66.89 0.46 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.974 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.4 ' O ' HD21 ' A' ' 60' ' ' LEU . 19.0 tt -80.09 154.08 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.5 133.35 14.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.22 -36.24 1.3 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.883 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.575 179.807 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.3 p30 -89.41 147.9 23.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.896 0.379 . . . . 0.0 110.613 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.35 139.95 22.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.43 113.42 11.64 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 m -118.4 135.43 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.694 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.98 115.02 22.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.569 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -84.69 134.14 27.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.53 120.62 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.555 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.3 -55.55 5.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.431 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 163.93 25.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.358 0.263 . . . . 0.0 110.989 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -167.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.473 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -99.34 128.04 45.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.936 0.398 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -126.65 162.82 24.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.063 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 2' ' ' ASN . 6.6 mp0 -105.69 145.26 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.97 147.06 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 123.64 30.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 111.065 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 t -121.97 152.25 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.718 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.75 -44.77 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.301 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -28.67 46.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.118 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 18.1 t70 -50.53 -29.53 10.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.7 25.95 61.75 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.732 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.405 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -107.49 179.05 4.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.887 0.375 . . . . 0.0 111.294 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.34 -32.35 66.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.074 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.78 -35.67 66.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.946 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.76 -44.71 90.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.511 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.975 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 t -70.53 -47.25 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.2 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.42 63.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.648 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 t -92.61 20.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.602 0.239 . . . . 0.0 111.275 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.76 45.12 2.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.2 88.57 2.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -115.81 120.5 35.66 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.96 -33.13 2.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.659 2.239 . . . . 0.0 112.8 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -79.54 -42.28 25.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.198 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.98 57.5 6.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.62 152.17 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.125 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -84.75 134.17 34.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -105.88 132.18 53.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.918 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 14.2 mt -101.55 151.52 21.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.25 139.35 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' ARG . 18.7 t70 -47.61 124.0 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -37.83 80.09 0.0 OUTLIER Glycine 0 C--N 1.339 0.74 0 O-C-N 124.204 0.94 . . . . 0.0 114.547 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.7 mtm-85 -131.46 126.4 21.18 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.516 0.198 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.46 -41.69 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.659 2.239 . . . . 0.0 112.702 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 m -141.1 108.41 6.3 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.497 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.63 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.942 2.428 . . . . 0.0 112.006 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -17.77 64.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.372 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.0 18.98 3.24 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -169.65 0.19 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.777 0.323 . . . . 0.0 111.271 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 m -122.71 165.1 17.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.055 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.81 159.39 41.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.214 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 1.5 pt-20 -47.59 -39.82 17.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 t -124.13 161.36 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.419 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.43 146.1 27.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -95.42 125.08 39.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.221 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.63 167.16 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.619 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.1 mttt -104.22 140.24 38.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.57 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -113.01 140.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.727 0.299 . . . . 0.0 111.329 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.51 131.05 54.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.54 -51.28 2.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.8 96.92 9.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.887 0.375 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -88.93 164.26 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.286 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 133.24 17.21 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 57.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.788 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.553 -1.137 . . . . 0.0 112.771 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.946 0.403 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.442 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 18.6 m120 -89.12 138.16 31.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.496 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 39.9 t -102.53 140.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 113.5 12.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.215 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.9 m -117.74 137.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.489 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.96 114.8 21.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.741 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 t -88.32 134.36 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.977 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.22 120.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.482 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.93 -33.01 5.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.784 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.01 163.95 14.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.416 0.286 . . . . 0.0 110.757 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -169.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.44 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -99.68 132.87 44.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.057 0.455 . . . . 0.0 111.236 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m -132.73 160.16 37.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' HB3' ' CB ' ' A' ' 2' ' ' ASN . 3.1 mp0 -89.2 132.83 34.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.22 145.95 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.304 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.21 125.94 32.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 111.361 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.0 137.76 51.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.941 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -27.59 47.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.681 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -40.81 63.31 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.949 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.24 -45.94 45.3 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.368 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.26 71.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.621 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.42 174.18 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -57.44 -38.51 74.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.205 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.1 78.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.407 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -59.35 -37.02 76.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.46 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.2 -42.71 77.6 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.28 -44.57 72.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 ttp85 -59.57 -36.03 75.43 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.289 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.31 -25.07 58.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.918 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.47 23.37 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.618 0.247 . . . . 0.0 111.255 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.93 48.23 2.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.101 0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -121.22 37.48 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.424 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -92.9 120.74 66.94 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.703 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 16.0 Cg_exo -67.68 -33.16 28.73 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.8 2.333 . . . . 0.0 112.54 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -79.57 -42.92 23.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 51.38 65.29 1.53 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.48 145.99 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.518 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 m -88.03 136.6 32.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.648 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 34.0 m -98.82 134.64 36.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.44 140.36 48.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.77 137.56 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -66.61 120.16 12.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.346 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 33.58 36.66 0.05 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.126 -0.943 . . . . 0.0 114.528 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.78 30.59 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 117.179 0.489 . . . . 0.0 111.249 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.42 -52.18 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.276 1.984 . . . . 0.0 112.263 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.7 m -160.74 144.45 10.1 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.891 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.77 43.51 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 112.678 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -68.3 -35.71 78.24 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.268 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.76 -16.95 37.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.552 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -64.0 147.76 51.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.731 0.301 . . . . 0.0 111.34 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.65 72.15 1.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.56 175.4 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -102.2 -35.11 9.0 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 m -130.89 161.85 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.298 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.27 156.67 42.47 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -95.12 124.63 39.27 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 16.0 m -134.92 167.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.16 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.88 130.78 55.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.572 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.6 m -103.3 141.74 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.06 127.52 53.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -38.25 83.07 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.021 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mt -142.48 127.97 18.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.9 tt -140.86 143.04 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.436 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 mttt 66.24 109.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.5 57.56 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.734 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.704 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.751 0.31 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.55 146.01 24.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.071 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.6 t -120.83 139.79 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.675 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -75.01 114.94 14.08 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.411 HG21 ' CG1' ' A' ' 59' ' ' VAL . 10.0 m -118.15 137.66 51.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.264 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.33 114.79 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.565 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.46 134.14 32.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.03 120.35 3.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.87 -118.36 3.43 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.183 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -120.93 152.88 37.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.55 165.09 0.22 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.123 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -117.99 135.43 54.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.679 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.15 159.98 15.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.394 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.73 127.27 45.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.222 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.18 149.26 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 127.05 34.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.356 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -116.98 148.77 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -23.38 67.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.758 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -54.24 -37.94 65.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.785 0.326 . . . . 0.0 110.808 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.97 -43.83 86.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.255 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.36 26.32 40.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.226 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 163.98 12.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.959 0.379 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -60.08 -38.4 82.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.365 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.46 71.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.259 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.09 -41.86 98.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.17 77.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.28 -44.33 94.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.664 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -35.89 82.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.89 -25.08 41.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.698 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.415 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 12.6 t -88.71 23.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.5 48.34 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 111.135 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.415 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 1.4 mt -130.65 44.81 2.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -99.18 136.53 20.47 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 -33.18 6.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.466 2.111 . . . . 0.0 112.529 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -42.35 23.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.203 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 54.59 59.35 4.18 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.4 146.32 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.268 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -90.49 138.48 31.52 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 34.5 m -96.59 132.0 42.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 140.21 45.34 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.67 135.49 38.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.96 120.46 13.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 110.231 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 30.85 39.1 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.57 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 133.95 24.22 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 117.149 0.474 . . . . 0.0 111.644 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.35 -38.26 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 0.0 112.403 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.93 131.87 11.63 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.209 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.56 1.66 8.85 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.648 2.232 . . . . 0.0 113.12 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.8 -28.58 67.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.582 0.229 . . . . 0.0 111.357 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 19.36 4.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.596 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -106.0 155.02 19.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.788 0.327 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -92.4 167.87 11.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.6 t 73.4 135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -58.34 -36.19 73.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.9 161.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.741 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -148.17 151.21 35.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.716 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -95.21 125.48 39.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.948 0.404 . . . . 0.0 110.663 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 15.5 m -132.25 167.35 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.17 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -108.49 136.7 47.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.679 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' CG1' HG21 ' A' ' 5' ' ' VAL . 15.0 m -102.18 140.81 19.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.311 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.31 132.2 56.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 18.9 ptt180 -66.94 -42.33 85.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.998 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 1.8 mp -152.74 128.09 9.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.767 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tp -155.36 145.67 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.402 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 157.9 18.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.293 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.67 86.15 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.769 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.412 -1.216 . . . . 0.0 112.6 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -85.26 133.16 34.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.725 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.08 140.45 21.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.922 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -74.73 113.19 11.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.313 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.0 m -118.75 138.05 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.249 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.76 115.0 20.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.406 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.0 p -99.24 133.94 40.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.06 120.77 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.2 -55.82 0.69 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.468 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 163.39 22.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.587 0.232 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.66 -82.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.99 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -127.95 135.01 49.36 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.037 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.7 p -120.62 147.91 44.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.487 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.73 128.97 55.83 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.35 145.86 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.416 ' CB ' ' HG3' ' A' ' 28' ' ' ARG . . . -84.19 138.28 33.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.64 160.09 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.265 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 5.5 t70 -99.05 -22.84 15.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.004 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -24.99 65.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -62.2 -60.55 3.43 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.42 35.74 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.859 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -89.97 178.61 6.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.912 0.356 . . . . 0.0 111.312 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -40.14 83.58 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.56 81.54 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.621 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.503 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 21.0 t0 -59.86 -37.92 80.67 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.61 -40.56 72.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.54 0.209 . . . . 0.0 110.687 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 t -71.26 -50.68 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HG3' ' CB ' ' A' ' 16' ' ' ALA . 8.3 mmt85 -63.06 -35.67 81.01 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.557 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.1 26.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.7 t -85.74 22.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.592 0.234 . . . . 0.0 111.441 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.35 47.98 2.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 110.983 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mp -116.09 38.05 3.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.959 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.15 121.52 71.42 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 120.727 0.298 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.34 -29.52 9.35 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 113.06 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -77.71 -42.62 33.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.097 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.09 70.49 0.4 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 111.402 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.45 155.61 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.489 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.8 t -85.32 138.32 32.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 28.7 m -110.36 129.73 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.456 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.8 139.99 45.61 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.72 135.11 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 44' ' ' ARG . 15.0 t0 -47.75 122.06 4.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -33.85 78.05 0.0 OUTLIER Glycine 0 CA--C 1.527 0.815 0 O-C-N 124.414 1.071 . . . . 0.0 115.014 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -132.15 157.67 77.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 122.135 0.174 . . . . 0.0 111.052 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.42 ' HD2' ' HB2' ' A' ' 44' ' ' ARG . 28.4 Cg_endo -62.52 155.15 59.91 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.407 2.072 . . . . 0.0 111.815 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.22 82.86 12.03 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.782 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.71 106.5 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.558 2.172 . . . . 0.0 111.742 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.91 -22.33 66.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.618 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.05 -18.15 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.2 154.86 46.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 111.651 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.09 157.8 6.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.219 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.01 174.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -73.7 -46.64 44.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.6 0.238 . . . . 0.0 110.985 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 161.84 22.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.786 0.327 . . . . 0.0 111.186 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.3 157.08 43.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -94.35 125.09 38.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.051 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' CG2' ' HB ' ' A' ' 39' ' ' VAL . 13.9 m -133.63 167.49 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.681 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 141.35 35.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m -116.54 141.32 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.794 0.33 . . . . 0.0 111.346 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mt -114.65 129.08 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -34.77 12.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.02 138.93 32.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.634 0.254 . . . . 0.0 110.983 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.64 154.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.23 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -74.79 111.66 10.21 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.55 -149.67 19.57 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.553 -179.955 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.674 0.273 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -85.02 135.62 33.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 t -102.34 140.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.562 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.47 118.65 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.511 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG23 ' CG1' ' A' ' 59' ' ' VAL . 18.0 m -117.2 137.45 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.068 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.41 114.66 20.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 t -87.75 134.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.64 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 t -57.31 120.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.89 -117.59 4.33 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.04 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -120.7 159.86 24.48 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.604 0.24 . . . . 0.0 111.251 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 69.49 145.71 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.016 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 135.03 54.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.408 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -118.58 163.35 16.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.7 144.12 44.39 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.032 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG23 ' CD2' ' A' ' 35' ' ' HIS . 11.8 p -120.13 139.63 46.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.65 130.24 34.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.868 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.54 160.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.901 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.42 -21.36 15.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.895 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -34.91 50.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.514 0.197 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -68.56 -51.63 40.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.61 26.02 18.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.468 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.95 178.72 6.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.05 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.41 -32.82 67.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.467 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.76 70.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.651 0.262 . . . . 0.0 110.92 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.72 -40.53 95.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.753 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -37.42 69.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.861 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.69 -51.2 48.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.979 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -36.27 79.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -28.44 61.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.71 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -93.55 21.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.672 0.272 . . . . 0.0 111.203 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 62.77 46.82 4.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.2 mp -128.06 50.95 2.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.6 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.51 119.69 67.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.31 -27.35 2.87 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.388 . . . . 0.0 112.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.446 ' CD2' HG23 ' A' ' 15' ' ' VAL . 10.4 p-80 -65.04 -43.39 92.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.96 45.52 8.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.985 0.421 . . . . 0.0 111.575 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 35' ' ' HIS . 18.6 m -126.88 160.52 35.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.91 122.99 44.44 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.9 m -82.0 135.17 25.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.96 145.27 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -101.68 126.07 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.17 120.0 12.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 29.71 37.84 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.947 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.77 138.04 31.07 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 117.231 0.516 . . . . 0.0 111.504 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.07 -44.0 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.13 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.18 139.56 12.44 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.09 36.45 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.69 2.26 . . . . 0.0 112.823 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -68.75 -35.4 77.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.174 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.98 -17.92 48.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.548 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -62.92 136.36 57.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.435 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.9 m -126.07 60.57 1.29 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 t -137.6 140.73 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.51 -44.51 89.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.24 162.18 39.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -148.59 154.81 40.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -94.83 125.26 39.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -133.62 167.88 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.582 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.18 136.48 41.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.082 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.465 ' CG1' HG23 ' A' ' 5' ' ' VAL . 2.3 m -108.41 140.24 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.855 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 pp -99.35 131.77 45.14 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.389 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -67.26 -59.76 3.16 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.68 -63.44 1.31 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.47 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -145.31 174.97 2.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.21 160.49 40.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.041 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.4 36.63 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.638 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -1.321 . . . . 0.0 112.835 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.743 0.306 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -93.1 147.3 22.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.026 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 m -112.12 139.6 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.844 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m -74.88 113.59 12.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.03 136.29 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.443 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -81.65 114.7 20.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 8.7 t -89.03 133.29 31.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.636 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.65 120.4 33.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.546 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.09 -24.92 13.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.973 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.7 163.97 15.68 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 110.796 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -169.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.795 0.331 . . . . 0.0 111.709 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 131.2 45.38 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.35 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -133.1 162.99 30.26 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.043 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.16 140.23 39.45 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.4 p -132.49 146.96 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 125.83 32.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.999 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.9 m -116.32 161.63 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.909 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.3 -33.86 59.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -39.2 58.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.863 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.01 -47.33 33.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.802 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.97 26.5 70.92 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.191 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.48 174.49 6.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.952 0.376 . . . . 0.0 111.143 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.86 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.313 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.42 -36.03 70.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.183 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 27.9 t0 -58.95 -39.33 81.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.892 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.43 -35.66 81.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.693 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.56 -51.34 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.067 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -63.28 -35.43 80.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.044 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.68 -25.05 37.75 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.508 ' HB ' ' CD1' ' A' ' 32' ' ' LEU . 2.5 t -85.72 23.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.93 48.28 2.39 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.247 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.508 ' CD1' ' HB ' ' A' ' 30' ' ' VAL . 2.1 mt -132.32 52.78 2.05 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.3 130.4 22.9 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.739 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.36 -32.93 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.615 2.21 . . . . 0.0 113.23 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.8 -43.0 23.24 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 48.37 67.45 0.85 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.345 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.06 149.59 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.502 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -85.2 138.66 32.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.5 m -99.31 131.62 46.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.296 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.9 151.26 23.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.9 t -118.25 139.27 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.814 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' ARG . 10.5 p-10 -47.55 124.45 7.03 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -36.57 80.91 0.0 OUTLIER Glycine 0 C--N 1.34 0.775 0 O-C-N 124.083 0.864 . . . . 0.0 114.356 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' ASP . 37.2 ptt180 -125.99 144.49 48.89 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 120.649 0.261 . . . . 0.0 111.402 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.9 -39.38 2.38 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.818 2.346 . . . . 0.0 112.7 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.73 156.04 76.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 56.5 5.14 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.688 2.259 . . . . 0.0 112.627 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -68.55 -30.09 68.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.95 19.47 4.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.312 -0.403 . . . . 0.0 112.074 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.02 86.97 0.06 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.951 0.405 . . . . 0.0 110.65 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -142.53 160.46 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t 71.81 137.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.21 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -57.05 -38.51 73.33 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.974 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.43 161.86 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 149.97 34.54 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.853 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 129.77 42.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.345 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.23 167.15 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.394 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -105.39 136.29 45.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.487 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.9 m -101.82 136.52 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.3 113.01 25.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.267 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -124.55 55.35 1.33 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 tp -149.05 34.61 0.74 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 pt -122.08 175.73 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.01 175.03 9.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.59 -32.08 6.87 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.792 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.54 -1.145 . . . . 0.0 112.669 -179.834 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.584 ' HB2' HG21 ' A' ' 22' ' ' THR . 25.9 tpp . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.813 0.34 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.32 149.36 23.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.82 140.01 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.51 113.54 11.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.6 m -117.43 137.27 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.672 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.46 115.24 21.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.83 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.0 t -90.01 134.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.56 120.38 30.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.15 17.91 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.042 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.64 163.71 16.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.771 0.285 . . . . 0.0 110.825 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -168.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.467 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -99.69 122.84 43.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.046 0.45 . . . . 0.0 111.195 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m -123.24 162.94 21.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.265 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.79 139.57 40.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.29 143.66 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.33 128.64 34.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 20' ' ' ASP . 28.8 m -116.18 161.11 15.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.92 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.73 -34.33 21.25 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -31.02 64.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.223 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -54.02 -46.83 71.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.83 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.7 26.06 54.83 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.584 HG21 ' HB2' ' A' ' 1' ' ' MET . 0.6 OUTLIER -95.74 179.09 5.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -58.11 -34.22 69.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.171 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.7 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.091 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.97 -42.72 90.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.78 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -58.76 -46.47 87.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.771 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.99 -50.44 79.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -58.89 -37.37 76.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.18 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.54 -27.46 49.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.834 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.1 t -94.26 23.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.289 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.05 48.35 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.09 0.471 . . . . 0.0 111.033 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.479 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -126.9 52.33 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.581 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . 52.6 p -90.2 120.48 69.16 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.64 -32.97 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.627 2.218 . . . . 0.0 112.916 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -39.68 31.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.402 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 39.52 62.1 1.25 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.869 0.468 . . . . 0.0 111.883 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.77 153.72 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.68 137.17 33.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.593 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.2 m -105.34 134.87 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 6.8 mp -100.33 147.21 26.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.663 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.72 117.81 47.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.87 120.25 12.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.301 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 CA-C-N 115.009 -0.996 . . . . 0.0 114.739 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.615 0.245 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' OD2' ' A' ' 20' ' ' ASP . 33.3 m -124.16 161.86 26.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.112 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -149.22 153.97 38.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -95.38 124.96 39.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.875 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.7 m -134.83 166.63 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.5 mttt -104.46 136.03 44.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.54 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.83 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.2 m -106.69 141.23 22.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.842 0.354 . . . . 0.0 111.426 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 119.04 38.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.69 0.281 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -84.91 146.71 27.13 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.1 p -117.37 140.13 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.709 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -74.6 113.24 11.62 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 57' ' ' VAL . 20.1 m -118.7 136.43 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.36 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.6 mt-10 -81.49 114.85 20.49 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.447 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 59' ' ' VAL . 21.6 t -89.67 133.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.805 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.86 120.61 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.89 -57.42 5.01 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.449 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.76 163.51 26.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.37 -172.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.521 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.5 m -99.52 121.05 40.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.951 0.405 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.5 t -120.96 161.71 21.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.55 140.83 33.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 37' ' ' VAL . 10.1 p -128.24 150.75 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 124.67 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.93 164.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.707 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -88.53 -29.54 19.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.55 -37.61 63.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 32.5 p30 -50.72 -30.39 13.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.54 25.62 75.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.983 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -103.07 179.14 4.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -57.02 -32.8 66.52 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.33 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.46 -36.96 69.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.207 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.74 -44.75 93.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.632 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -57.2 -36.29 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.049 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 t -70.88 -51.08 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.888 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -35.89 76.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.185 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.2 65.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.577 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.8 t -94.53 20.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.276 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.36 47.85 3.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.991 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.97 49.63 1.95 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 p -93.28 120.43 66.69 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 14.1 Cg_exo -68.99 -32.95 20.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.705 2.27 . . . . 0.0 112.583 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.459 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -79.77 -42.77 23.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.377 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.17 55.23 6.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.082 0.468 . . . . 0.0 110.952 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 15' ' ' VAL . 11.7 m -124.04 148.83 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.298 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.2 m -84.68 133.46 34.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.5 m -109.42 131.2 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.493 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.98 141.67 40.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.695 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.81 139.27 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -74.43 120.69 20.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.253 0.549 . . . . 0.0 109.643 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.884 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.154 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.7 pt-20 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.435 0.16 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.5 m -117.83 162.17 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.208 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.799 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.9 t70 -148.28 155.86 41.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -94.72 127.66 40.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.715 0.293 . . . . 0.0 110.347 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.2 m -131.64 167.23 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.903 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -102.78 140.75 36.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.779 HG23 HG22 ' A' ' 7' ' ' VAL . 3.8 m -118.49 141.94 35.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.12 115.29 29.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.779 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -85.61 142.46 29.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 55' ' ' ASP . 41.2 t -129.22 139.91 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -75.0 113.62 12.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.436 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 ' CG1' ' A' ' 59' ' ' VAL . 22.7 m -118.04 137.56 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.363 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.87 115.04 20.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.783 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.2 t -88.88 134.12 29.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.75 120.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.27 -57.19 5.04 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.397 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 163.57 26.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.63 -170.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.48 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -99.73 122.53 42.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 111.014 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -121.34 162.56 20.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.083 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -100.47 138.44 37.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 HG21 ' A' ' 37' ' ' VAL . 27.3 m -131.5 150.56 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.339 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.58 127.02 33.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.819 0.342 . . . . 0.0 111.398 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 39' ' ' VAL . 3.4 m -121.94 139.55 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.5 -21.93 64.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -35.16 47.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.59 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.16 -48.3 80.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.447 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.11 26.55 52.41 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.429 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -88.06 176.4 7.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.206 0.503 . . . . 0.0 111.46 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -60.44 -38.95 85.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.75 76.17 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.174 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.65 -37.18 83.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -55.78 -35.46 66.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.543 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 -49.27 73.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.936 0.398 . . . . 0.0 110.831 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.9 -35.79 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.9 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.854 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 32' ' ' LEU . 11.3 t -87.45 23.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 63.53 48.08 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.828 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.6 mt -133.57 48.24 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m -97.49 123.03 53.8 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.934 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.28 -27.76 6.3 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.734 2.289 . . . . 0.0 112.718 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -73.31 -43.07 61.55 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.326 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 46.55 60.05 3.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.94 HG21 HG11 ' A' ' 15' ' ' VAL . 16.0 m -124.19 148.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.376 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.98 137.27 33.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.457 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.737 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.9 m -107.33 129.8 60.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 111.634 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.45 138.22 51.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.593 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.82 135.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -62.94 120.56 11.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.391 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.891 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -154.31 162.06 2.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.108 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.867 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -148.48 147.49 29.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.406 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -94.76 125.37 39.37 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.829 0.347 . . . . 0.0 110.316 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.9 m -130.16 167.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.649 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.36 136.47 42.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.783 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -106.39 139.16 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.836 0.351 . . . . 0.0 111.549 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 121.22 40.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.909 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 . . . . . 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.254 -179.906 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -85.92 143.39 28.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.783 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 15' ' ' VAL . 30.9 m -102.35 139.79 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.731 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -74.66 115.87 14.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.237 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG1' HG23 ' A' ' 57' ' ' VAL . 17.7 m -115.57 137.33 49.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.183 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.28 117.27 21.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.538 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 59' ' ' VAL . 20.1 t -89.46 133.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.03 120.65 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.36 -117.13 4.59 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.081 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -120.8 159.93 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.544 0.211 . . . . 0.0 111.249 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 72.61 147.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.928 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -116.99 135.11 53.95 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.8 m -114.24 162.84 16.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.206 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -125.96 133.97 51.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 39' ' ' VAL . 11.5 p -121.65 147.18 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.64 133.56 34.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.71 161.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.98 -38.32 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.63 -31.65 16.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.036 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -68.07 -51.54 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.89 25.73 31.23 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.158 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.09 179.18 6.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -57.46 -36.14 71.05 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.61 74.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.95 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.84 -44.42 97.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.2 tp -59.61 -44.66 93.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.45 -50.53 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.972 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -59.1 -36.77 75.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.288 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -27.72 65.34 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.607 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 32' ' ' LEU . 10.5 t -93.44 23.59 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.215 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 60.34 48.15 8.25 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.54 44.88 2.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.776 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -83.82 120.3 74.86 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.696 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.51 -31.18 3.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.765 2.31 . . . . 0.0 112.801 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -77.05 -42.81 36.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.819 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 48.41 61.98 2.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.233 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.56 146.1 29.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -85.72 119.57 26.2 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.59 ' HB ' HG21 ' A' ' 57' ' ' VAL . 31.6 m -88.89 134.76 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.458 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 7.4 mp -107.05 144.44 33.71 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 t -101.59 139.38 22.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.13 121.64 15.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.309 0.575 . . . . 0.0 110.344 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.42 179.719 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.63 0.252 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.6 m -109.06 163.83 6.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.485 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.41 150.35 34.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.851 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -95.33 126.11 40.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.2 m -134.74 167.08 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 1.6 mttt -103.43 138.4 40.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.6 m -112.77 139.3 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 111.476 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tp -108.22 119.61 39.98 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 CA--C 1.529 0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.085 179.784 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.693 0.283 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 3.2 m120 -87.0 143.4 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.3 p -102.04 140.16 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.678 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -75.0 115.2 14.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.58 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.5 m -115.97 137.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.49 114.83 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.658 HG22 ' CG2' ' A' ' 59' ' ' VAL . 23.1 t -88.69 133.93 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.633 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.37 120.69 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.28 -117.06 3.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.162 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.74 159.83 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 111.175 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 68.61 162.32 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -126.6 135.11 50.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.605 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' VAL . 40.5 m -111.9 163.42 14.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.243 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 52.3 mt-10 -124.61 137.81 54.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.3 p -125.53 143.96 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.86 131.61 34.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.839 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.77 133.3 63.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.671 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.98 -28.29 67.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.528 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.58 -33.87 61.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.276 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.55 -54.92 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 26.75 16.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 170.4 9.28 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.909 0.355 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -62.62 -38.74 91.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.416 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -38.55 74.29 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -64.73 -38.07 89.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.964 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.7 tp -57.61 -42.12 82.63 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.569 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.2 t -65.55 -49.68 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.972 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -60.22 -35.81 76.28 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.14 64.28 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.644 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.0 t -90.93 23.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.187 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.83 46.46 2.97 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.099 0.476 . . . . 0.0 111.167 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.36 34.43 5.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 p -91.22 120.58 68.44 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.499 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.05 -31.48 9.68 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.53 2.153 . . . . 0.0 112.484 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 15' ' ' VAL . 8.7 p-80 -79.38 -41.61 27.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.33 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 43.97 73.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.228 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.568 HG21 HG11 ' A' ' 59' ' ' VAL . 14.0 m -133.28 148.81 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.308 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -85.23 137.62 32.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.77 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.73 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.0 m -96.3 126.96 48.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.392 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.42 141.74 41.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.63 117.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' GLY . 8.3 t70 -63.73 120.49 11.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 C--N 1.335 0.527 0 O-C-N 124.597 1.185 . . . . 0.0 115.002 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.59 161.44 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 111.531 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.815 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.2 m-20 -142.63 157.22 44.91 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.574 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -94.74 125.46 39.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 110.497 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' A' ' 39' ' ' VAL . 14.9 m -133.9 167.86 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.36 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 139.53 47.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.399 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -104.89 141.25 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.603 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -105.22 135.84 45.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.237 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.897 0.379 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.69 136.78 32.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.517 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 15' ' ' VAL . 23.2 m -102.35 139.69 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.026 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 m -74.88 117.58 16.89 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' CG1' HG23 ' A' ' 57' ' ' VAL . 14.4 m -118.03 137.51 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.022 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 114.67 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 59' ' ' VAL . 27.1 t -86.13 133.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.69 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.08 120.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.88 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.92 -114.24 3.06 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.234 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 1.3 pm0 -121.03 158.97 26.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 111.651 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 5.0 mt-10 66.73 163.6 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.923 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -126.88 134.39 50.49 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.494 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 m -110.63 162.92 14.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.79 135.0 52.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.577 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 3' ' ' VAL . 16.4 t -130.04 149.23 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.875 0.369 . . . . 0.0 111.406 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.18 35.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.75 163.83 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.95 -14.85 58.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.546 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.15 -35.44 62.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.25 -44.97 20.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.33 27.02 34.36 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.618 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.78 175.68 7.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -57.15 -32.9 66.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.544 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.22 74.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.14 -40.92 97.2 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -56.99 -39.95 75.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.42 -51.01 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -35.9 77.87 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.092 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -30.0 67.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.534 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.9 t -94.7 23.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.53 48.5 9.62 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.675 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.68 42.54 3.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 t -99.24 132.23 23.76 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.61 -32.89 4.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.535 2.157 . . . . 0.0 112.59 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -80.21 -42.75 22.72 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 46.89 61.67 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.455 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -126.04 146.0 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.212 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 134.97 33.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.046 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' HG21 ' A' ' 57' ' ' VAL . 32.2 m -91.28 135.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.0 152.57 20.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.51 119.92 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.612 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.18 120.03 7.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 CA-C-N 114.801 -1.091 . . . . 0.0 114.76 -179.624 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.457 0.17 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' HB ' HG12 ' A' ' 3' ' ' VAL . 33.2 m -111.21 161.91 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -146.09 156.97 43.82 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -95.32 126.33 40.56 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.492 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.5 m -134.42 167.52 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.22 135.94 42.92 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 7' ' ' VAL . 5.4 m -117.14 140.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 111.523 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.35 119.41 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.843 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.757 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 8.2 m-80 -85.01 145.75 27.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 31.6 t -127.96 139.66 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.62 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.95 113.51 12.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.964 0.411 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.8 m -117.93 137.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.385 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -81.87 115.01 20.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.675 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.3 t -89.98 133.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.41 120.78 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.719 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.41 -56.98 5.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.443 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.58 163.64 26.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.618 0.246 . . . . 0.0 110.95 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -58.77 -174.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.407 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -99.63 131.69 45.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.151 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.22 162.06 34.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 21.6 mt-10 -94.79 139.35 31.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.693 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 HG21 ' A' ' 37' ' ' VAL . 35.2 m -132.58 148.27 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.386 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.39 129.05 34.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.922 HG12 HG11 ' A' ' 39' ' ' VAL . 4.1 m -116.76 150.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.814 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.6 p30 -70.79 -20.67 62.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.044 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.2 -41.35 62.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.786 0.327 . . . . 0.0 111.015 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -54.78 -45.49 74.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.51 26.51 46.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.996 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.48 170.53 9.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 111.465 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.76 75.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.56 -35.18 67.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.058 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.5 m-20 -68.5 -42.64 78.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -43.52 98.7 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 24' ' ' ALA . 8.2 p -70.94 -39.87 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.258 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -66.9 -35.94 81.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.985 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.56 -25.03 23.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 30' ' ' VAL . 10.0 t -89.31 23.35 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.706 0.289 . . . . 0.0 111.392 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 62.84 48.28 4.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 32.57 5.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.93 140.61 25.02 Favored Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.064 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 -32.86 7.22 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.66 -42.75 27.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.132 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.79 72.19 0.34 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 111.024 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.992 HG21 HG11 ' A' ' 15' ' ' VAL . 17.8 m -123.74 146.85 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.343 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 137.85 35.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.746 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.922 HG11 HG12 ' A' ' 17' ' ' VAL . 29.8 m -86.84 131.7 34.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.12 147.46 37.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.223 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.37 117.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.404 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.04 120.09 6.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.335 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 O-C-N 124.447 1.092 . . . . 0.0 115.048 -179.858 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 54' ' ' VAL . 11.5 pt-20 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.6 m -111.39 162.31 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.047 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 23.1 t70 -149.07 154.45 39.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.976 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -94.95 125.2 39.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 110.046 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.1 m -135.86 167.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.265 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.11 140.92 40.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.517 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.675 ' CG2' HG22 ' A' ' 7' ' ' VAL . 6.0 m -101.27 140.88 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 125.81 54.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.689 0.28 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.52 148.96 22.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.466 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.43 139.91 22.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.844 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -74.88 113.34 12.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.11 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' HG23 ' A' ' 57' ' ' VAL . 35.7 m -117.7 135.69 57.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.228 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 114.89 23.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.6 t -83.74 130.96 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.38 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.62 120.43 16.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.19 -57.41 4.77 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.161 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 163.53 26.07 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.683 0.278 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.55 -177.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -99.65 134.25 42.8 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.959 0.409 . . . . 0.0 111.07 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 m -137.19 160.45 38.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.228 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.34 137.39 32.41 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 37' ' ' VAL . 9.1 p -130.77 145.69 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.48 125.83 32.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.727 ' CG1' HG11 ' A' ' 39' ' ' VAL . 9.2 m -119.76 161.42 19.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.672 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.94 -36.94 64.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.052 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -31.37 65.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.48 -48.05 72.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.85 26.06 63.37 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.606 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -100.62 178.89 4.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.015 0.408 . . . . 0.0 111.03 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -59.09 -34.63 72.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -36.1 72.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.78 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -59.25 -38.7 80.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.21 -45.22 91.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.686 0.279 . . . . 0.0 110.779 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.05 -47.73 59.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.97 81.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.673 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.12 53.51 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.731 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.4 t -90.57 23.48 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.988 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.29 48.36 10.31 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.009 0.433 . . . . 0.0 111.042 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -127.12 45.24 2.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -84.65 129.11 58.36 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -33.09 10.61 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.95 -40.97 26.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.189 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.27 59.14 2.78 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.671 HG23 HG21 ' A' ' 15' ' ' VAL . 5.6 m -126.44 146.01 33.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 m -86.13 123.3 31.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.727 HG11 ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -91.52 127.65 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.38 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -116.76 133.28 56.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 57' ' ' VAL . 30.2 t -101.48 117.79 47.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' GLY . 13.4 t70 -56.23 120.66 7.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.902 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 C--N 1.339 0.746 0 O-C-N 124.843 1.34 . . . . 0.0 115.679 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.519 0.2 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.51 162.29 30.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.707 0.289 . . . . 0.0 111.34 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.94 154.69 39.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -95.56 129.93 42.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 39' ' ' VAL . 4.2 m -135.23 167.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.261 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.37 138.2 50.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.477 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.807 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.7 m -103.1 138.4 27.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.46 117.17 33.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.176 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.066 179.86 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.457 0.17 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -86.16 148.96 25.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -102.19 139.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.466 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.13 113.57 11.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.286 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.986 HG21 HG13 ' A' ' 59' ' ' VAL . 2.1 p -114.39 135.12 55.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.268 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.5 114.94 22.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.849 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.7 t -85.93 133.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -77.33 120.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -23.68 11.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.111 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.64 164.11 15.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.573 0.349 . . . . 0.0 110.826 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.91 -173.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.39 129.34 45.58 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -126.29 163.09 23.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.22 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.9 137.67 42.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.89 146.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.38 31.01 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.228 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.53 157.89 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -18.23 48.93 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -41.02 73.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.556 0.217 . . . . 0.0 111.315 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -51.64 -35.94 44.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.792 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.31 26.07 69.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.588 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -93.34 166.75 12.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.215 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -34.58 74.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.44 70.22 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.278 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 13.9 m-20 -58.98 -38.12 78.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.993 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -58.51 -34.25 70.74 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.622 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -70.45 -51.57 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 25' ' ' ASP . 1.4 ptm180 -65.18 -35.43 81.05 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.171 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -25.32 39.97 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.2 t -87.48 23.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.615 0.245 . . . . 0.0 111.156 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 65.47 47.5 2.26 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.6 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -128.18 37.18 4.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.728 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -77.61 124.71 86.58 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.77 -32.78 2.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.697 2.265 . . . . 0.0 112.913 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -42.9 32.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.2 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.02 72.1 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.216 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' HE ' ' A' ' 61' ' ' ARG . 19.1 m -123.68 157.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.413 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 m -84.76 116.92 23.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.554 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -94.3 137.07 23.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 58' ' ' LYS . 6.7 mt -81.99 157.81 24.09 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.45 139.68 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.58 130.33 13.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.718 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 -179.431 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.08 171.57 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.355 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -146.22 157.39 43.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.214 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 133.99 38.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.602 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' VAL . 6.3 m -129.47 167.38 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.858 ' HB2' HD12 ' A' ' 40' ' ' LEU . 23.0 mmtp -115.75 133.47 56.0 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.986 HG13 HG21 ' A' ' 5' ' ' VAL . 19.0 m -100.76 131.69 47.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.902 0.382 . . . . 0.0 111.307 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 111.24 23.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HE ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.647 0.26 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -84.9 146.61 27.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 111.002 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.0 p -134.24 140.02 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.81 113.41 12.06 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.104 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' VAL . 15.3 m -118.59 136.19 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.246 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -81.51 114.72 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.791 HG22 ' CG2' ' A' ' 59' ' ' VAL . 14.2 t -90.15 130.48 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.2 120.68 23.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.717 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.52 -51.37 3.0 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.395 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 163.39 14.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.658 0.266 . . . . 0.0 111.037 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.44 -177.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -99.62 127.02 45.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.193 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -131.12 162.64 29.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.267 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -92.89 137.77 32.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.836 HG11 HG21 ' A' ' 37' ' ' VAL . 24.4 m -129.87 150.47 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.202 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.49 126.85 33.65 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG12 HG11 ' A' ' 39' ' ' VAL . 7.2 m -116.51 160.7 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.765 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -84.71 -31.86 23.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.307 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.51 -31.63 24.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.078 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -51.92 -40.99 61.66 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.515 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.52 26.16 70.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -95.06 179.09 5.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 111.155 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.13 -32.88 66.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.238 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.6 67.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.366 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -58.48 -43.92 89.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.556 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -45.02 85.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.27 -45.65 78.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -35.88 73.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.028 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.73 34.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.637 ' HB ' HD13 ' A' ' 32' ' ' LEU . 9.4 t -91.26 23.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.675 0.274 . . . . 0.0 111.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 64.62 48.2 2.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.056 0.455 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.637 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -119.22 48.9 1.41 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.5 t -99.01 120.37 58.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.54 -33.02 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.571 2.181 . . . . 0.0 113.224 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -79.89 -42.66 23.7 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.264 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 50.42 66.37 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.076 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 15' ' ' VAL . 26.2 m -123.81 151.31 28.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 121.33 33.85 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.656 HG11 HG12 ' A' ' 17' ' ' VAL . 16.8 m -90.92 132.47 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 4.3 mm? -102.17 134.93 44.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 130.65 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -63.58 119.77 10.47 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.573 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.88 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.686 ' HG3' HG13 ' A' ' 54' ' ' VAL . 16.9 pt-20 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.408 0.147 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.686 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.9 m -108.0 161.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.387 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 3' ' ' VAL . 23.9 t70 -147.92 154.11 39.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.667 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -94.93 125.94 39.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.203 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.2 m -134.18 167.37 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.62 141.1 36.0 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.791 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.8 m -112.49 131.83 62.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 111.318 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.06 122.38 44.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HG21 ' A' ' 22' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.602 0.239 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -92.67 146.98 23.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.745 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.5 t -121.76 139.57 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.931 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.21 113.42 12.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 57' ' ' VAL . 17.4 m -118.44 137.22 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -81.8 114.81 20.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.5 t -86.86 133.23 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.72 120.66 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.638 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.82 -57.58 5.05 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.418 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.53 163.78 25.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -58.22 -175.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.249 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 5' ' ' VAL . 60.1 m -99.64 130.44 45.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.928 0.394 . . . . 0.0 111.187 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -127.48 162.72 25.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.55 130.89 42.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.977 HG11 HG21 ' A' ' 37' ' ' VAL . 26.8 m -129.77 144.3 38.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 35' ' ' HIS . . . -84.25 126.61 33.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.041 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 20' ' ' ASP . 26.8 m -117.11 161.98 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.135 0.493 . . . . 0.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.72 -41.94 78.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.335 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.69 -41.57 56.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.962 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' VAL . 1.6 t0 -47.19 -40.94 17.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.387 0.429 . . . . 0.0 111.582 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.94 26.38 69.14 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.931 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -99.55 178.47 4.85 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.87 0.367 . . . . 0.0 111.111 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -32.75 66.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.219 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.82 70.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.17 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.42 -44.03 95.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.869 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.68 -46.43 89.08 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.69 0.281 . . . . 0.0 110.8 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 32' ' ' LEU . 20.5 t -67.53 -44.88 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.52 -36.15 81.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.23 -26.87 42.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.84 23.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.562 0.22 . . . . 0.0 111.331 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.3 42.0 9.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.059 0.457 . . . . 0.0 110.964 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 27' ' ' VAL . 3.5 mt -121.1 39.43 3.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.529 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.08 120.67 72.65 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.22 -33.15 7.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.505 2.136 . . . . 0.0 112.494 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.526 ' ND1' HG22 ' A' ' 37' ' ' VAL . 14.7 p80 -79.89 -42.07 24.92 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.096 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 51.67 70.26 0.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.977 HG21 HG11 ' A' ' 15' ' ' VAL . 26.9 m -135.68 147.29 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.414 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.18 136.97 32.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.796 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.2 m -93.34 133.96 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.399 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.83 148.01 31.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 t -106.65 117.72 52.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.01 120.18 11.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.149 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.684 0 O-C-N 124.411 1.069 . . . . 0.0 114.786 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 . . . . . 0 N--CA 1.464 0.246 0 CA-C-O 120.435 0.159 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 55' ' ' ASP . 8.7 t -110.65 161.66 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 110.546 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.745 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 145.72 28.28 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -95.0 125.24 39.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.288 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.1 m -136.21 167.17 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -102.24 141.67 34.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 7' ' ' VAL . 4.4 m -106.07 137.61 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.838 0.352 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.75 128.49 56.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.174 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.353 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.86 0.362 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -89.3 142.16 27.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.31 140.0 21.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -74.67 113.2 11.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 110.485 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG23 ' A' ' 57' ' ' VAL . 31.9 m -118.87 137.6 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.378 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.15 114.95 21.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.781 HG22 ' CG2' ' A' ' 59' ' ' VAL . 21.6 t -88.66 133.98 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.419 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.22 120.62 4.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.6 -49.44 3.15 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.55 163.3 26.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.626 0.251 . . . . 0.0 110.972 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.41 -100.0 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -127.96 135.06 49.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 111.349 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 t -132.07 162.89 29.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.245 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -123.47 138.54 54.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG21 HG23 ' A' ' 37' ' ' VAL . 11.4 p -131.98 147.88 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.257 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.736 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 125.79 32.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.17 161.05 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.47 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.6 -26.98 37.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.725 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.54 -34.87 67.46 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.599 0.238 . . . . 0.0 110.929 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -52.73 -61.09 2.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.18 57.11 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.709 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.73 178.91 5.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 111.141 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -57.17 -38.93 74.32 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.15 82.76 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.932 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -60.38 -37.51 80.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -41.73 78.52 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.809 0.338 . . . . 0.0 110.555 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.96 -50.71 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 tmt_? -59.34 -36.16 75.18 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.213 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.31 36.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.99 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 30' ' ' VAL . 8.4 t -92.14 23.46 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.702 0.287 . . . . 0.0 111.309 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.61 47.32 4.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.134 0.492 . . . . 0.0 111.454 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 33.16 4.99 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.8 120.27 68.81 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.863 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.82 -32.47 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.951 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.93 -41.12 75.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.97 69.37 0.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.036 0.446 . . . . 0.0 111.176 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 HG21 ' A' ' 15' ' ' VAL . 23.4 m -124.02 145.8 30.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.239 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.8 m -96.77 119.43 35.22 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.831 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.2 m -84.18 131.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.519 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.1 mt -105.51 147.64 28.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 t -102.15 136.68 33.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.864 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.85 120.83 14.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.65 0.262 . . . . 0.0 110.333 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 CA-C-N 115.191 -0.913 . . . . 0.0 114.625 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' HG13 ' A' ' 54' ' ' VAL . 17.2 pt-20 . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.516 0.198 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.543 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.4 m -113.41 162.22 11.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.797 0.332 . . . . 0.0 111.214 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -147.97 152.3 37.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -97.13 125.12 41.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.41 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.505 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.4 m -136.26 167.13 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.15 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -110.64 128.71 55.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.781 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -100.86 141.62 17.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.975 0.417 . . . . 0.0 111.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 61' ' ' ARG . 4.3 tt -97.64 128.53 44.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.959 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.507 0.194 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -91.59 148.78 22.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.76 0.315 . . . . 0.0 110.648 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 15' ' ' VAL . 20.4 m -102.15 139.96 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.727 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -74.48 114.3 12.72 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.3 m -116.48 137.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.303 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 114.76 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' CG2' ' A' ' 59' ' ' VAL . 18.5 t -88.15 134.22 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.96 120.26 3.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.475 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.38 -118.14 4.19 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.246 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -120.73 159.04 26.19 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 70.19 155.19 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.05 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.1 m -116.23 134.9 54.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.393 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.442 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.6 t -108.51 161.98 14.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.298 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.01 131.93 52.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 3' ' ' VAL . 9.9 p -122.92 144.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.778 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . . . -85.19 134.97 34.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.241 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.58 159.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 111.88 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.85 -33.78 45.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.299 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -56.73 -35.82 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -55.18 -48.54 73.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.779 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.21 42.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.15 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 179.17 5.55 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -57.31 -32.65 66.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.181 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.76 74.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.06 -44.4 91.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.559 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -41.1 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.12 -50.08 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 1.1 mtp-105 -60.39 -36.05 77.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.359 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.596 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 30' ' ' VAL . 10.7 t -95.58 23.15 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.717 0.294 . . . . 0.0 111.221 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 59.27 46.94 12.14 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.47 46.02 2.31 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.64 120.46 72.96 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-O 120.598 0.237 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.674 2.25 . . . . 0.0 113.008 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.75 23.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 111.175 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.24 61.97 2.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.089 0.471 . . . . 0.0 111.173 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.51 146.08 29.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 m -85.49 132.21 34.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.7 m -93.71 131.42 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.61 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 3.9 mm? -107.29 147.71 29.9 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.19 117.79 52.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.86 120.12 11.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.419 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 CA-C-N 114.827 -1.078 . . . . 0.0 115.153 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 120.424 0.154 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.96 161.63 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 111.498 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 152.63 40.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -95.63 125.23 40.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.525 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.561 HG21 ' HB ' ' A' ' 39' ' ' VAL . 12.4 m -135.69 167.09 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.4 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 6.2 mmtt -107.65 140.11 41.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.729 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.9 m -102.2 136.12 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.315 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.2 112.41 23.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.604 0.24 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.81 144.21 26.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.0 t -111.98 139.91 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -74.7 113.49 12.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.98 135.55 53.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.398 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.71 114.65 20.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.828 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.3 t -89.27 133.9 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.03 120.45 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.91 -45.09 2.32 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.53 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.41 164.01 12.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.458 0.303 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.31 -176.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -99.25 132.5 44.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -134.69 163.01 30.73 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -94.91 138.12 33.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.217 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 37' ' ' VAL . 11.1 p -131.33 147.61 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 127.85 34.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.65 160.6 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -76.05 -34.52 59.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.897 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -52.77 -35.56 56.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.794 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.29 -51.18 70.42 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.85 26.19 46.49 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.799 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -88.28 162.25 16.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.378 . . . . 0.0 111.265 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -57.57 -35.62 70.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.056 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.76 73.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.246 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.39 -37.31 77.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.373 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.23 -40.01 73.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.794 0.331 . . . . 0.0 110.577 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.07 -48.05 57.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.841 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -61.89 -35.7 79.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.27 -25.14 32.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.1 t -88.8 23.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.6 0.238 . . . . 0.0 111.218 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 64.34 47.5 3.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.466 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.6 mp -122.58 34.9 5.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 4.1 p -94.68 120.51 64.72 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 23.7 Cg_exo -64.04 -32.78 64.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.678 2.252 . . . . 0.0 112.56 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -43.04 23.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.341 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 48.53 67.2 0.89 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.069 0.462 . . . . 0.0 111.04 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.502 ' CG2' HG11 ' A' ' 59' ' ' VAL . 16.1 m -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.39 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 m -91.37 135.66 33.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.5 m -88.3 130.05 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 149.1 33.29 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -116.4 119.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.623 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 17.8 t0 -52.47 120.59 5.77 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.53 0 O-C-N 124.481 1.113 . . . . 0.0 114.904 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.541 0.21 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.09 165.99 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.952 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.1 m-20 -145.99 154.9 42.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -94.64 125.45 39.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 110.539 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.647 HG21 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m -134.53 167.78 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.952 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 42' ' ' ASP . 6.7 ptpp? -109.72 139.9 44.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.828 ' CG2' HG22 ' A' ' 7' ' ' VAL . 9.4 m -106.1 141.66 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 111.443 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.62 118.48 36.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.785 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.3 p30 -89.41 147.9 23.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.896 0.379 . . . . 0.0 110.613 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' A' ' 54' ' ' VAL . 27.6 m -102.35 139.95 22.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.43 113.42 11.64 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.4 m -118.4 135.43 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.694 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.98 115.02 22.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.569 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.818 HG22 HG23 ' A' ' 59' ' ' VAL . 17.8 t -84.69 134.14 27.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.53 120.62 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.555 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.3 -55.55 5.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.431 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 163.93 25.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.358 0.263 . . . . 0.0 110.989 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -167.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.473 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -99.34 128.04 45.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.936 0.398 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -126.65 162.82 24.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.063 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 2' ' ' ASN . 6.6 mp0 -105.69 145.26 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG21 ' CG2' ' A' ' 37' ' ' VAL . 7.4 p -130.97 147.06 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 123.64 30.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 111.065 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.416 HG23 HG22 ' A' ' 3' ' ' VAL . 20.1 t -121.97 152.25 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.718 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.75 -44.77 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.301 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -28.67 46.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.118 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' OD1' HG13 ' A' ' 54' ' ' VAL . 18.1 t70 -50.53 -29.53 10.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.7 25.95 61.75 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.732 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -107.49 179.05 4.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.887 0.375 . . . . 0.0 111.294 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.34 -32.35 66.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.074 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.78 -35.67 66.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.946 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.76 -44.71 90.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.511 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.975 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 t -70.53 -47.25 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.2 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.42 63.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.648 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.6 t -92.61 20.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.602 0.239 . . . . 0.0 111.275 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.76 45.12 2.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.2 88.57 2.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -115.81 120.5 35.66 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.96 -33.13 2.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.659 2.239 . . . . 0.0 112.8 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.54 -42.28 25.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.198 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.98 57.5 6.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' A' ' 15' ' ' VAL . 10.6 m -123.62 152.17 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -84.75 134.17 34.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.4 m -105.88 132.18 53.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.918 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 14.2 mt -101.55 151.52 21.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.25 139.35 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -47.61 124.0 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.74 0 O-C-N 124.204 0.94 . . . . 0.0 114.547 -178.846 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG3' HG23 ' A' ' 54' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.687 0.279 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 53' ' ' GLU . 3.3 t -124.13 161.36 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.43 146.1 27.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -95.42 125.08 39.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.221 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 39' ' ' VAL . 29.5 m -130.63 167.16 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.1 mttt -104.22 140.24 38.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.57 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.818 HG23 HG22 ' A' ' 7' ' ' VAL . 2.3 m -113.01 140.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.727 0.299 . . . . 0.0 111.329 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.51 131.05 54.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.946 0.403 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 53.6 m-20 -89.12 138.16 31.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.496 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 39.9 t -102.53 140.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 113.5 12.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.215 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.9 m -117.74 137.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.489 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.96 114.8 21.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.741 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.651 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.4 t -88.32 134.36 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.22 120.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.482 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.93 -33.01 5.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.784 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.01 163.95 14.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.416 0.286 . . . . 0.0 110.757 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -169.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.44 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -99.68 132.87 44.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.057 0.455 . . . . 0.0 111.236 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m -132.73 160.16 37.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 2' ' ' ASN . 3.1 mp0 -89.2 132.83 34.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.845 HG11 HG21 ' A' ' 37' ' ' VAL . 30.0 m -130.22 145.95 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.304 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.21 125.94 32.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 111.361 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 3.3 m -119.0 137.76 51.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.941 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -27.59 47.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.681 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -40.81 63.31 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.949 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' CG ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -49.24 -45.94 45.3 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.368 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.26 71.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.621 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.42 174.18 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -57.44 -38.51 74.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.205 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.1 78.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.407 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -59.35 -37.02 76.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.46 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.2 -42.71 77.6 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.28 -44.57 72.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG3' ' HB3' ' A' ' 33' ' ' SER . 10.6 ttp85 -59.57 -36.03 75.43 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.289 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.31 -25.07 58.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.918 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 30' ' ' VAL . 9.0 t -89.47 23.37 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.618 0.247 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.93 48.23 2.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.101 0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -121.22 37.48 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -92.9 120.74 66.94 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.703 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 16.0 Cg_exo -67.68 -33.16 28.73 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.8 2.333 . . . . 0.0 112.54 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -79.57 -42.92 23.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 51.38 65.29 1.53 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.845 HG21 HG11 ' A' ' 15' ' ' VAL . 3.4 m -125.48 145.99 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.518 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 m -88.03 136.6 32.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.648 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.749 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.0 m -98.82 134.64 36.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.44 140.36 48.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.77 137.56 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -66.61 120.16 12.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.346 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 CA-C-N 115.126 -0.943 . . . . 0.0 114.528 -179.865 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.409 0.147 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 20' ' ' ASP . 25.6 m -130.89 161.85 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.298 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -149.27 156.67 42.47 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -95.12 124.63 39.27 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.749 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.0 m -134.92 167.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.16 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.88 130.78 55.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.572 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.651 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -103.3 141.74 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.06 127.52 53.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.021 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.751 0.31 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.55 146.01 24.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.071 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 55' ' ' ASP . 23.6 t -120.83 139.79 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -75.01 114.94 14.08 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 57' ' ' VAL . 10.0 m -118.15 137.66 51.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.264 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.33 114.79 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.565 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.46 134.14 32.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.03 120.35 3.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.87 -118.36 3.43 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.183 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -120.93 152.88 37.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.55 165.09 0.22 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.123 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -117.99 135.43 54.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.679 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.15 159.98 15.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.394 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.73 127.27 45.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.222 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.18 149.26 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 127.05 34.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.356 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 4.2 m -116.98 148.77 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -23.38 67.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.758 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -54.24 -37.94 65.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.785 0.326 . . . . 0.0 110.808 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.97 -43.83 86.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.255 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.36 26.32 40.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.226 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 163.98 12.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.959 0.379 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -60.08 -38.4 82.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.365 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.46 71.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.259 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.09 -41.86 98.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.17 77.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.28 -44.33 94.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.664 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -35.89 82.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.89 -25.08 41.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.698 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.808 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.6 t -88.71 23.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.5 48.34 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 111.135 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.808 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.4 mt -130.65 44.81 2.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -99.18 136.53 20.47 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 -33.18 6.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.466 2.111 . . . . 0.0 112.529 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -42.35 23.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.203 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 54.59 59.35 4.18 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.4 146.32 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.268 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -90.49 138.48 31.52 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.801 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.5 m -96.59 132.0 42.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 140.21 45.34 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.67 135.49 38.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.96 120.46 13.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 110.231 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.612 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.57 -179.815 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.596 0.236 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.9 161.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.741 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 3' ' ' VAL . 28.1 t70 -148.17 151.21 35.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -95.21 125.48 39.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.948 0.404 . . . . 0.0 110.663 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.5 m -132.25 167.35 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.17 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -108.49 136.7 47.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.679 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 5' ' ' VAL . 15.0 m -102.18 140.81 19.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.311 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.31 132.2 56.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 . . . . . 0 CA--C 1.532 0.262 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.998 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -85.26 133.16 34.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.725 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.8 p -103.08 140.45 21.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.922 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -74.73 113.19 11.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.313 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.485 HG23 ' OG ' ' A' ' 13' ' ' SER . 30.0 m -118.75 138.05 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.249 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.76 115.0 20.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.406 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 59' ' ' VAL . 10.0 p -99.24 133.94 40.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.06 120.77 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.2 -55.82 0.69 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.468 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 163.39 22.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.587 0.232 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.66 -82.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.99 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -127.95 135.01 49.36 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.037 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.485 ' OG ' HG23 ' A' ' 5' ' ' VAL . 26.7 p -120.62 147.91 44.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.487 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.73 128.97 55.83 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.35 145.86 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB2' HH11 ' A' ' 28' ' ' ARG . . . -84.19 138.28 33.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.64 160.09 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.265 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 5.5 t70 -99.05 -22.84 15.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.004 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -24.99 65.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -62.2 -60.55 3.43 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.42 35.74 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.859 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -89.97 178.61 6.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.912 0.356 . . . . 0.0 111.312 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -40.14 83.58 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.56 81.54 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.621 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 21.0 t0 -59.86 -37.92 80.67 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.61 -40.56 72.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.54 0.209 . . . . 0.0 110.687 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 t -71.26 -50.68 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HB2' ' A' ' 16' ' ' ALA . 8.3 mmt85 -63.06 -35.67 81.01 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.557 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.1 26.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' HD13 ' A' ' 32' ' ' LEU . 8.7 t -85.74 22.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.592 0.234 . . . . 0.0 111.441 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.35 47.98 2.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 110.983 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.609 HD13 ' HB ' ' A' ' 30' ' ' VAL . 9.8 mp -116.09 38.05 3.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.959 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.15 121.52 71.42 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 120.727 0.298 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.34 -29.52 9.35 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 113.06 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -77.71 -42.62 33.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.097 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.09 70.49 0.4 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 111.402 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.45 155.61 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.489 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 t -85.32 138.32 32.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.7 m -110.36 129.73 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.456 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.8 139.99 45.61 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.72 135.11 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -47.75 122.06 4.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 O-C-N 124.414 1.071 . . . . 0.0 115.014 -178.532 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.6 0.238 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 161.84 22.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.786 0.327 . . . . 0.0 111.186 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.825 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 157.08 43.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -94.35 125.09 38.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.051 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.9 m -133.63 167.49 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.681 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 141.35 35.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 5' ' ' VAL . 16.2 m -116.54 141.32 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.794 0.33 . . . . 0.0 111.346 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mt -114.65 129.08 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.674 0.273 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -85.02 135.62 33.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.882 HG11 ' O ' ' A' ' 55' ' ' ASP . 11.8 t -102.34 140.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.47 118.65 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.511 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 57' ' ' VAL . 18.0 m -117.2 137.45 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.068 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.41 114.66 20.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 59' ' ' VAL . 16.1 t -87.75 134.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 t -57.31 120.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.89 -117.59 4.33 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.04 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -120.7 159.86 24.48 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.604 0.24 . . . . 0.0 111.251 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 69.49 145.71 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.016 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 135.03 54.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.408 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -118.58 163.35 16.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.7 144.12 44.39 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.032 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG11 HG12 ' A' ' 39' ' ' VAL . 11.8 p -120.13 139.63 46.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.65 130.24 34.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.868 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.54 160.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.901 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.42 -21.36 15.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.895 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -34.91 50.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.514 0.197 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -68.56 -51.63 40.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.61 26.02 18.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.468 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.95 178.72 6.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.05 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.41 -32.82 67.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.467 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.76 70.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.651 0.262 . . . . 0.0 110.92 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.72 -40.53 95.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.753 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.18 -37.42 69.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.861 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.69 -51.2 48.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.979 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -36.27 79.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -28.44 61.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.71 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.587 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.7 t -93.55 21.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.672 0.272 . . . . 0.0 111.203 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 62.77 46.82 4.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 30' ' ' VAL . 1.2 mp -128.06 50.95 2.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.6 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.51 119.69 67.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.31 -27.35 2.87 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.388 . . . . 0.0 112.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 37' ' ' VAL . 7.0 p80 -65.04 -43.39 92.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.96 45.52 8.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.985 0.421 . . . . 0.0 111.575 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 35' ' ' HIS . 18.6 m -126.88 160.52 35.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.91 122.99 44.44 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.722 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.9 m -82.0 135.17 25.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -103.96 145.27 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -101.68 126.07 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.17 120.0 12.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.771 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.947 179.897 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.47 0.176 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.24 162.18 39.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.882 ' O ' HG11 ' A' ' 3' ' ' VAL . 2.1 p30 -148.59 154.81 40.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -94.83 125.26 39.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.3 m -133.62 167.88 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.582 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.18 136.48 41.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.082 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.3 m -108.41 140.24 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.855 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 60' ' ' LEU . 3.2 pp -99.35 131.77 45.14 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.526 HH21 HG11 ' A' ' 7' ' ' VAL . 12.5 ttm180 . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.743 0.306 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -93.1 147.3 22.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.026 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 15' ' ' VAL . 12.7 m -112.12 139.6 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m -74.88 113.59 12.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 59' ' ' VAL . 27.7 m -117.03 136.29 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.443 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -81.65 114.7 20.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.761 HG22 ' CG2' ' A' ' 59' ' ' VAL . 8.7 t -89.03 133.29 31.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.636 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.65 120.4 33.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.546 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.09 -24.92 13.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.973 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.7 163.97 15.68 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 110.796 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -169.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.795 0.331 . . . . 0.0 111.709 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 131.2 45.38 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.35 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -133.1 162.99 30.26 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.043 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.16 140.23 39.45 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 3' ' ' VAL . 11.4 p -132.49 146.96 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 125.83 32.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.999 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 39' ' ' VAL . 6.9 m -116.32 161.63 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.909 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.3 -33.86 59.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -39.2 58.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.863 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 54' ' ' VAL . 1.3 t70 -48.01 -47.33 33.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.802 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.97 26.5 70.92 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.191 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.48 174.49 6.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.952 0.376 . . . . 0.0 111.143 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.86 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.313 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.42 -36.03 70.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.183 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 27.9 t0 -58.95 -39.33 81.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.892 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -65.43 -35.66 81.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.693 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.56 -51.34 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.067 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -63.28 -35.43 80.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.044 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.68 -25.05 37.75 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.82 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.5 t -85.72 23.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.93 48.28 2.39 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.247 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.1 mt -132.32 52.78 2.05 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.3 130.4 22.9 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.739 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.36 -32.93 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.615 2.21 . . . . 0.0 113.23 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.8 -43.0 23.24 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 48.37 67.45 0.85 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.345 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 59' ' ' VAL . 22.7 m -128.06 149.59 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.502 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -85.2 138.66 32.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 17' ' ' VAL . 31.5 m -99.31 131.62 46.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.296 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' LEU . 4.0 mm? -103.9 151.26 23.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.9 t -118.25 139.27 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.814 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -47.55 124.45 7.03 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.775 0 O-C-N 124.083 0.864 . . . . 0.0 114.356 -178.626 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.9 pt-20 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.534 0.207 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.451 HG12 ' OD2' ' A' ' 20' ' ' ASP . 35.9 m -106.43 161.86 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 149.97 34.54 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.853 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 129.77 42.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.345 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.612 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.6 m -135.23 167.15 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.394 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -105.39 136.29 45.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.487 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.761 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.9 m -101.82 136.52 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.3 113.01 25.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.267 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.651 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.584 ' HB2' HG21 ' A' ' 22' ' ' THR . 25.9 tpp . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.813 0.34 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.32 149.36 23.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.82 140.01 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.51 113.54 11.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.6 m -117.43 137.27 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.672 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.46 115.24 21.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.83 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.0 t -90.01 134.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.56 120.38 30.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.15 17.91 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.042 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.64 163.71 16.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.771 0.285 . . . . 0.0 110.825 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -168.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.467 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -99.69 122.84 43.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.046 0.45 . . . . 0.0 111.195 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m -123.24 162.94 21.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.265 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.79 139.57 40.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.29 143.66 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.33 128.64 34.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 20' ' ' ASP . 28.8 m -116.18 161.11 15.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.92 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.73 -34.33 21.25 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -31.02 64.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.223 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -54.02 -46.83 71.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.83 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.7 26.06 54.83 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.584 HG21 ' HB2' ' A' ' 1' ' ' MET . 0.6 OUTLIER -95.74 179.09 5.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -58.11 -34.22 69.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.171 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.7 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.091 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.97 -42.72 90.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.78 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -58.76 -46.47 87.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.771 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.99 -50.44 79.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -58.89 -37.37 76.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.18 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.54 -27.46 49.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.834 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.1 t -94.26 23.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.289 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.05 48.35 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.09 0.471 . . . . 0.0 111.033 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.479 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -126.9 52.33 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.581 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . 52.6 p -90.2 120.48 69.16 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.64 -32.97 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.627 2.218 . . . . 0.0 112.916 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -39.68 31.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.402 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 39.52 62.1 1.25 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.869 0.468 . . . . 0.0 111.883 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.77 153.72 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.68 137.17 33.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.593 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.2 m -105.34 134.87 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 6.8 mp -100.33 147.21 26.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.663 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.822 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.0 t -101.72 117.81 47.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.87 120.25 12.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.301 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 32.79 36.54 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.009 -0.996 . . . . 0.0 114.739 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.822 ' HB2' HG12 ' A' ' 41' ' ' VAL . 16.6 mtt85 -132.61 120.51 16.74 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 117.151 0.475 . . . . 0.0 111.531 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.32 -40.18 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 112.771 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.04 103.59 11.77 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-O 120.794 0.33 . . . . 0.0 111.306 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.55 -17.64 42.65 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.956 2.437 . . . . 0.0 112.685 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.35 -21.28 59.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.386 0.274 . . . . 0.0 111.48 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.47 -13.69 60.09 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.49 0.186 . . . . 0.0 111.247 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -107.5 166.54 10.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.1 t -146.95 92.9 2.19 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 t -145.73 141.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.45 -46.08 76.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.082 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' OD2' ' A' ' 20' ' ' ASP . 33.3 m -124.16 161.86 26.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.112 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -149.22 153.97 38.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -95.38 124.96 39.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.875 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.7 m -134.83 166.63 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.5 mttt -104.46 136.03 44.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.54 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.83 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.2 m -106.69 141.23 22.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.842 0.354 . . . . 0.0 111.426 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 119.04 38.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -35.37 79.03 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 tp -149.28 110.97 4.52 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.76 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 66' ' ' GLY . 2.7 pp -67.72 156.9 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.537 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.01 -43.54 13.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.404 ' C ' HD13 ' A' ' 63' ' ' ILE . . . -124.81 -49.77 0.2 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.651 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' N ' HD13 ' A' ' 63' ' ' ILE . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.555 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.69 0.281 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -84.91 146.71 27.13 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.1 p -117.37 140.13 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.709 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -74.6 113.24 11.62 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 57' ' ' VAL . 20.1 m -118.7 136.43 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.36 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.6 mt-10 -81.49 114.85 20.49 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.447 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 59' ' ' VAL . 21.6 t -89.67 133.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.805 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.86 120.61 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.89 -57.42 5.01 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.449 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.76 163.51 26.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.37 -172.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.521 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.5 m -99.52 121.05 40.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.951 0.405 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.5 t -120.96 161.71 21.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.55 140.83 33.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 37' ' ' VAL . 10.1 p -128.24 150.75 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 124.67 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.93 164.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.707 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -88.53 -29.54 19.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.55 -37.61 63.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 32.5 p30 -50.72 -30.39 13.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.54 25.62 75.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.983 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -103.07 179.14 4.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -57.02 -32.8 66.52 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.33 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.46 -36.96 69.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.207 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.74 -44.75 93.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.632 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -57.2 -36.29 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.049 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 t -70.88 -51.08 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.888 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -35.89 76.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.185 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.2 65.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.577 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.8 t -94.53 20.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.276 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.36 47.85 3.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.991 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.97 49.63 1.95 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 p -93.28 120.43 66.69 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 14.1 Cg_exo -68.99 -32.95 20.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.705 2.27 . . . . 0.0 112.583 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.459 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -79.77 -42.77 23.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.377 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.17 55.23 6.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.082 0.468 . . . . 0.0 110.952 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 15' ' ' VAL . 11.7 m -124.04 148.83 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.298 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.2 m -84.68 133.46 34.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.5 m -109.42 131.2 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.493 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.98 141.67 40.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.695 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.443 HG21 ' HD3' ' A' ' 47' ' ' PRO . 23.0 t -100.81 139.27 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -74.43 120.69 20.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.253 0.549 . . . . 0.0 109.643 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.94 -54.54 0.56 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.154 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.17 163.6 36.98 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.634 0.254 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.34 -49.93 4.09 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.657 2.238 . . . . 0.0 112.589 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.92 152.61 74.39 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.923 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD3' HG21 ' A' ' 41' ' ' VAL . 38.5 Cg_exo -60.94 95.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.863 2.375 . . . . 0.0 112.239 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.06 -35.35 78.07 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.5 -18.23 13.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.711 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 59.61 54.27 4.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -63.8 131.44 47.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.145 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t 69.22 153.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.111 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.7 pt-20 -58.83 -48.43 81.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.86 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.5 m -117.83 162.17 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.208 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.799 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.9 t70 -148.28 155.86 41.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -94.72 127.66 40.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.715 0.293 . . . . 0.0 110.347 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.2 m -131.64 167.23 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.903 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -102.78 140.75 36.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.779 HG23 HG22 ' A' ' 7' ' ' VAL . 3.8 m -118.49 141.94 35.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.12 115.29 29.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -45.14 68.62 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tp -175.99 98.99 0.07 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.622 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.2 tp -95.31 141.98 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.305 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -166.69 35.16 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.83 123.28 0.12 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.655 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.674 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.779 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -85.61 142.46 29.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 55' ' ' ASP . 41.2 t -129.22 139.91 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -75.0 113.62 12.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.436 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 ' CG1' ' A' ' 59' ' ' VAL . 22.7 m -118.04 137.56 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.363 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.87 115.04 20.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.783 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.2 t -88.88 134.12 29.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.75 120.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.27 -57.19 5.04 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.397 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 163.57 26.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.63 -170.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.48 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -99.73 122.53 42.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 111.014 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -121.34 162.56 20.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.083 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -100.47 138.44 37.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 HG21 ' A' ' 37' ' ' VAL . 27.3 m -131.5 150.56 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.339 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.58 127.02 33.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.819 0.342 . . . . 0.0 111.398 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 39' ' ' VAL . 3.4 m -121.94 139.55 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.5 -21.93 64.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -35.16 47.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.59 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.16 -48.3 80.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.447 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.11 26.55 52.41 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.429 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -88.06 176.4 7.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.206 0.503 . . . . 0.0 111.46 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -60.44 -38.95 85.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.75 76.17 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.174 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.65 -37.18 83.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -55.78 -35.46 66.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.543 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 -49.27 73.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.936 0.398 . . . . 0.0 110.831 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.9 -35.79 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.9 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.854 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 32' ' ' LEU . 11.3 t -87.45 23.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 63.53 48.08 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.828 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.6 mt -133.57 48.24 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m -97.49 123.03 53.8 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.934 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.28 -27.76 6.3 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.734 2.289 . . . . 0.0 112.718 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -73.31 -43.07 61.55 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.326 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 46.55 60.05 3.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.94 HG21 HG11 ' A' ' 15' ' ' VAL . 16.0 m -124.19 148.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.376 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.98 137.27 33.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.457 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.737 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.9 m -107.33 129.8 60.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 111.634 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.45 138.22 51.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.593 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.717 HG21 ' HG3' ' A' ' 47' ' ' PRO . 4.6 t -101.82 135.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -62.94 120.56 11.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.391 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 27.98 42.39 0.02 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.891 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.55 ' HB2' HG12 ' A' ' 41' ' ' VAL . 18.2 mmt85 -132.37 128.6 21.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 117.195 0.497 . . . . 0.0 111.375 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.41 -42.71 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.648 2.232 . . . . 0.0 113.077 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.74 96.66 25.99 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.716 0.293 . . . . 0.0 111.197 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.717 ' HG3' HG21 ' A' ' 41' ' ' VAL . 72.4 Cg_endo -75.95 -18.11 17.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.752 2.302 . . . . 0.0 112.806 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.86 -23.18 64.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.626 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -86.5 18.9 3.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -104.03 158.23 16.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.901 0.381 . . . . 0.0 110.981 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 t -74.73 177.72 5.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.674 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 54' ' ' VAL . 13.4 t 71.81 154.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.763 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.83 21.83 4.6 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.521 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 52' ' ' VAL . 29.8 m -154.31 162.06 2.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.108 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.867 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -148.48 147.49 29.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.406 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -94.76 125.37 39.37 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.829 0.347 . . . . 0.0 110.316 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.9 m -130.16 167.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.649 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.36 136.47 42.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.783 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -106.39 139.16 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.836 0.351 . . . . 0.0 111.549 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 121.22 40.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.909 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -133.94 -61.48 0.79 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mp -96.26 113.52 25.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.105 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 19.3 tt -79.57 150.65 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 3.6 mtmp? 70.19 151.95 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.372 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.79 66.51 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.469 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.302 -1.277 . . . . 0.0 112.549 -179.773 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -85.92 143.39 28.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.783 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 15' ' ' VAL . 30.9 m -102.35 139.79 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.731 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -74.66 115.87 14.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.237 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG1' HG23 ' A' ' 57' ' ' VAL . 17.7 m -115.57 137.33 49.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.183 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.28 117.27 21.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.538 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 59' ' ' VAL . 20.1 t -89.46 133.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.03 120.65 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.36 -117.13 4.59 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.081 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -120.8 159.93 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.544 0.211 . . . . 0.0 111.249 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 72.61 147.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.928 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -116.99 135.11 53.95 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.8 m -114.24 162.84 16.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.206 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -125.96 133.97 51.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 39' ' ' VAL . 11.5 p -121.65 147.18 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.64 133.56 34.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.71 161.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.98 -38.32 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.63 -31.65 16.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.036 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -68.07 -51.54 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.89 25.73 31.23 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.158 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.09 179.18 6.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -57.46 -36.14 71.05 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.61 74.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.95 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.84 -44.42 97.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.2 tp -59.61 -44.66 93.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.45 -50.53 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.972 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -59.1 -36.77 75.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.288 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -27.72 65.34 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.607 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 32' ' ' LEU . 10.5 t -93.44 23.59 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.215 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 60.34 48.15 8.25 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.54 44.88 2.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.776 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -83.82 120.3 74.86 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.696 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.51 -31.18 3.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.765 2.31 . . . . 0.0 112.801 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -77.05 -42.81 36.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.819 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 48.41 61.98 2.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.233 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.56 146.1 29.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -85.72 119.57 26.2 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.59 ' HB ' HG21 ' A' ' 57' ' ' VAL . 31.6 m -88.89 134.76 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.458 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 7.4 mp -107.05 144.44 33.71 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 45' ' ' PRO . 13.7 t -101.59 139.38 22.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.13 121.64 15.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.309 0.575 . . . . 0.0 110.344 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.77 -71.7 2.92 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.42 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 61.3 mtt180 -131.96 145.94 59.57 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 71.8 Cg_endo -75.61 48.27 2.11 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.821 2.347 . . . . 0.0 113.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.5 t -151.3 114.33 3.08 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.11 57.17 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.897 2.398 . . . . 0.0 112.319 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.68 -35.59 77.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.223 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -18.87 55.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.69 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.41 174.1 0.14 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.173 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.95 -167.92 0.8 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.15 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.02 -175.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.696 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -49.24 -36.74 21.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.274 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.6 m -109.06 163.83 6.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.485 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.41 150.35 34.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.851 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -95.33 126.11 40.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.2 m -134.74 167.08 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 1.6 mttt -103.43 138.4 40.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.6 m -112.77 139.3 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 111.476 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tp -108.22 119.61 39.98 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -73.52 -40.31 64.14 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.085 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 88.17 3.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 66' ' ' GLY . 2.5 pp -81.96 157.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.187 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.45 102.52 4.98 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 48.98 4.19 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.703 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.494 ' C ' HD13 ' A' ' 63' ' ' ILE . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.551 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.693 0.283 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 3.2 m120 -87.0 143.4 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.3 p -102.04 140.16 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.678 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -75.0 115.2 14.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.58 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.5 m -115.97 137.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.49 114.83 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.658 HG22 ' CG2' ' A' ' 59' ' ' VAL . 23.1 t -88.69 133.93 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.633 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.37 120.69 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.28 -117.06 3.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.162 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.74 159.83 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 111.175 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 68.61 162.32 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -126.6 135.11 50.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.605 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' VAL . 40.5 m -111.9 163.42 14.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.243 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 52.3 mt-10 -124.61 137.81 54.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.3 p -125.53 143.96 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.86 131.61 34.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.839 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.77 133.3 63.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.671 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.98 -28.29 67.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.528 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.58 -33.87 61.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.276 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.55 -54.92 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 26.75 16.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 170.4 9.28 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.909 0.355 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -62.62 -38.74 91.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.416 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -38.55 74.29 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -64.73 -38.07 89.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.964 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.7 tp -57.61 -42.12 82.63 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.569 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.2 t -65.55 -49.68 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.972 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -60.22 -35.81 76.28 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.14 64.28 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.644 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.0 t -90.93 23.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.187 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.83 46.46 2.97 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.099 0.476 . . . . 0.0 111.167 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.36 34.43 5.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 p -91.22 120.58 68.44 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.499 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.05 -31.48 9.68 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.53 2.153 . . . . 0.0 112.484 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 15' ' ' VAL . 8.7 p-80 -79.38 -41.61 27.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.33 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 43.97 73.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.228 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.568 HG21 HG11 ' A' ' 59' ' ' VAL . 14.0 m -133.28 148.81 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.308 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -85.23 137.62 32.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.77 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.73 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.0 m -96.3 126.96 48.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.392 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.42 141.74 41.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG12 ' HB2' ' A' ' 44' ' ' ARG . 39.1 t -101.63 117.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' GLY . 8.3 t70 -63.73 120.49 11.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 16.56 54.62 0.01 OUTLIER Glycine 0 C--N 1.335 0.527 0 O-C-N 124.597 1.185 . . . . 0.0 115.002 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.605 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -132.05 120.38 17.24 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.53 0.205 . . . . 0.0 111.389 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.67 53.51 4.16 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.018 2.478 . . . . 0.0 112.294 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t 61.92 90.6 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.03 94.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.113 2.542 . . . . 0.0 112.858 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -29.79 70.4 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.31 18.26 5.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.643 ' HG2' HG22 ' A' ' 52' ' ' VAL . 3.3 tt0 -115.47 99.68 7.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.767 0.318 . . . . 0.0 110.725 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.74 34.82 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.643 HG22 ' HG2' ' A' ' 50' ' ' GLN . 34.5 m -80.28 178.17 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.377 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.4 -31.43 11.32 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.273 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.59 161.44 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 111.531 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.815 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.2 m-20 -142.63 157.22 44.91 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.574 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -94.74 125.46 39.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 110.497 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' A' ' 39' ' ' VAL . 14.9 m -133.9 167.86 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.36 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 139.53 47.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.399 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -104.89 141.25 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.603 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -105.22 135.84 45.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -73.83 0.22 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.237 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -92.63 149.75 21.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.115 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -158.64 143.89 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.288 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.611 ' N ' HD13 ' A' ' 63' ' ' ILE . 6.0 mttt -128.66 -48.5 1.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.981 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.02 -62.0 0.11 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.179 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.07 -179.918 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.897 0.379 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.69 136.78 32.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.517 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 15' ' ' VAL . 23.2 m -102.35 139.69 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.026 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 m -74.88 117.58 16.89 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' CG1' HG23 ' A' ' 57' ' ' VAL . 14.4 m -118.03 137.51 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.022 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 114.67 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 59' ' ' VAL . 27.1 t -86.13 133.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.69 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.08 120.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.88 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.92 -114.24 3.06 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.234 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 1.3 pm0 -121.03 158.97 26.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 111.651 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 5.0 mt-10 66.73 163.6 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.923 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -126.88 134.39 50.49 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.494 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 m -110.63 162.92 14.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.79 135.0 52.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.577 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 3' ' ' VAL . 16.4 t -130.04 149.23 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.875 0.369 . . . . 0.0 111.406 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.18 35.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.75 163.83 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.95 -14.85 58.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.546 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.15 -35.44 62.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.25 -44.97 20.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.33 27.02 34.36 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.618 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.78 175.68 7.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -57.15 -32.9 66.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.544 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.22 74.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.14 -40.92 97.2 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -56.99 -39.95 75.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.42 -51.01 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -35.9 77.87 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.092 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -30.0 67.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.534 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.9 t -94.7 23.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.53 48.5 9.62 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.675 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.68 42.54 3.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 t -99.24 132.23 23.76 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.61 -32.89 4.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.535 2.157 . . . . 0.0 112.59 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -80.21 -42.75 22.72 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 46.89 61.67 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.455 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -126.04 146.0 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.212 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 134.97 33.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.046 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' HG21 ' A' ' 57' ' ' VAL . 32.2 m -91.28 135.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.0 152.57 20.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.51 119.92 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.612 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.18 120.03 7.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 33.97 32.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.801 -1.091 . . . . 0.0 114.76 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 148.32 69.02 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 117.289 0.544 . . . . 0.0 111.613 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' O ' HG13 ' A' ' 46' ' ' VAL . 57.8 Cg_endo -74.89 -48.09 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.429 2.086 . . . . 0.0 112.125 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -161.3 126.21 2.14 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.09 51.79 4.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.571 2.181 . . . . 0.0 112.702 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.57 -35.8 77.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.34 19.44 15.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.582 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -75.64 140.71 42.74 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.72 167.39 20.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.961 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 54' ' ' VAL . 22.1 t 74.04 135.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.67 70.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' H ' HG12 ' A' ' 52' ' ' VAL . 33.2 m -111.21 161.91 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -146.09 156.97 43.82 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -95.32 126.33 40.56 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.492 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.5 m -134.42 167.52 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.22 135.94 42.92 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 7' ' ' VAL . 5.4 m -117.14 140.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 111.523 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -113.35 119.41 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.843 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -60.19 -33.2 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 60' ' ' LEU . 8.6 mt -116.51 146.12 42.83 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 tt -155.42 147.6 12.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.019 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttm 62.52 38.72 12.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.41 -96.25 1.0 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.382 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.483 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 8.2 m-80 -85.01 145.75 27.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 31.6 t -127.96 139.66 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.62 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.95 113.51 12.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.964 0.411 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.8 m -117.93 137.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.385 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -81.87 115.01 20.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.675 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.3 t -89.98 133.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' HB ' HD21 ' A' ' 62' ' ' LEU . 21.3 t -72.41 120.78 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.41 -56.98 5.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.443 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.58 163.64 26.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.618 0.246 . . . . 0.0 110.95 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -58.77 -174.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.407 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -99.63 131.69 45.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.151 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.22 162.06 34.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 21.6 mt-10 -94.79 139.35 31.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.693 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 HG21 ' A' ' 37' ' ' VAL . 35.2 m -132.58 148.27 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.386 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.39 129.05 34.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.922 HG12 HG11 ' A' ' 39' ' ' VAL . 4.1 m -116.76 150.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.814 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.6 p30 -70.79 -20.67 62.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.044 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.2 -41.35 62.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.786 0.327 . . . . 0.0 111.015 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -54.78 -45.49 74.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.51 26.51 46.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.996 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.48 170.53 9.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 111.465 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.76 75.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.56 -35.18 67.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.058 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.5 m-20 -68.5 -42.64 78.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -43.52 98.7 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 24' ' ' ALA . 8.2 p -70.94 -39.87 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.258 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -66.9 -35.94 81.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.985 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.56 -25.03 23.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.0 t -89.31 23.35 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.706 0.289 . . . . 0.0 111.392 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 62.84 48.28 4.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 32.57 5.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.93 140.61 25.02 Favored Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.064 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 -32.86 7.22 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.66 -42.75 27.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.132 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.79 72.19 0.34 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 111.024 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.992 HG21 HG11 ' A' ' 15' ' ' VAL . 17.8 m -123.74 146.85 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.343 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 137.85 35.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.746 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.922 HG11 HG12 ' A' ' 17' ' ' VAL . 29.8 m -86.84 131.7 34.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.12 147.46 37.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.223 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 44' ' ' ARG . 2.0 t -113.37 117.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.404 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 44' ' ' ARG . 10.6 t70 -56.04 120.09 6.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.335 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 24.44 43.47 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 124.447 1.092 . . . . 0.0 115.048 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.59 ' HB3' HG12 ' A' ' 41' ' ' VAL . 10.0 tpp180 -132.91 124.79 18.84 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.964 0.382 . . . . 0.0 111.153 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.87 -47.21 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.445 2.097 . . . . 0.0 112.091 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.483 HG23 ' HG2' ' A' ' 48' ' ' GLU . 12.0 m -155.88 153.6 26.18 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.03 74.98 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.98 2.453 . . . . 0.0 112.121 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.483 ' HG2' HG23 ' A' ' 46' ' ' VAL . 1.5 mt-10 -68.59 -22.2 64.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.66 5.73 30.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 66.22 96.74 0.05 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.921 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -94.37 154.68 17.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.124 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 54' ' ' VAL . 27.6 m -70.08 -175.05 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 54' ' ' VAL . 11.5 pt-20 -51.82 -42.62 62.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.357 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.6 m -111.39 162.31 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.047 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 23.1 t70 -149.07 154.45 39.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.976 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -94.95 125.2 39.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 110.046 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.1 m -135.86 167.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.265 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.11 140.92 40.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.517 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.675 ' CG2' HG22 ' A' ' 7' ' ' VAL . 6.0 m -101.27 140.88 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -113.9 125.81 54.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 48.7 1.83 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -157.87 -48.97 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.221 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG22 HD12 ' A' ' 62' ' ' LEU . 14.0 tt -131.07 154.03 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.826 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt 62.05 37.68 14.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.957 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.23 145.9 19.34 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.391 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.427 179.872 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.689 0.28 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.52 148.96 22.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.466 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.43 139.91 22.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.844 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -74.88 113.34 12.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.11 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' HG23 ' A' ' 57' ' ' VAL . 35.7 m -117.7 135.69 57.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.228 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 114.89 23.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.6 t -83.74 130.96 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.38 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.62 120.43 16.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.19 -57.41 4.77 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.161 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 163.53 26.07 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.683 0.278 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.55 -177.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -99.65 134.25 42.8 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.959 0.409 . . . . 0.0 111.07 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 m -137.19 160.45 38.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.228 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.34 137.39 32.41 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 37' ' ' VAL . 9.1 p -130.77 145.69 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.48 125.83 32.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.727 ' CG1' HG11 ' A' ' 39' ' ' VAL . 9.2 m -119.76 161.42 19.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.672 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.94 -36.94 64.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.052 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -31.37 65.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.48 -48.05 72.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.85 26.06 63.37 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.606 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -100.62 178.89 4.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.015 0.408 . . . . 0.0 111.03 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -59.09 -34.63 72.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -36.1 72.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.78 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -59.25 -38.7 80.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.21 -45.22 91.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.686 0.279 . . . . 0.0 110.779 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.05 -47.73 59.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.97 81.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.673 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.12 53.51 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.731 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.4 t -90.57 23.48 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.988 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.29 48.36 10.31 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.009 0.433 . . . . 0.0 111.042 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -127.12 45.24 2.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -84.65 129.11 58.36 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -33.09 10.61 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.95 -40.97 26.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.189 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.27 59.14 2.78 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.671 HG23 HG21 ' A' ' 15' ' ' VAL . 5.6 m -126.44 146.01 33.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 m -86.13 123.3 31.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG11 ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -91.52 127.65 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.38 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -116.76 133.28 56.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 57' ' ' VAL . 30.2 t -101.48 117.79 47.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 44' ' ' ARG . 13.4 t70 -56.23 120.66 7.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.902 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 3.78 61.11 0.0 OUTLIER Glycine 0 C--N 1.339 0.746 0 O-C-N 124.843 1.34 . . . . 0.0 115.679 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASP . 26.5 mtm180 -132.09 120.48 17.26 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 12.7 Cg_exo -68.81 -58.5 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.921 2.414 . . . . 0.0 111.982 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.7 t -140.72 140.51 22.21 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.247 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.05 90.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.81 2.34 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.8 -33.74 74.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.223 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.81 -18.85 58.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.599 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.05 158.82 0.13 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.056 0.455 . . . . 0.0 111.407 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -167.79 -172.8 1.95 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 54' ' ' VAL . 20.7 t -82.4 60.68 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.272 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 55.81 23.86 6.83 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.436 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 52' ' ' VAL . 34.7 m -126.51 162.29 30.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.707 0.289 . . . . 0.0 111.34 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.94 154.69 39.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -95.56 129.93 42.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 39' ' ' VAL . 4.2 m -135.23 167.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.261 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.37 138.2 50.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.477 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.807 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.7 m -103.1 138.4 27.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.46 117.17 33.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.176 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -111.36 -47.06 3.22 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.066 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.98 157.85 17.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.1 tt -163.44 150.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -130.5 84.13 2.17 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.11 -84.77 1.07 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.186 -1.341 . . . . 0.0 112.953 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.457 0.17 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -86.16 148.96 25.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -102.19 139.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.466 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.13 113.57 11.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.286 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.986 HG21 HG13 ' A' ' 59' ' ' VAL . 2.1 p -114.39 135.12 55.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.268 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.5 114.94 22.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.849 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.7 t -85.93 133.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -77.33 120.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -23.68 11.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.111 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.64 164.11 15.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.573 0.349 . . . . 0.0 110.826 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.91 -173.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.39 129.34 45.58 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -126.29 163.09 23.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.22 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.9 137.67 42.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.89 146.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.38 31.01 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.228 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.53 157.89 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -18.23 48.93 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -41.02 73.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.556 0.217 . . . . 0.0 111.315 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -51.64 -35.94 44.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.792 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.31 26.07 69.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.588 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -93.34 166.75 12.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.215 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -34.58 74.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.44 70.22 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.278 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 13.9 m-20 -58.98 -38.12 78.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.993 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -58.51 -34.25 70.74 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.622 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -70.45 -51.57 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 25' ' ' ASP . 1.4 ptm180 -65.18 -35.43 81.05 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.171 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -25.32 39.97 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.2 t -87.48 23.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.615 0.245 . . . . 0.0 111.156 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 65.47 47.5 2.26 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.6 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -128.18 37.18 4.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.728 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -77.61 124.71 86.58 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.77 -32.78 2.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.697 2.265 . . . . 0.0 112.913 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -42.9 32.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.2 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.02 72.1 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.216 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' HE ' ' A' ' 61' ' ' ARG . 19.1 m -123.68 157.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.413 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 m -84.76 116.92 23.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.554 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -94.3 137.07 23.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 58' ' ' LYS . 6.7 mt -81.99 157.81 24.09 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.45 139.68 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.58 130.33 13.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.718 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.93 -30.49 0.18 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -95.46 165.35 16.91 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.67 86.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.942 2.428 . . . . 0.0 112.734 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -149.8 137.09 11.32 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.755 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.51 37.1 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 112.624 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -68.5 -16.77 64.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.656 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.78 -7.83 56.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -120.14 99.34 6.54 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.69 0.281 . . . . 0.0 111.414 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -170.96 39.54 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.654 HG12 ' HG3' ' A' ' 53' ' ' GLU . 54.6 t 62.49 -85.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.162 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.654 ' HG3' HG12 ' A' ' 52' ' ' VAL . 6.6 mt-10 -123.42 -10.16 7.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 51' ' ' SER . 34.2 m -106.08 171.57 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.355 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -146.22 157.39 43.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.214 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 133.99 38.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.602 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' VAL . 6.3 m -129.47 167.38 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.858 ' HB2' HD12 ' A' ' 40' ' ' LEU . 23.0 mmtp -115.75 133.47 56.0 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.986 HG13 HG21 ' A' ' 5' ' ' VAL . 19.0 m -100.76 131.69 47.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.902 0.382 . . . . 0.0 111.307 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 111.24 23.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HE ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -125.31 30.91 5.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -173.71 150.01 1.67 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.5 tt -160.0 151.99 5.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -45.66 1.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.381 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.83 -46.09 0.12 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.518 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.541 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.647 0.26 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -84.9 146.61 27.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 111.002 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.0 p -134.24 140.02 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.81 113.41 12.06 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.104 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' VAL . 15.3 m -118.59 136.19 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.246 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -81.51 114.72 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.791 HG22 ' CG2' ' A' ' 59' ' ' VAL . 14.2 t -90.15 130.48 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.2 120.68 23.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.717 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.52 -51.37 3.0 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.395 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 163.39 14.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.658 0.266 . . . . 0.0 111.037 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.44 -177.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -99.62 127.02 45.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.193 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -131.12 162.64 29.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.267 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -92.89 137.77 32.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.836 HG11 HG21 ' A' ' 37' ' ' VAL . 24.4 m -129.87 150.47 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.202 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.49 126.85 33.65 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG12 HG11 ' A' ' 39' ' ' VAL . 7.2 m -116.51 160.7 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.765 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -84.71 -31.86 23.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.307 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.51 -31.63 24.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.078 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -51.92 -40.99 61.66 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.515 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.52 26.16 70.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -95.06 179.09 5.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 111.155 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.13 -32.88 66.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.238 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.6 67.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.366 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -58.48 -43.92 89.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.556 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -45.02 85.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.27 -45.65 78.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -35.88 73.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.028 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.73 34.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.637 ' HB ' HD13 ' A' ' 32' ' ' LEU . 9.4 t -91.26 23.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.675 0.274 . . . . 0.0 111.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 64.62 48.2 2.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.056 0.455 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.637 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -119.22 48.9 1.41 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.5 t -99.01 120.37 58.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.54 -33.02 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.571 2.181 . . . . 0.0 113.224 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -79.89 -42.66 23.7 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.264 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 50.42 66.37 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.076 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 15' ' ' VAL . 26.2 m -123.81 151.31 28.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 121.33 33.85 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.656 HG11 HG12 ' A' ' 17' ' ' VAL . 16.8 m -90.92 132.47 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 4.3 mm? -102.17 134.93 44.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 44' ' ' ARG . 3.6 t -101.51 130.65 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' ARG . 19.7 p-10 -63.58 119.77 10.47 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.573 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 28.07 35.64 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB2' HG12 ' A' ' 41' ' ' VAL . 5.5 mmm180 -133.22 120.77 16.24 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 117.684 0.742 . . . . 0.0 111.107 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.2 -54.85 3.41 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.34 2.026 . . . . 0.0 112.092 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.87 148.44 17.86 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.61 78.7 1.62 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.826 2.351 . . . . 0.0 112.332 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.34 -35.41 77.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.02 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.671 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.0 64.89 1.41 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.143 0.497 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.43 112.27 11.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 t 68.33 154.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.344 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.686 ' HG3' HG13 ' A' ' 54' ' ' VAL . 16.9 pt-20 -66.39 -44.1 84.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.686 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.9 m -108.0 161.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.387 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 3' ' ' VAL . 23.9 t70 -147.92 154.11 39.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.667 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -94.93 125.94 39.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.203 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.2 m -134.18 167.37 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.62 141.1 36.0 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.791 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.8 m -112.49 131.83 62.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 111.318 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.06 122.38 44.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.83 -53.83 2.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.3 90.93 3.44 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.869 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 tp -82.42 145.63 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.186 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -135.22 154.82 51.46 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.38 -65.18 0.26 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.405 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.51 179.797 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HG21 ' A' ' 22' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.602 0.239 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -92.67 146.98 23.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.745 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.5 t -121.76 139.57 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.931 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.21 113.42 12.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 57' ' ' VAL . 17.4 m -118.44 137.22 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -81.8 114.81 20.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.5 t -86.86 133.23 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.72 120.66 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.638 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.82 -57.58 5.05 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.418 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.53 163.78 25.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -58.22 -175.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.249 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 5' ' ' VAL . 60.1 m -99.64 130.44 45.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.928 0.394 . . . . 0.0 111.187 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -127.48 162.72 25.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.55 130.89 42.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.977 HG11 HG21 ' A' ' 37' ' ' VAL . 26.8 m -129.77 144.3 38.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 35' ' ' HIS . . . -84.25 126.61 33.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.041 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 20' ' ' ASP . 26.8 m -117.11 161.98 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.135 0.493 . . . . 0.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.72 -41.94 78.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.335 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.69 -41.57 56.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.962 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' VAL . 1.6 t0 -47.19 -40.94 17.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.387 0.429 . . . . 0.0 111.582 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.94 26.38 69.14 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.931 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -99.55 178.47 4.85 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.87 0.367 . . . . 0.0 111.111 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -32.75 66.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.219 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.82 70.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.17 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.42 -44.03 95.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.869 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.68 -46.43 89.08 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.69 0.281 . . . . 0.0 110.8 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 32' ' ' LEU . 20.5 t -67.53 -44.88 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.52 -36.15 81.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.23 -26.87 42.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.84 23.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.562 0.22 . . . . 0.0 111.331 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.3 42.0 9.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.059 0.457 . . . . 0.0 110.964 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 27' ' ' VAL . 3.5 mt -121.1 39.43 3.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.529 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.08 120.67 72.65 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.22 -33.15 7.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.505 2.136 . . . . 0.0 112.494 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.526 ' ND1' HG22 ' A' ' 37' ' ' VAL . 14.7 p80 -79.89 -42.07 24.92 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.096 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 51.67 70.26 0.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.977 HG21 HG11 ' A' ' 15' ' ' VAL . 26.9 m -135.68 147.29 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.414 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.18 136.97 32.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.796 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.2 m -93.34 133.96 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.399 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.83 148.01 31.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 44' ' ' ARG . 17.4 t -106.65 117.72 52.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.01 120.18 11.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.149 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 23.1 47.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 124.411 1.069 . . . . 0.0 114.786 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -132.81 121.03 16.81 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.874 0.337 . . . . 0.0 111.366 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.05 -51.8 6.15 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.528 2.152 . . . . 0.0 112.118 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 t -150.61 144.09 17.02 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.73 47.28 2.4 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.836 2.357 . . . . 0.0 112.469 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.59 -31.83 71.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.82 19.28 6.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.664 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -98.32 119.0 36.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.059 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.1 m -120.29 33.71 5.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.987 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 54' ' ' VAL . 17.4 t -121.66 138.47 51.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.722 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.77 -35.98 71.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.231 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.484 ' H ' HG12 ' A' ' 52' ' ' VAL . 8.7 t -110.65 161.66 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 110.546 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.745 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 145.72 28.28 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -95.0 125.24 39.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.288 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.1 m -136.21 167.17 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -102.24 141.67 34.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 7' ' ' VAL . 4.4 m -106.07 137.61 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.838 0.352 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.75 128.49 56.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.174 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -95.08 -55.23 3.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.353 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -92.06 102.45 14.99 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 tp -101.43 146.21 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.281 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.83 114.71 14.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.65 131.01 7.89 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.558 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.348 -1.251 . . . . 0.0 112.518 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.86 0.362 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -89.3 142.16 27.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.31 140.0 21.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -74.67 113.2 11.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 110.485 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG23 ' A' ' 57' ' ' VAL . 31.9 m -118.87 137.6 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.378 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.15 114.95 21.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.781 HG22 ' CG2' ' A' ' 59' ' ' VAL . 21.6 t -88.66 133.98 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.419 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.22 120.62 4.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.6 -49.44 3.15 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.55 163.3 26.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.626 0.251 . . . . 0.0 110.972 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.41 -100.0 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -127.96 135.06 49.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 111.349 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 t -132.07 162.89 29.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.245 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -123.47 138.54 54.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG21 HG23 ' A' ' 37' ' ' VAL . 11.4 p -131.98 147.88 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.257 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.736 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 125.79 32.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.17 161.05 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.47 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.6 -26.98 37.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.725 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.54 -34.87 67.46 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.599 0.238 . . . . 0.0 110.929 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -52.73 -61.09 2.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.18 57.11 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.709 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.73 178.91 5.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 111.141 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -57.17 -38.93 74.32 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.15 82.76 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.932 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -60.38 -37.51 80.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -41.73 78.52 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.809 0.338 . . . . 0.0 110.555 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.96 -50.71 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 tmt_? -59.34 -36.16 75.18 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.213 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.31 36.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.99 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 30' ' ' VAL . 8.4 t -92.14 23.46 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.702 0.287 . . . . 0.0 111.309 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.61 47.32 4.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.134 0.492 . . . . 0.0 111.454 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 33.16 4.99 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.8 120.27 68.81 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.863 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.82 -32.47 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.951 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.93 -41.12 75.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.97 69.37 0.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.036 0.446 . . . . 0.0 111.176 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 HG21 ' A' ' 15' ' ' VAL . 23.4 m -124.02 145.8 30.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.239 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.8 m -96.77 119.43 35.22 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.831 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.2 m -84.18 131.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.519 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.1 mt -105.51 147.64 28.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 44' ' ' ARG . 10.0 t -102.15 136.68 33.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.864 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.85 120.83 14.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.65 0.262 . . . . 0.0 110.333 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 26.24 47.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.191 -0.913 . . . . 0.0 114.625 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.585 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -132.31 120.36 16.97 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.943 0.371 . . . . 0.0 111.0 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.81 -61.03 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.752 2.301 . . . . 0.0 112.834 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.65 161.5 43.56 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.25 53.07 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 0.0 112.44 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -68.51 -32.94 73.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.498 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.96 19.69 5.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.872 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.05 94.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.83 159.7 39.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.75 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t 72.21 146.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' HG13 ' A' ' 54' ' ' VAL . 17.2 pt-20 -59.1 -45.07 91.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.186 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.543 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.4 m -113.41 162.22 11.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.797 0.332 . . . . 0.0 111.214 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -147.97 152.3 37.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -97.13 125.12 41.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.41 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.505 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.4 m -136.26 167.13 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.15 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -110.64 128.71 55.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.781 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -100.86 141.62 17.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.975 0.417 . . . . 0.0 111.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 61' ' ' ARG . 4.3 tt -97.64 128.53 44.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.959 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -107.27 -56.39 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.36 -72.6 0.67 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' CA ' HD21 ' A' ' 60' ' ' LEU . 5.3 pt -147.05 171.76 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.259 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -171.06 93.97 0.18 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.6 -178.02 28.3 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.896 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.094 179.801 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.507 0.194 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -91.59 148.78 22.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.76 0.315 . . . . 0.0 110.648 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 15' ' ' VAL . 20.4 m -102.15 139.96 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.727 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -74.48 114.3 12.72 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.3 m -116.48 137.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.303 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 114.76 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' CG2' ' A' ' 59' ' ' VAL . 18.5 t -88.15 134.22 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.96 120.26 3.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.475 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.38 -118.14 4.19 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.246 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -120.73 159.04 26.19 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 70.19 155.19 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.05 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.1 m -116.23 134.9 54.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.393 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.442 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.6 t -108.51 161.98 14.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.298 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.01 131.93 52.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 3' ' ' VAL . 9.9 p -122.92 144.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.778 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . . . -85.19 134.97 34.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.241 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.58 159.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 111.88 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.85 -33.78 45.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.299 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -56.73 -35.82 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -55.18 -48.54 73.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.779 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.21 42.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.15 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 179.17 5.55 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -57.31 -32.65 66.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.181 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.76 74.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.06 -44.4 91.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.559 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -41.1 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.12 -50.08 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 1.1 mtp-105 -60.39 -36.05 77.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.359 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.596 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 30' ' ' VAL . 10.7 t -95.58 23.15 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.717 0.294 . . . . 0.0 111.221 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 59.27 46.94 12.14 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.47 46.02 2.31 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.64 120.46 72.96 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-O 120.598 0.237 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.674 2.25 . . . . 0.0 113.008 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.75 23.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 111.175 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.24 61.97 2.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.089 0.471 . . . . 0.0 111.173 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.51 146.08 29.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 m -85.49 132.21 34.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.7 m -93.71 131.42 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.61 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 3.9 mm? -107.29 147.71 29.9 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG12 ' CB ' ' A' ' 44' ' ' ARG . 16.5 t -106.19 117.79 52.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.86 120.12 11.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.419 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 31.94 35.72 0.02 OUTLIER Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.827 -1.078 . . . . 0.0 115.153 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' CB ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -133.07 143.94 50.62 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 117.349 0.574 . . . . 0.0 111.555 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.87 -47.53 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.417 2.078 . . . . 0.0 112.165 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HG2' ' A' ' 48' ' ' GLU . 3.2 m -154.15 110.11 2.46 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.953 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD3' HG11 ' A' ' 41' ' ' VAL . 89.9 Cg_endo -81.24 6.22 5.74 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.534 2.156 . . . . 0.0 113.1 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HG2' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.8 -15.61 59.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.6 -10.92 59.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.56 150.54 31.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.588 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -96.88 45.93 1.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 m -139.46 166.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.293 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -85.68 -37.48 19.37 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.3 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.96 161.63 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 111.498 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 152.63 40.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -95.63 125.23 40.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.525 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.561 HG21 ' HB ' ' A' ' 39' ' ' VAL . 12.4 m -135.69 167.09 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.4 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 6.2 mmtt -107.65 140.11 41.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.729 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.9 m -102.2 136.12 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.315 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.2 112.41 23.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -141.19 34.04 1.71 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -171.26 98.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.6 tt -110.2 147.52 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.278 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -89.92 -54.15 4.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.44 123.41 0.7 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.25 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.269 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.102 179.914 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.604 0.24 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -89.81 144.21 26.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.0 t -111.98 139.91 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -74.7 113.49 12.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.98 135.55 53.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.398 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.71 114.65 20.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.828 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.3 t -89.27 133.9 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.03 120.45 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.91 -45.09 2.32 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.53 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.41 164.01 12.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.458 0.303 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.31 -176.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -99.25 132.5 44.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -134.69 163.01 30.73 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -94.91 138.12 33.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.217 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 37' ' ' VAL . 11.1 p -131.33 147.61 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 127.85 34.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.65 160.6 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -76.05 -34.52 59.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.897 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -52.77 -35.56 56.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.794 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.29 -51.18 70.42 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.85 26.19 46.49 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.799 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -88.28 162.25 16.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.378 . . . . 0.0 111.265 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -57.57 -35.62 70.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.056 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.76 73.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.246 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.39 -37.31 77.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.373 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.23 -40.01 73.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.794 0.331 . . . . 0.0 110.577 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.07 -48.05 57.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.841 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -61.89 -35.7 79.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.27 -25.14 32.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.1 t -88.8 23.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.6 0.238 . . . . 0.0 111.218 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 64.34 47.5 3.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.466 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.6 mp -122.58 34.9 5.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 4.1 p -94.68 120.51 64.72 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 23.7 Cg_exo -64.04 -32.78 64.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.678 2.252 . . . . 0.0 112.56 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -43.04 23.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.341 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 48.53 67.2 0.89 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.069 0.462 . . . . 0.0 111.04 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' CG2' HG11 ' A' ' 59' ' ' VAL . 16.1 m -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.39 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 m -91.37 135.66 33.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.5 m -88.3 130.05 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 149.1 33.29 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 44' ' ' ARG . 4.8 t -116.4 119.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.623 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 17.8 t0 -52.47 120.59 5.77 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 18.88 54.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.53 0 O-C-N 124.481 1.113 . . . . 0.0 114.904 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.671 ' HB2' HG12 ' A' ' 41' ' ' VAL . 26.6 mtt-85 -131.82 119.72 17.17 Favored Pre-proline 0 C--O 1.232 0.163 0 CA-C-N 116.759 0.279 . . . . 0.0 111.304 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.91 -45.81 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.664 2.242 . . . . 0.0 112.566 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.2 m -150.57 93.3 3.8 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.07 78.57 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.01 2.473 . . . . 0.0 112.588 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.58 -29.94 70.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.33 19.36 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.13 136.06 57.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.703 0.287 . . . . 0.0 111.149 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -129.85 158.81 38.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 54' ' ' VAL . 14.1 t 72.89 146.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.23 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -34.68 68.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.995 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 52' ' ' VAL . 34.6 m -107.09 165.99 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.952 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.1 m-20 -145.99 154.9 42.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -94.64 125.45 39.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 110.539 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.647 HG21 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m -134.53 167.78 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.952 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 42' ' ' ASP . 6.7 ptpp? -109.72 139.9 44.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.828 ' CG2' HG22 ' A' ' 7' ' ' VAL . 9.4 m -106.1 141.66 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 111.443 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.719 HD21 HG23 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -110.62 118.48 36.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.785 -179.802 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -118.94 -58.29 1.96 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.56 -66.89 0.46 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.974 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.719 HG23 HD21 ' A' ' 60' ' ' LEU . 19.0 tt -80.09 154.08 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.5 133.35 14.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.22 -36.24 1.3 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.883 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.575 179.807 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.3 p30 -89.41 147.9 23.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.896 0.379 . . . . 0.0 110.613 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' A' ' 54' ' ' VAL . 27.6 m -102.35 139.95 22.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.43 113.42 11.64 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.4 m -118.4 135.43 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.694 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.98 115.02 22.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.569 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.818 HG22 HG23 ' A' ' 59' ' ' VAL . 17.8 t -84.69 134.14 27.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.53 120.62 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.555 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.3 -55.55 5.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.431 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 163.93 25.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.358 0.263 . . . . 0.0 110.989 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -167.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.473 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -99.34 128.04 45.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.936 0.398 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -126.65 162.82 24.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.063 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 2' ' ' ASN . 6.6 mp0 -105.69 145.26 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG21 ' CG2' ' A' ' 37' ' ' VAL . 7.4 p -130.97 147.06 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 123.64 30.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 111.065 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.416 HG23 HG22 ' A' ' 3' ' ' VAL . 20.1 t -121.97 152.25 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.718 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.75 -44.77 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.301 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -28.67 46.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.118 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' OD1' HG13 ' A' ' 54' ' ' VAL . 18.1 t70 -50.53 -29.53 10.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.7 25.95 61.75 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.732 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -107.49 179.05 4.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.887 0.375 . . . . 0.0 111.294 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.34 -32.35 66.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.074 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.78 -35.67 66.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.946 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.76 -44.71 90.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.511 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.975 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 t -70.53 -47.25 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.2 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.42 63.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.648 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.6 t -92.61 20.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.602 0.239 . . . . 0.0 111.275 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.76 45.12 2.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.2 88.57 2.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -115.81 120.5 35.66 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.96 -33.13 2.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.659 2.239 . . . . 0.0 112.8 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -79.54 -42.28 25.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.198 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.98 57.5 6.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' A' ' 15' ' ' VAL . 10.6 m -123.62 152.17 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -84.75 134.17 34.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.4 m -105.88 132.18 53.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.918 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 14.2 mt -101.55 151.52 21.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.25 139.35 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' ARG . 18.7 t70 -47.61 124.0 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -37.83 80.09 0.0 OUTLIER Glycine 0 C--N 1.339 0.74 0 O-C-N 124.204 0.94 . . . . 0.0 114.547 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.7 mtm-85 -131.46 126.4 21.18 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.516 0.198 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.46 -41.69 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.659 2.239 . . . . 0.0 112.702 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.8 m -141.1 108.41 6.3 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.63 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.942 2.428 . . . . 0.0 112.006 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -17.77 64.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.372 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.0 18.98 3.24 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -169.65 0.19 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.777 0.323 . . . . 0.0 111.271 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 m -122.71 165.1 17.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.055 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG12 ' HG2' ' A' ' 53' ' ' GLU . 10.6 t -129.81 159.39 41.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.214 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG3' HG23 ' A' ' 54' ' ' VAL . 1.5 pt-20 -47.59 -39.82 17.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 53' ' ' GLU . 3.3 t -124.13 161.36 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.43 146.1 27.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -95.42 125.08 39.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.221 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 39' ' ' VAL . 29.5 m -130.63 167.16 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.1 mttt -104.22 140.24 38.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.57 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.818 HG23 HG22 ' A' ' 7' ' ' VAL . 2.3 m -113.01 140.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.727 0.299 . . . . 0.0 111.329 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.51 131.05 54.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.54 -51.28 2.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.8 96.92 9.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.887 0.375 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -88.93 164.26 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.286 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 133.24 17.21 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 57.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.788 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.553 -1.137 . . . . 0.0 112.771 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.946 0.403 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 53.6 m-20 -89.12 138.16 31.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.496 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 39.9 t -102.53 140.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 113.5 12.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.215 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.9 m -117.74 137.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.489 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.96 114.8 21.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.741 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.651 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.4 t -88.32 134.36 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.22 120.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.482 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.93 -33.01 5.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.784 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.01 163.95 14.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.416 0.286 . . . . 0.0 110.757 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -169.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.44 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -99.68 132.87 44.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.057 0.455 . . . . 0.0 111.236 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m -132.73 160.16 37.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 2' ' ' ASN . 3.1 mp0 -89.2 132.83 34.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.845 HG11 HG21 ' A' ' 37' ' ' VAL . 30.0 m -130.22 145.95 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.304 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.21 125.94 32.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 111.361 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 3.3 m -119.0 137.76 51.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.941 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -27.59 47.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.681 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -40.81 63.31 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.949 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' CG ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -49.24 -45.94 45.3 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.368 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.26 71.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.621 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.42 174.18 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -57.44 -38.51 74.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.205 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.1 78.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.407 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -59.35 -37.02 76.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.46 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.2 -42.71 77.6 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.28 -44.57 72.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG3' ' HB3' ' A' ' 33' ' ' SER . 10.6 ttp85 -59.57 -36.03 75.43 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.289 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.31 -25.07 58.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.918 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 30' ' ' VAL . 9.0 t -89.47 23.37 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.618 0.247 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.93 48.23 2.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.101 0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -121.22 37.48 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -92.9 120.74 66.94 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.703 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 16.0 Cg_exo -67.68 -33.16 28.73 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.8 2.333 . . . . 0.0 112.54 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -79.57 -42.92 23.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 51.38 65.29 1.53 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.845 HG21 HG11 ' A' ' 15' ' ' VAL . 3.4 m -125.48 145.99 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.518 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 m -88.03 136.6 32.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.648 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.749 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.0 m -98.82 134.64 36.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.44 140.36 48.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.77 137.56 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -66.61 120.16 12.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.346 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 33.58 36.66 0.05 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.126 -0.943 . . . . 0.0 114.528 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.78 30.59 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 117.179 0.489 . . . . 0.0 111.249 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 46' ' ' VAL . 50.4 Cg_endo -73.42 -52.18 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.276 1.984 . . . . 0.0 112.263 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 45' ' ' PRO . 1.7 m -160.74 144.45 10.1 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.891 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.77 43.51 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 112.678 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -68.3 -35.71 78.24 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.268 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.76 -16.95 37.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.552 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -64.0 147.76 51.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.731 0.301 . . . . 0.0 111.34 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.65 72.15 1.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.56 175.4 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -102.2 -35.11 9.0 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 20' ' ' ASP . 25.6 m -130.89 161.85 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.298 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -149.27 156.67 42.47 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -95.12 124.63 39.27 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.749 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.0 m -134.92 167.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.16 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.88 130.78 55.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.572 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.651 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -103.3 141.74 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.06 127.52 53.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -38.25 83.07 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.021 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mt -142.48 127.97 18.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.9 tt -140.86 143.04 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.436 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 mttt 66.24 109.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.5 57.56 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.734 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.704 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.751 0.31 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.55 146.01 24.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.071 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 55' ' ' ASP . 23.6 t -120.83 139.79 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -75.01 114.94 14.08 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 57' ' ' VAL . 10.0 m -118.15 137.66 51.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.264 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.33 114.79 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.565 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.46 134.14 32.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.03 120.35 3.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.87 -118.36 3.43 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.183 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -120.93 152.88 37.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.55 165.09 0.22 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.123 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -117.99 135.43 54.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.679 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.15 159.98 15.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.394 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.73 127.27 45.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.222 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.18 149.26 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 127.05 34.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.356 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 4.2 m -116.98 148.77 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -23.38 67.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.758 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -54.24 -37.94 65.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.785 0.326 . . . . 0.0 110.808 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.97 -43.83 86.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.255 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.36 26.32 40.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.226 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 163.98 12.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.959 0.379 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -60.08 -38.4 82.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.365 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.46 71.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.259 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.09 -41.86 98.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.17 77.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.28 -44.33 94.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.664 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -35.89 82.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.89 -25.08 41.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.698 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.808 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.6 t -88.71 23.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.5 48.34 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 111.135 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.808 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.4 mt -130.65 44.81 2.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -99.18 136.53 20.47 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 -33.18 6.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.466 2.111 . . . . 0.0 112.529 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -42.35 23.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.203 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 54.59 59.35 4.18 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.4 146.32 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.268 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -90.49 138.48 31.52 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.801 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.5 m -96.59 132.0 42.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 140.21 45.34 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.67 135.49 38.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.96 120.46 13.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 110.231 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 30.85 39.1 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.57 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 133.95 24.22 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 117.149 0.474 . . . . 0.0 111.644 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.35 -38.26 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 0.0 112.403 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.93 131.87 11.63 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.209 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.56 1.66 8.85 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.648 2.232 . . . . 0.0 113.12 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.8 -28.58 67.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.582 0.229 . . . . 0.0 111.357 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 19.36 4.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.596 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -106.0 155.02 19.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.788 0.327 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -92.4 167.87 11.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 54' ' ' VAL . 18.6 t 73.4 135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -58.34 -36.19 73.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' H ' HG12 ' A' ' 52' ' ' VAL . 2.5 t -106.9 161.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.741 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 3' ' ' VAL . 28.1 t70 -148.17 151.21 35.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -95.21 125.48 39.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.948 0.404 . . . . 0.0 110.663 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.5 m -132.25 167.35 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.17 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -108.49 136.7 47.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.679 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 5' ' ' VAL . 15.0 m -102.18 140.81 19.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.311 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.31 132.2 56.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 18.9 ptt180 -66.94 -42.33 85.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.998 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 1.8 mp -152.74 128.09 9.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.767 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tp -155.36 145.67 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.402 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 157.9 18.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.293 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.67 86.15 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.769 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.412 -1.216 . . . . 0.0 112.6 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -85.26 133.16 34.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.725 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.8 p -103.08 140.45 21.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.922 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -74.73 113.19 11.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.313 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG23 ' OG ' ' A' ' 13' ' ' SER . 30.0 m -118.75 138.05 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.249 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.76 115.0 20.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.406 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 59' ' ' VAL . 10.0 p -99.24 133.94 40.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.06 120.77 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.2 -55.82 0.69 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.468 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 163.39 22.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.587 0.232 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.66 -82.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.99 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -127.95 135.01 49.36 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.037 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.485 ' OG ' HG23 ' A' ' 5' ' ' VAL . 26.7 p -120.62 147.91 44.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.487 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.73 128.97 55.83 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.35 145.86 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB2' HH11 ' A' ' 28' ' ' ARG . . . -84.19 138.28 33.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.64 160.09 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.265 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 5.5 t70 -99.05 -22.84 15.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.004 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -24.99 65.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -62.2 -60.55 3.43 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.42 35.74 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.859 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -89.97 178.61 6.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.912 0.356 . . . . 0.0 111.312 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -40.14 83.58 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.56 81.54 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.621 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 21.0 t0 -59.86 -37.92 80.67 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.61 -40.56 72.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.54 0.209 . . . . 0.0 110.687 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 t -71.26 -50.68 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HB2' ' A' ' 16' ' ' ALA . 8.3 mmt85 -63.06 -35.67 81.01 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.557 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.1 26.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' HD13 ' A' ' 32' ' ' LEU . 8.7 t -85.74 22.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.592 0.234 . . . . 0.0 111.441 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.35 47.98 2.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 110.983 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD13 ' HB ' ' A' ' 30' ' ' VAL . 9.8 mp -116.09 38.05 3.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.959 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.15 121.52 71.42 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 120.727 0.298 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.34 -29.52 9.35 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 113.06 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -77.71 -42.62 33.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.097 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.09 70.49 0.4 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 111.402 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.45 155.61 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.489 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 t -85.32 138.32 32.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.7 m -110.36 129.73 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.456 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.8 139.99 45.61 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.72 135.11 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 44' ' ' ARG . 15.0 t0 -47.75 122.06 4.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -33.85 78.05 0.0 OUTLIER Glycine 0 CA--C 1.527 0.815 0 O-C-N 124.414 1.071 . . . . 0.0 115.014 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -132.15 157.67 77.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 122.135 0.174 . . . . 0.0 111.052 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 44' ' ' ARG . 28.4 Cg_endo -62.52 155.15 59.91 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.407 2.072 . . . . 0.0 111.815 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.22 82.86 12.03 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.782 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 45' ' ' PRO . 24.6 Cg_exo -62.71 106.5 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.558 2.172 . . . . 0.0 111.742 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.91 -22.33 66.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.618 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.05 -18.15 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.2 154.86 46.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 111.651 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.09 157.8 6.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.219 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.01 174.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -73.7 -46.64 44.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.6 0.238 . . . . 0.0 110.985 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 161.84 22.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.786 0.327 . . . . 0.0 111.186 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.825 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 157.08 43.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -94.35 125.09 38.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.051 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.9 m -133.63 167.49 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.681 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 141.35 35.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 5' ' ' VAL . 16.2 m -116.54 141.32 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.794 0.33 . . . . 0.0 111.346 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mt -114.65 129.08 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -34.77 12.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.02 138.93 32.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.634 0.254 . . . . 0.0 110.983 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.64 154.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.23 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -74.79 111.66 10.21 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.55 -149.67 19.57 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.553 -179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.674 0.273 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -85.02 135.62 33.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.882 HG11 ' O ' ' A' ' 55' ' ' ASP . 11.8 t -102.34 140.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.47 118.65 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.511 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 57' ' ' VAL . 18.0 m -117.2 137.45 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.068 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.41 114.66 20.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 59' ' ' VAL . 16.1 t -87.75 134.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 t -57.31 120.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.89 -117.59 4.33 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.04 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -120.7 159.86 24.48 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.604 0.24 . . . . 0.0 111.251 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 69.49 145.71 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.016 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 135.03 54.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.408 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -118.58 163.35 16.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.7 144.12 44.39 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.032 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG11 HG12 ' A' ' 39' ' ' VAL . 11.8 p -120.13 139.63 46.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.65 130.24 34.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.868 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.54 160.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.901 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.42 -21.36 15.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.895 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -34.91 50.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.514 0.197 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -68.56 -51.63 40.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.61 26.02 18.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.468 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.95 178.72 6.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.05 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.41 -32.82 67.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.467 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.76 70.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.651 0.262 . . . . 0.0 110.92 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.72 -40.53 95.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.753 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.18 -37.42 69.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.861 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.69 -51.2 48.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.979 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -36.27 79.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -28.44 61.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.71 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.587 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.7 t -93.55 21.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.672 0.272 . . . . 0.0 111.203 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 62.77 46.82 4.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 30' ' ' VAL . 1.2 mp -128.06 50.95 2.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.6 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.51 119.69 67.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.31 -27.35 2.87 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.388 . . . . 0.0 112.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 37' ' ' VAL . 7.0 p80 -65.04 -43.39 92.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.96 45.52 8.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.985 0.421 . . . . 0.0 111.575 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 35' ' ' HIS . 18.6 m -126.88 160.52 35.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.91 122.99 44.44 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.722 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.9 m -82.0 135.17 25.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -103.96 145.27 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -101.68 126.07 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.17 120.0 12.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 29.71 37.84 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.947 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.77 138.04 31.07 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 117.231 0.516 . . . . 0.0 111.504 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.07 -44.0 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.13 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG21 ' OE2' ' A' ' 48' ' ' GLU . 17.5 m -153.18 139.56 12.44 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.09 36.45 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.69 2.26 . . . . 0.0 112.823 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' OE2' HG21 ' A' ' 46' ' ' VAL . 39.6 mt-10 -68.75 -35.4 77.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.98 -17.92 48.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.548 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -62.92 136.36 57.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.435 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.9 m -126.07 60.57 1.29 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 t -137.6 140.73 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.51 -44.51 89.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.24 162.18 39.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.882 ' O ' HG11 ' A' ' 3' ' ' VAL . 2.1 p30 -148.59 154.81 40.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -94.83 125.26 39.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.3 m -133.62 167.88 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.582 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.18 136.48 41.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.082 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.3 m -108.41 140.24 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.855 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' ' 64' ' ' LYS . 3.2 pp -99.35 131.77 45.14 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.526 HH21 HG11 ' A' ' 7' ' ' VAL . 12.5 ttm180 -67.26 -59.76 3.16 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.68 -63.44 1.31 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.47 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -145.31 174.97 2.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HB2' HD22 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -155.21 160.49 40.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.041 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.4 36.63 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.638 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -1.321 . . . . 0.0 112.835 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.743 0.306 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -93.1 147.3 22.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.026 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 15' ' ' VAL . 12.7 m -112.12 139.6 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m -74.88 113.59 12.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 59' ' ' VAL . 27.7 m -117.03 136.29 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.443 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -81.65 114.7 20.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.761 HG22 ' CG2' ' A' ' 59' ' ' VAL . 8.7 t -89.03 133.29 31.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.636 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.65 120.4 33.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.546 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.09 -24.92 13.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.973 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.7 163.97 15.68 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 110.796 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -169.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.795 0.331 . . . . 0.0 111.709 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 131.2 45.38 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.35 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -133.1 162.99 30.26 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.043 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.16 140.23 39.45 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 3' ' ' VAL . 11.4 p -132.49 146.96 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 125.83 32.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.999 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 39' ' ' VAL . 6.9 m -116.32 161.63 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.909 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.3 -33.86 59.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -39.2 58.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.863 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 54' ' ' VAL . 1.3 t70 -48.01 -47.33 33.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.802 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.97 26.5 70.92 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.191 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.48 174.49 6.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.952 0.376 . . . . 0.0 111.143 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.86 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.313 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.42 -36.03 70.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.183 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 27.9 t0 -58.95 -39.33 81.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.892 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -65.43 -35.66 81.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.693 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.56 -51.34 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.067 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -63.28 -35.43 80.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.044 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.68 -25.05 37.75 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.82 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.5 t -85.72 23.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.93 48.28 2.39 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.247 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.1 mt -132.32 52.78 2.05 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.3 130.4 22.9 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.739 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.36 -32.93 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.615 2.21 . . . . 0.0 113.23 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.8 -43.0 23.24 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 48.37 67.45 0.85 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.345 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 59' ' ' VAL . 22.7 m -128.06 149.59 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.502 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -85.2 138.66 32.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 17' ' ' VAL . 31.5 m -99.31 131.62 46.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.296 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' LEU . 4.0 mm? -103.9 151.26 23.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.9 t -118.25 139.27 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.814 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' ARG . 10.5 p-10 -47.55 124.45 7.03 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -36.57 80.91 0.0 OUTLIER Glycine 0 C--N 1.34 0.775 0 O-C-N 124.083 0.864 . . . . 0.0 114.356 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' ASP . 37.2 ptt180 -125.99 144.49 48.89 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 120.649 0.261 . . . . 0.0 111.402 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.9 -39.38 2.38 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.818 2.346 . . . . 0.0 112.7 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.73 156.04 76.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 56.5 5.14 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.688 2.259 . . . . 0.0 112.627 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -68.55 -30.09 68.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.95 19.47 4.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.312 -0.403 . . . . 0.0 112.074 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.02 86.97 0.06 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.951 0.405 . . . . 0.0 110.65 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -142.53 160.46 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 54' ' ' VAL . 21.3 t 71.81 137.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.21 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.9 pt-20 -57.05 -38.51 73.33 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.974 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.484 ' H ' HG12 ' A' ' 52' ' ' VAL . 35.9 m -106.43 161.86 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 149.97 34.54 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.853 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 129.77 42.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.345 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.612 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.6 m -135.23 167.15 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.394 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -105.39 136.29 45.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.487 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.761 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.9 m -101.82 136.52 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 63' ' ' ILE . 1.5 tt -100.3 113.01 25.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.267 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -124.55 55.35 1.33 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 tp -149.05 34.61 0.74 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.609 HG23 HD22 ' A' ' 60' ' ' LEU . 2.3 pt -122.08 175.73 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.01 175.03 9.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.59 -32.08 6.87 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.792 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.54 -1.145 . . . . 0.0 112.669 -179.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.584 ' HB2' HG21 ' A' ' 22' ' ' THR . 25.9 tpp . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.813 0.34 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.32 149.36 23.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.82 140.01 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.51 113.54 11.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.6 m -117.43 137.27 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.672 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.46 115.24 21.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.83 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.0 t -90.01 134.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.56 120.38 30.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.15 17.91 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.042 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.64 163.71 16.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.771 0.285 . . . . 0.0 110.825 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -168.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.467 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -99.69 122.84 43.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.046 0.45 . . . . 0.0 111.195 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m -123.24 162.94 21.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.265 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.79 139.57 40.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.29 143.66 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.33 128.64 34.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 20' ' ' ASP . 28.8 m -116.18 161.11 15.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.92 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.73 -34.33 21.25 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -31.02 64.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.223 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -54.02 -46.83 71.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.83 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.7 26.06 54.83 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.584 HG21 ' HB2' ' A' ' 1' ' ' MET . 0.6 OUTLIER -95.74 179.09 5.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -58.11 -34.22 69.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.171 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.7 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.091 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.97 -42.72 90.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.78 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -58.76 -46.47 87.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.771 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.99 -50.44 79.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -58.89 -37.37 76.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.18 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.54 -27.46 49.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.834 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.1 t -94.26 23.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.289 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.05 48.35 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.09 0.471 . . . . 0.0 111.033 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.479 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -126.9 52.33 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.581 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . 52.6 p -90.2 120.48 69.16 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.64 -32.97 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.627 2.218 . . . . 0.0 112.916 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -39.68 31.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.402 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 39.52 62.1 1.25 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.869 0.468 . . . . 0.0 111.883 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.77 153.72 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.68 137.17 33.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.593 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.2 m -105.34 134.87 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 6.8 mp -100.33 147.21 26.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.663 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -101.72 117.81 47.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.87 120.25 12.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.301 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 CA-C-N 115.009 -0.996 . . . . 0.0 114.739 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 120.615 0.245 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' OD2' ' A' ' 20' ' ' ASP . 33.3 m -124.16 161.86 26.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.112 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -149.22 153.97 38.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -95.38 124.96 39.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.875 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.7 m -134.83 166.63 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.5 mttt -104.46 136.03 44.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.54 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.83 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.2 m -106.69 141.23 22.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.842 0.354 . . . . 0.0 111.426 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 119.04 38.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.69 0.281 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -84.91 146.71 27.13 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.1 p -117.37 140.13 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.709 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -74.6 113.24 11.62 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 57' ' ' VAL . 20.1 m -118.7 136.43 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.36 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.6 mt-10 -81.49 114.85 20.49 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.447 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 59' ' ' VAL . 21.6 t -89.67 133.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.805 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.86 120.61 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.89 -57.42 5.01 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.449 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.76 163.51 26.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.37 -172.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.521 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.5 m -99.52 121.05 40.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.951 0.405 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.5 t -120.96 161.71 21.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.55 140.83 33.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 37' ' ' VAL . 10.1 p -128.24 150.75 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 124.67 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.93 164.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.707 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -88.53 -29.54 19.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.55 -37.61 63.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 32.5 p30 -50.72 -30.39 13.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.54 25.62 75.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.983 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -103.07 179.14 4.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -57.02 -32.8 66.52 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.33 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.46 -36.96 69.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.207 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.74 -44.75 93.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.632 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -57.2 -36.29 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.049 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 t -70.88 -51.08 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.888 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -35.89 76.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.185 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.2 65.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.577 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.8 t -94.53 20.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.276 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.36 47.85 3.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.991 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.97 49.63 1.95 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 p -93.28 120.43 66.69 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 14.1 Cg_exo -68.99 -32.95 20.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.705 2.27 . . . . 0.0 112.583 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.459 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -79.77 -42.77 23.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.377 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.17 55.23 6.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.082 0.468 . . . . 0.0 110.952 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 15' ' ' VAL . 11.7 m -124.04 148.83 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.298 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.2 m -84.68 133.46 34.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.5 m -109.42 131.2 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.493 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.98 141.67 40.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.695 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -100.81 139.27 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -74.43 120.69 20.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.253 0.549 . . . . 0.0 109.643 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.884 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.154 -179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.7 pt-20 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.435 0.16 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.5 m -117.83 162.17 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.208 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.799 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.9 t70 -148.28 155.86 41.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -94.72 127.66 40.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.715 0.293 . . . . 0.0 110.347 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.2 m -131.64 167.23 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.903 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -102.78 140.75 36.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.779 HG23 HG22 ' A' ' 7' ' ' VAL . 3.8 m -118.49 141.94 35.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.12 115.29 29.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.779 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -85.61 142.46 29.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 55' ' ' ASP . 41.2 t -129.22 139.91 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -75.0 113.62 12.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.436 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 ' CG1' ' A' ' 59' ' ' VAL . 22.7 m -118.04 137.56 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.363 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.87 115.04 20.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.783 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.2 t -88.88 134.12 29.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.75 120.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.27 -57.19 5.04 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.397 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 163.57 26.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.63 -170.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.48 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -99.73 122.53 42.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 111.014 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -121.34 162.56 20.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.083 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -100.47 138.44 37.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 HG21 ' A' ' 37' ' ' VAL . 27.3 m -131.5 150.56 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.339 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.58 127.02 33.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.819 0.342 . . . . 0.0 111.398 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 39' ' ' VAL . 3.4 m -121.94 139.55 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.5 -21.93 64.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -35.16 47.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.59 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.16 -48.3 80.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.447 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.11 26.55 52.41 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.429 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -88.06 176.4 7.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.206 0.503 . . . . 0.0 111.46 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -60.44 -38.95 85.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.75 76.17 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.174 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.65 -37.18 83.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -55.78 -35.46 66.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.543 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 -49.27 73.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.936 0.398 . . . . 0.0 110.831 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.9 -35.79 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.9 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.854 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 32' ' ' LEU . 11.3 t -87.45 23.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 63.53 48.08 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.828 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.6 mt -133.57 48.24 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m -97.49 123.03 53.8 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.934 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.28 -27.76 6.3 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.734 2.289 . . . . 0.0 112.718 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -73.31 -43.07 61.55 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.326 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 46.55 60.05 3.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.94 HG21 HG11 ' A' ' 15' ' ' VAL . 16.0 m -124.19 148.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.376 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.98 137.27 33.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.457 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.737 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.9 m -107.33 129.8 60.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 111.634 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.45 138.22 51.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.593 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.82 135.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -62.94 120.56 11.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.391 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.891 -179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -154.31 162.06 2.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.108 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.867 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -148.48 147.49 29.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.406 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -94.76 125.37 39.37 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.829 0.347 . . . . 0.0 110.316 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.9 m -130.16 167.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.649 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.36 136.47 42.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.783 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -106.39 139.16 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.836 0.351 . . . . 0.0 111.549 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 121.22 40.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.909 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 . . . . . 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.254 -179.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -85.92 143.39 28.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.783 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 15' ' ' VAL . 30.9 m -102.35 139.79 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.731 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -74.66 115.87 14.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.237 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG1' HG23 ' A' ' 57' ' ' VAL . 17.7 m -115.57 137.33 49.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.183 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.28 117.27 21.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.538 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 59' ' ' VAL . 20.1 t -89.46 133.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.03 120.65 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.36 -117.13 4.59 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.081 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -120.8 159.93 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.544 0.211 . . . . 0.0 111.249 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 72.61 147.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.928 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -116.99 135.11 53.95 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.8 m -114.24 162.84 16.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.206 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -125.96 133.97 51.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 39' ' ' VAL . 11.5 p -121.65 147.18 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.64 133.56 34.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.71 161.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.98 -38.32 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.63 -31.65 16.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.036 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -68.07 -51.54 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.89 25.73 31.23 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.158 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.09 179.18 6.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -57.46 -36.14 71.05 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.61 74.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.95 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.84 -44.42 97.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.2 tp -59.61 -44.66 93.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.45 -50.53 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.972 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -59.1 -36.77 75.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.288 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -27.72 65.34 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.607 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 32' ' ' LEU . 10.5 t -93.44 23.59 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.215 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 60.34 48.15 8.25 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.54 44.88 2.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.776 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -83.82 120.3 74.86 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.696 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.51 -31.18 3.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.765 2.31 . . . . 0.0 112.801 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -77.05 -42.81 36.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.819 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 48.41 61.98 2.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.233 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.56 146.1 29.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -85.72 119.57 26.2 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.59 ' HB ' HG21 ' A' ' 57' ' ' VAL . 31.6 m -88.89 134.76 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.458 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 7.4 mp -107.05 144.44 33.71 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.7 t -101.59 139.38 22.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.13 121.64 15.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.309 0.575 . . . . 0.0 110.344 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.42 179.719 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 . . . . . 0 N--CA 1.468 0.444 0 CA-C-O 120.63 0.252 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.6 m -109.06 163.83 6.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.485 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.41 150.35 34.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.851 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -95.33 126.11 40.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.2 m -134.74 167.08 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 1.6 mttt -103.43 138.4 40.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.6 m -112.77 139.3 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 111.476 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tp -108.22 119.61 39.98 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 CA--C 1.529 0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.085 179.784 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.693 0.283 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 3.2 m120 -87.0 143.4 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.3 p -102.04 140.16 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.678 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -75.0 115.2 14.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.58 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.5 m -115.97 137.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.49 114.83 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.658 HG22 ' CG2' ' A' ' 59' ' ' VAL . 23.1 t -88.69 133.93 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.633 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.37 120.69 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.28 -117.06 3.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.162 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.74 159.83 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 111.175 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 68.61 162.32 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -126.6 135.11 50.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.605 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' VAL . 40.5 m -111.9 163.42 14.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.243 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 52.3 mt-10 -124.61 137.81 54.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.3 p -125.53 143.96 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.86 131.61 34.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.839 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.77 133.3 63.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.671 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.98 -28.29 67.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.528 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.58 -33.87 61.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.276 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.55 -54.92 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 26.75 16.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 170.4 9.28 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.909 0.355 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -62.62 -38.74 91.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.416 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -38.55 74.29 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -64.73 -38.07 89.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.964 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.7 tp -57.61 -42.12 82.63 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.569 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.2 t -65.55 -49.68 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.972 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -60.22 -35.81 76.28 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.14 64.28 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.644 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.0 t -90.93 23.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.187 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.83 46.46 2.97 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.099 0.476 . . . . 0.0 111.167 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.36 34.43 5.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 p -91.22 120.58 68.44 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.499 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.05 -31.48 9.68 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.53 2.153 . . . . 0.0 112.484 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 15' ' ' VAL . 8.7 p-80 -79.38 -41.61 27.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.33 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 43.97 73.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.228 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.568 HG21 HG11 ' A' ' 59' ' ' VAL . 14.0 m -133.28 148.81 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.308 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -85.23 137.62 32.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.77 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.73 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.0 m -96.3 126.96 48.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.392 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.42 141.74 41.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.1 t -101.63 117.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' GLY . 8.3 t70 -63.73 120.49 11.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 C--N 1.335 0.527 0 O-C-N 124.597 1.185 . . . . 0.0 115.002 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.59 161.44 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 111.531 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.815 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.2 m-20 -142.63 157.22 44.91 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.574 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -94.74 125.46 39.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 110.497 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' A' ' 39' ' ' VAL . 14.9 m -133.9 167.86 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.36 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 139.53 47.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.399 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -104.89 141.25 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.603 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -105.22 135.84 45.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.237 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.897 0.379 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.69 136.78 32.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.517 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 15' ' ' VAL . 23.2 m -102.35 139.69 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.026 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 m -74.88 117.58 16.89 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' CG1' HG23 ' A' ' 57' ' ' VAL . 14.4 m -118.03 137.51 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.022 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 114.67 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 59' ' ' VAL . 27.1 t -86.13 133.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.69 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.08 120.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.88 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.92 -114.24 3.06 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.234 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 1.3 pm0 -121.03 158.97 26.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 111.651 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 5.0 mt-10 66.73 163.6 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.923 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -126.88 134.39 50.49 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.494 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 m -110.63 162.92 14.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.79 135.0 52.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.577 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 3' ' ' VAL . 16.4 t -130.04 149.23 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.875 0.369 . . . . 0.0 111.406 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.18 35.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.75 163.83 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.95 -14.85 58.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.546 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.15 -35.44 62.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.25 -44.97 20.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.33 27.02 34.36 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.618 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.78 175.68 7.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -57.15 -32.9 66.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.544 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.22 74.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.14 -40.92 97.2 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -56.99 -39.95 75.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.42 -51.01 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -35.9 77.87 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.092 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -30.0 67.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.534 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.9 t -94.7 23.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.53 48.5 9.62 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.675 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.68 42.54 3.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 t -99.24 132.23 23.76 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.61 -32.89 4.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.535 2.157 . . . . 0.0 112.59 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -80.21 -42.75 22.72 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 46.89 61.67 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.455 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -126.04 146.0 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.212 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 134.97 33.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.046 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' HG21 ' A' ' 57' ' ' VAL . 32.2 m -91.28 135.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.0 152.57 20.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.51 119.92 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.612 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.18 120.03 7.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.77 0 CA-C-N 114.801 -1.091 . . . . 0.0 114.76 -179.624 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.457 0.17 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.459 ' HB ' HG12 ' A' ' 3' ' ' VAL . 33.2 m -111.21 161.91 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -146.09 156.97 43.82 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -95.32 126.33 40.56 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.492 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.5 m -134.42 167.52 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.22 135.94 42.92 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 7' ' ' VAL . 5.4 m -117.14 140.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 111.523 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.35 119.41 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.843 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.757 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 8.2 m-80 -85.01 145.75 27.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 31.6 t -127.96 139.66 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.62 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.95 113.51 12.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.964 0.411 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.8 m -117.93 137.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.385 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -81.87 115.01 20.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.675 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.3 t -89.98 133.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.3 t -72.41 120.78 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.719 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.41 -56.98 5.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.443 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.58 163.64 26.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.618 0.246 . . . . 0.0 110.95 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -58.77 -174.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.407 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -99.63 131.69 45.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.151 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.22 162.06 34.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 21.6 mt-10 -94.79 139.35 31.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.693 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 HG21 ' A' ' 37' ' ' VAL . 35.2 m -132.58 148.27 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.386 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.39 129.05 34.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.922 HG12 HG11 ' A' ' 39' ' ' VAL . 4.1 m -116.76 150.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.814 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.6 p30 -70.79 -20.67 62.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.044 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.2 -41.35 62.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.786 0.327 . . . . 0.0 111.015 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -54.78 -45.49 74.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.51 26.51 46.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.996 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.48 170.53 9.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 111.465 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.76 75.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.56 -35.18 67.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.058 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.5 m-20 -68.5 -42.64 78.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -43.52 98.7 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 24' ' ' ALA . 8.2 p -70.94 -39.87 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.258 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -66.9 -35.94 81.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.985 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.56 -25.03 23.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 30' ' ' VAL . 10.0 t -89.31 23.35 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.706 0.289 . . . . 0.0 111.392 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 62.84 48.28 4.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 32.57 5.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.93 140.61 25.02 Favored Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.064 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 -32.86 7.22 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.66 -42.75 27.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.132 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.79 72.19 0.34 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 111.024 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.992 HG21 HG11 ' A' ' 15' ' ' VAL . 17.8 m -123.74 146.85 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.343 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 137.85 35.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.746 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.922 HG11 HG12 ' A' ' 17' ' ' VAL . 29.8 m -86.84 131.7 34.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.12 147.46 37.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.223 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.37 117.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.404 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.04 120.09 6.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.335 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.693 0 O-C-N 124.447 1.092 . . . . 0.0 115.048 -179.858 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 54' ' ' VAL . 11.5 pt-20 . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 120.501 0.191 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.6 m -111.39 162.31 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.047 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 23.1 t70 -149.07 154.45 39.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.976 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -94.95 125.2 39.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 110.046 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.1 m -135.86 167.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.265 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.11 140.92 40.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.517 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.675 ' CG2' HG22 ' A' ' 7' ' ' VAL . 6.0 m -101.27 140.88 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.9 125.81 54.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.689 0.28 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.52 148.96 22.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.466 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.43 139.91 22.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.844 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -74.88 113.34 12.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.11 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' HG23 ' A' ' 57' ' ' VAL . 35.7 m -117.7 135.69 57.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.228 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 114.89 23.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.6 t -83.74 130.96 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.38 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.62 120.43 16.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.19 -57.41 4.77 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.161 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 163.53 26.07 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.683 0.278 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.55 -177.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -99.65 134.25 42.8 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.959 0.409 . . . . 0.0 111.07 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 m -137.19 160.45 38.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.228 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.34 137.39 32.41 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 37' ' ' VAL . 9.1 p -130.77 145.69 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.48 125.83 32.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.727 ' CG1' HG11 ' A' ' 39' ' ' VAL . 9.2 m -119.76 161.42 19.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.672 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.94 -36.94 64.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.052 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -31.37 65.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.48 -48.05 72.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.85 26.06 63.37 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.606 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -100.62 178.89 4.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.015 0.408 . . . . 0.0 111.03 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -59.09 -34.63 72.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -36.1 72.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.78 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -59.25 -38.7 80.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.21 -45.22 91.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.686 0.279 . . . . 0.0 110.779 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.05 -47.73 59.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.97 81.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.673 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.12 53.51 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.731 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.4 t -90.57 23.48 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.988 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.29 48.36 10.31 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.009 0.433 . . . . 0.0 111.042 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -127.12 45.24 2.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -84.65 129.11 58.36 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -33.09 10.61 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.95 -40.97 26.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.189 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.27 59.14 2.78 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.671 HG23 HG21 ' A' ' 15' ' ' VAL . 5.6 m -126.44 146.01 33.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 m -86.13 123.3 31.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.727 HG11 ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -91.52 127.65 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.38 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -116.76 133.28 56.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 57' ' ' VAL . 30.2 t -101.48 117.79 47.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 43' ' ' GLY . 13.4 t70 -56.23 120.66 7.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.902 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 C--N 1.339 0.746 0 O-C-N 124.843 1.34 . . . . 0.0 115.679 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 120.519 0.2 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.51 162.29 30.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.707 0.289 . . . . 0.0 111.34 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.94 154.69 39.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -95.56 129.93 42.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 39' ' ' VAL . 4.2 m -135.23 167.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.261 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.37 138.2 50.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.477 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.807 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.7 m -103.1 138.4 27.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.46 117.17 33.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.176 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 . . . . . 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.066 179.86 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.457 0.17 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -86.16 148.96 25.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -102.19 139.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.466 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.13 113.57 11.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.286 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.986 HG21 HG13 ' A' ' 59' ' ' VAL . 2.1 p -114.39 135.12 55.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.268 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.5 114.94 22.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.849 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.7 t -85.93 133.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -77.33 120.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -23.68 11.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.111 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.64 164.11 15.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.573 0.349 . . . . 0.0 110.826 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.91 -173.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.39 129.34 45.58 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -126.29 163.09 23.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.22 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.9 137.67 42.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.89 146.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.38 31.01 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.228 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.53 157.89 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -18.23 48.93 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -41.02 73.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.556 0.217 . . . . 0.0 111.315 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -51.64 -35.94 44.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.792 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.31 26.07 69.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.588 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -93.34 166.75 12.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.215 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -34.58 74.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.44 70.22 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.278 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 13.9 m-20 -58.98 -38.12 78.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.993 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -58.51 -34.25 70.74 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.622 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -70.45 -51.57 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 25' ' ' ASP . 1.4 ptm180 -65.18 -35.43 81.05 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.171 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -25.32 39.97 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.2 t -87.48 23.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.615 0.245 . . . . 0.0 111.156 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 65.47 47.5 2.26 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.6 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -128.18 37.18 4.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.728 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -77.61 124.71 86.58 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.77 -32.78 2.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.697 2.265 . . . . 0.0 112.913 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -42.9 32.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.2 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.02 72.1 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.216 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' HE ' ' A' ' 61' ' ' ARG . 19.1 m -123.68 157.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.413 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 m -84.76 116.92 23.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.554 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -94.3 137.07 23.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 58' ' ' LYS . 6.7 mt -81.99 157.81 24.09 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.45 139.68 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.58 130.33 13.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.718 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 -179.431 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -106.08 171.57 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.355 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -146.22 157.39 43.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.214 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 133.99 38.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.602 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' VAL . 6.3 m -129.47 167.38 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.858 ' HB2' HD12 ' A' ' 40' ' ' LEU . 23.0 mmtp -115.75 133.47 56.0 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.986 HG13 HG21 ' A' ' 5' ' ' VAL . 19.0 m -100.76 131.69 47.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.902 0.382 . . . . 0.0 111.307 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 111.24 23.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HE ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.647 0.26 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -84.9 146.61 27.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 111.002 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.0 p -134.24 140.02 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.81 113.41 12.06 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.104 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' VAL . 15.3 m -118.59 136.19 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.246 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -81.51 114.72 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.791 HG22 ' CG2' ' A' ' 59' ' ' VAL . 14.2 t -90.15 130.48 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.2 120.68 23.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.717 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.52 -51.37 3.0 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.395 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 163.39 14.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.658 0.266 . . . . 0.0 111.037 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.44 -177.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -99.62 127.02 45.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.193 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -131.12 162.64 29.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.267 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -92.89 137.77 32.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.836 HG11 HG21 ' A' ' 37' ' ' VAL . 24.4 m -129.87 150.47 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.202 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.49 126.85 33.65 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG12 HG11 ' A' ' 39' ' ' VAL . 7.2 m -116.51 160.7 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.765 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -84.71 -31.86 23.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.307 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.51 -31.63 24.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.078 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -51.92 -40.99 61.66 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.515 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.52 26.16 70.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -95.06 179.09 5.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 111.155 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.13 -32.88 66.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.238 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.6 67.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.366 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -58.48 -43.92 89.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.556 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -45.02 85.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.27 -45.65 78.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -35.88 73.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.028 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.73 34.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.637 ' HB ' HD13 ' A' ' 32' ' ' LEU . 9.4 t -91.26 23.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.675 0.274 . . . . 0.0 111.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 64.62 48.2 2.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.056 0.455 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.637 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -119.22 48.9 1.41 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.5 t -99.01 120.37 58.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.54 -33.02 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.571 2.181 . . . . 0.0 113.224 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -79.89 -42.66 23.7 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.264 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 50.42 66.37 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.076 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 15' ' ' VAL . 26.2 m -123.81 151.31 28.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 121.33 33.85 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.656 HG11 HG12 ' A' ' 17' ' ' VAL . 16.8 m -90.92 132.47 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 4.3 mm? -102.17 134.93 44.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 130.65 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -63.58 119.77 10.47 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.573 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.88 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.686 ' HG3' HG13 ' A' ' 54' ' ' VAL . 16.9 pt-20 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.408 0.147 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.686 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.9 m -108.0 161.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.387 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 3' ' ' VAL . 23.9 t70 -147.92 154.11 39.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.667 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -94.93 125.94 39.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.203 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.2 m -134.18 167.37 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.62 141.1 36.0 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.791 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.8 m -112.49 131.83 62.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 111.318 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.06 122.38 44.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HG21 ' A' ' 22' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.602 0.239 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -92.67 146.98 23.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.745 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.5 t -121.76 139.57 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.931 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.21 113.42 12.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 57' ' ' VAL . 17.4 m -118.44 137.22 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -81.8 114.81 20.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.5 t -86.86 133.23 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.72 120.66 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.638 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.82 -57.58 5.05 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.418 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.53 163.78 25.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -58.22 -175.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.249 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 5' ' ' VAL . 60.1 m -99.64 130.44 45.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.928 0.394 . . . . 0.0 111.187 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -127.48 162.72 25.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.55 130.89 42.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.977 HG11 HG21 ' A' ' 37' ' ' VAL . 26.8 m -129.77 144.3 38.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 35' ' ' HIS . . . -84.25 126.61 33.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.041 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 20' ' ' ASP . 26.8 m -117.11 161.98 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.135 0.493 . . . . 0.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.72 -41.94 78.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.335 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.69 -41.57 56.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.962 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' VAL . 1.6 t0 -47.19 -40.94 17.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.387 0.429 . . . . 0.0 111.582 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.94 26.38 69.14 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.931 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -99.55 178.47 4.85 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.87 0.367 . . . . 0.0 111.111 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -32.75 66.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.219 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.82 70.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.17 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.42 -44.03 95.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.869 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.68 -46.43 89.08 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.69 0.281 . . . . 0.0 110.8 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 32' ' ' LEU . 20.5 t -67.53 -44.88 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.52 -36.15 81.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.23 -26.87 42.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.84 23.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.562 0.22 . . . . 0.0 111.331 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.3 42.0 9.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.059 0.457 . . . . 0.0 110.964 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 27' ' ' VAL . 3.5 mt -121.1 39.43 3.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.529 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.08 120.67 72.65 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.22 -33.15 7.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.505 2.136 . . . . 0.0 112.494 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.526 ' ND1' HG22 ' A' ' 37' ' ' VAL . 14.7 p80 -79.89 -42.07 24.92 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.096 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 51.67 70.26 0.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.977 HG21 HG11 ' A' ' 15' ' ' VAL . 26.9 m -135.68 147.29 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.414 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.18 136.97 32.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.796 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.2 m -93.34 133.96 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.399 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.83 148.01 31.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 t -106.65 117.72 52.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.01 120.18 11.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.149 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.684 0 O-C-N 124.411 1.069 . . . . 0.0 114.786 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 . . . . . 0 N--CA 1.464 0.246 0 CA-C-O 120.435 0.159 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 55' ' ' ASP . 8.7 t -110.65 161.66 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 110.546 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.745 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 145.72 28.28 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -95.0 125.24 39.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.288 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.1 m -136.21 167.17 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -102.24 141.67 34.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 7' ' ' VAL . 4.4 m -106.07 137.61 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.838 0.352 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.75 128.49 56.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.174 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.353 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.86 0.362 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -89.3 142.16 27.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.31 140.0 21.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -74.67 113.2 11.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 110.485 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG23 ' A' ' 57' ' ' VAL . 31.9 m -118.87 137.6 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.378 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.15 114.95 21.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.781 HG22 ' CG2' ' A' ' 59' ' ' VAL . 21.6 t -88.66 133.98 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.419 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.22 120.62 4.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.6 -49.44 3.15 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.55 163.3 26.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.626 0.251 . . . . 0.0 110.972 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.41 -100.0 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -127.96 135.06 49.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 111.349 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 t -132.07 162.89 29.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.245 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -123.47 138.54 54.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG21 HG23 ' A' ' 37' ' ' VAL . 11.4 p -131.98 147.88 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.257 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.736 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 125.79 32.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.17 161.05 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.47 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.6 -26.98 37.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.725 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.54 -34.87 67.46 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.599 0.238 . . . . 0.0 110.929 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -52.73 -61.09 2.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.18 57.11 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.709 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.73 178.91 5.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 111.141 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -57.17 -38.93 74.32 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.15 82.76 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.932 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -60.38 -37.51 80.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -41.73 78.52 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.809 0.338 . . . . 0.0 110.555 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.96 -50.71 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 tmt_? -59.34 -36.16 75.18 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.213 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.31 36.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.99 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 30' ' ' VAL . 8.4 t -92.14 23.46 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.702 0.287 . . . . 0.0 111.309 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.61 47.32 4.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.134 0.492 . . . . 0.0 111.454 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 33.16 4.99 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.8 120.27 68.81 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.863 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.82 -32.47 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.951 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.93 -41.12 75.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.97 69.37 0.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.036 0.446 . . . . 0.0 111.176 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 HG21 ' A' ' 15' ' ' VAL . 23.4 m -124.02 145.8 30.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.239 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.8 m -96.77 119.43 35.22 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.831 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.2 m -84.18 131.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.519 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.1 mt -105.51 147.64 28.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.0 t -102.15 136.68 33.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.864 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.85 120.83 14.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.65 0.262 . . . . 0.0 110.333 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 CA-C-N 115.191 -0.913 . . . . 0.0 114.625 179.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' HG13 ' A' ' 54' ' ' VAL . 17.2 pt-20 . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.516 0.198 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.543 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.4 m -113.41 162.22 11.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.797 0.332 . . . . 0.0 111.214 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -147.97 152.3 37.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -97.13 125.12 41.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.41 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.505 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.4 m -136.26 167.13 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.15 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -110.64 128.71 55.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.781 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -100.86 141.62 17.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.975 0.417 . . . . 0.0 111.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 61' ' ' ARG . 4.3 tt -97.64 128.53 44.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.959 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.507 0.194 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -91.59 148.78 22.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.76 0.315 . . . . 0.0 110.648 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 15' ' ' VAL . 20.4 m -102.15 139.96 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.727 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -74.48 114.3 12.72 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.3 m -116.48 137.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.303 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 114.76 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' CG2' ' A' ' 59' ' ' VAL . 18.5 t -88.15 134.22 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.96 120.26 3.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.475 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.38 -118.14 4.19 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.246 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -120.73 159.04 26.19 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 70.19 155.19 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.05 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.1 m -116.23 134.9 54.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.393 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.442 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.6 t -108.51 161.98 14.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.298 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.01 131.93 52.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 3' ' ' VAL . 9.9 p -122.92 144.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.778 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . . . -85.19 134.97 34.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.241 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.58 159.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 111.88 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.85 -33.78 45.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.299 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -56.73 -35.82 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -55.18 -48.54 73.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.779 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.21 42.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.15 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 179.17 5.55 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -57.31 -32.65 66.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.181 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.76 74.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.06 -44.4 91.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.559 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -41.1 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.12 -50.08 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 1.1 mtp-105 -60.39 -36.05 77.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.359 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.596 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 30' ' ' VAL . 10.7 t -95.58 23.15 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.717 0.294 . . . . 0.0 111.221 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 59.27 46.94 12.14 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.47 46.02 2.31 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.64 120.46 72.96 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-O 120.598 0.237 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.674 2.25 . . . . 0.0 113.008 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.75 23.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 111.175 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.24 61.97 2.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.089 0.471 . . . . 0.0 111.173 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.51 146.08 29.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 m -85.49 132.21 34.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.7 m -93.71 131.42 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.61 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 3.9 mm? -107.29 147.71 29.9 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.19 117.79 52.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.86 120.12 11.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.419 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 CA-C-N 114.827 -1.078 . . . . 0.0 115.153 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 120.424 0.154 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.96 161.63 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 111.498 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 152.63 40.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -95.63 125.23 40.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.525 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.561 HG21 ' HB ' ' A' ' 39' ' ' VAL . 12.4 m -135.69 167.09 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.4 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 6.2 mmtt -107.65 140.11 41.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.729 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.9 m -102.2 136.12 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.315 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.2 112.41 23.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.604 0.24 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -89.81 144.21 26.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.0 t -111.98 139.91 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -74.7 113.49 12.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.98 135.55 53.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.398 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.71 114.65 20.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.828 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.3 t -89.27 133.9 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.03 120.45 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.91 -45.09 2.32 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.53 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.41 164.01 12.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.458 0.303 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.31 -176.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -99.25 132.5 44.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -134.69 163.01 30.73 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -94.91 138.12 33.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.217 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 37' ' ' VAL . 11.1 p -131.33 147.61 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 127.85 34.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.65 160.6 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -76.05 -34.52 59.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.897 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -52.77 -35.56 56.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.794 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.29 -51.18 70.42 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.85 26.19 46.49 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.799 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -88.28 162.25 16.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.378 . . . . 0.0 111.265 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -57.57 -35.62 70.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.056 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.76 73.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.246 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.39 -37.31 77.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.373 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.23 -40.01 73.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.794 0.331 . . . . 0.0 110.577 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.07 -48.05 57.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.841 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -61.89 -35.7 79.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.27 -25.14 32.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.1 t -88.8 23.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.6 0.238 . . . . 0.0 111.218 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 64.34 47.5 3.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.466 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.6 mp -122.58 34.9 5.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 4.1 p -94.68 120.51 64.72 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 23.7 Cg_exo -64.04 -32.78 64.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.678 2.252 . . . . 0.0 112.56 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -43.04 23.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.341 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 48.53 67.2 0.89 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.069 0.462 . . . . 0.0 111.04 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.502 ' CG2' HG11 ' A' ' 59' ' ' VAL . 16.1 m -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.39 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 m -91.37 135.66 33.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.5 m -88.3 130.05 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 149.1 33.29 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.8 t -116.4 119.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.623 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 17.8 t0 -52.47 120.59 5.77 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . . . . . . 0 CA--C 1.522 0.53 0 O-C-N 124.481 1.113 . . . . 0.0 114.904 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.468 0.436 0 CA-C-O 120.541 0.21 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.09 165.99 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.952 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.1 m-20 -145.99 154.9 42.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -94.64 125.45 39.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 110.539 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.647 HG21 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m -134.53 167.78 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.952 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 42' ' ' ASP . 6.7 ptpp? -109.72 139.9 44.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.828 ' CG2' HG22 ' A' ' 7' ' ' VAL . 9.4 m -106.1 141.66 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 111.443 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.62 118.48 36.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.785 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 . . . . . 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -179.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.3 p30 -89.41 147.9 23.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.896 0.379 . . . . 0.0 110.613 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' A' ' 54' ' ' VAL . 27.6 m -102.35 139.95 22.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.43 113.42 11.64 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.4 m -118.4 135.43 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.694 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.98 115.02 22.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.569 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.818 HG22 HG23 ' A' ' 59' ' ' VAL . 17.8 t -84.69 134.14 27.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.53 120.62 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.555 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.3 -55.55 5.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.431 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 163.93 25.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.358 0.263 . . . . 0.0 110.989 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -167.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.473 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -99.34 128.04 45.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.936 0.398 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -126.65 162.82 24.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.063 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 2' ' ' ASN . 6.6 mp0 -105.69 145.26 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.435 HG21 ' CG2' ' A' ' 37' ' ' VAL . 7.4 p -130.97 147.06 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 123.64 30.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 111.065 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.416 HG23 HG22 ' A' ' 3' ' ' VAL . 20.1 t -121.97 152.25 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.718 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.75 -44.77 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.301 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -28.67 46.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.118 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' OD1' HG13 ' A' ' 54' ' ' VAL . 18.1 t70 -50.53 -29.53 10.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.7 25.95 61.75 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.732 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -107.49 179.05 4.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.887 0.375 . . . . 0.0 111.294 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.34 -32.35 66.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.074 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.78 -35.67 66.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.946 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.76 -44.71 90.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.511 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.975 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 t -70.53 -47.25 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.2 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.42 63.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.648 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.6 t -92.61 20.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.602 0.239 . . . . 0.0 111.275 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.76 45.12 2.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.2 88.57 2.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -115.81 120.5 35.66 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.96 -33.13 2.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.659 2.239 . . . . 0.0 112.8 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -79.54 -42.28 25.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.198 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.98 57.5 6.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' A' ' 15' ' ' VAL . 10.6 m -123.62 152.17 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -84.75 134.17 34.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.4 m -105.88 132.18 53.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.918 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 14.2 mt -101.55 151.52 21.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.25 139.35 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -47.61 124.0 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.74 0 O-C-N 124.204 0.94 . . . . 0.0 114.547 -178.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG3' HG23 ' A' ' 54' ' ' VAL . 1.5 pt-20 . . . . . 0 N--CA 1.466 0.351 0 CA-C-O 120.687 0.279 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 53' ' ' GLU . 3.3 t -124.13 161.36 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.43 146.1 27.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -95.42 125.08 39.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.221 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 39' ' ' VAL . 29.5 m -130.63 167.16 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.1 mttt -104.22 140.24 38.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.57 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.818 HG23 HG22 ' A' ' 7' ' ' VAL . 2.3 m -113.01 140.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.727 0.299 . . . . 0.0 111.329 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.51 131.05 54.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.946 0.403 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 18.6 m120 -89.12 138.16 31.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.496 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 39.9 t -102.53 140.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 113.5 12.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.215 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.9 m -117.74 137.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.489 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.96 114.8 21.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.741 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.651 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.4 t -88.32 134.36 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.22 120.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.482 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.93 -33.01 5.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.784 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.01 163.95 14.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.416 0.286 . . . . 0.0 110.757 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -169.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.44 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -99.68 132.87 44.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.057 0.455 . . . . 0.0 111.236 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m -132.73 160.16 37.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 2' ' ' ASN . 3.1 mp0 -89.2 132.83 34.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.845 HG11 HG21 ' A' ' 37' ' ' VAL . 30.0 m -130.22 145.95 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.304 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.21 125.94 32.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 111.361 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 3.3 m -119.0 137.76 51.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.941 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -27.59 47.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.681 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -40.81 63.31 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.949 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.411 ' CG ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -49.24 -45.94 45.3 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.368 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.26 71.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.621 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.42 174.18 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -57.44 -38.51 74.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.205 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.1 78.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.407 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -59.35 -37.02 76.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.46 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.2 -42.71 77.6 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.28 -44.57 72.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG3' ' HB3' ' A' ' 33' ' ' SER . 10.6 ttp85 -59.57 -36.03 75.43 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.289 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.31 -25.07 58.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.918 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 30' ' ' VAL . 9.0 t -89.47 23.37 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.618 0.247 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.93 48.23 2.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.101 0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -121.22 37.48 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -92.9 120.74 66.94 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.703 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 16.0 Cg_exo -67.68 -33.16 28.73 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.8 2.333 . . . . 0.0 112.54 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -79.57 -42.92 23.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 51.38 65.29 1.53 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.845 HG21 HG11 ' A' ' 15' ' ' VAL . 3.4 m -125.48 145.99 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.518 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 m -88.03 136.6 32.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.648 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.749 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.0 m -98.82 134.64 36.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.44 140.36 48.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.77 137.56 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -66.61 120.16 12.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.346 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.708 0 CA-C-N 115.126 -0.943 . . . . 0.0 114.528 -179.865 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 CA--C 1.532 0.251 0 CA-C-O 120.409 0.147 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 20' ' ' ASP . 25.6 m -130.89 161.85 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.298 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -149.27 156.67 42.47 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -95.12 124.63 39.27 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.749 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.0 m -134.92 167.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.16 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.88 130.78 55.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.572 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.651 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -103.3 141.74 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.06 127.52 53.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.258 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.021 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.751 0.31 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.55 146.01 24.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.071 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 55' ' ' ASP . 23.6 t -120.83 139.79 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -75.01 114.94 14.08 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 57' ' ' VAL . 10.0 m -118.15 137.66 51.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.264 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.33 114.79 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.565 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.46 134.14 32.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.03 120.35 3.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.87 -118.36 3.43 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.183 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -120.93 152.88 37.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.55 165.09 0.22 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.123 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -117.99 135.43 54.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.679 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.15 159.98 15.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.394 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.73 127.27 45.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.222 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.18 149.26 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 127.05 34.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.356 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 4.2 m -116.98 148.77 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -23.38 67.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.758 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -54.24 -37.94 65.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.785 0.326 . . . . 0.0 110.808 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.97 -43.83 86.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.255 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.36 26.32 40.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.226 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 163.98 12.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.959 0.379 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -60.08 -38.4 82.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.365 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.46 71.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.259 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.09 -41.86 98.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.17 77.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.28 -44.33 94.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.664 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -35.89 82.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.89 -25.08 41.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.698 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.808 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.6 t -88.71 23.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.5 48.34 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 111.135 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.808 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.4 mt -130.65 44.81 2.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -99.18 136.53 20.47 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 -33.18 6.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.466 2.111 . . . . 0.0 112.529 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -42.35 23.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.203 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 54.59 59.35 4.18 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.4 146.32 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.268 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -90.49 138.48 31.52 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.801 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.5 m -96.59 132.0 42.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 140.21 45.34 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.67 135.49 38.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.96 120.46 13.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 110.231 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.612 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.57 -179.815 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 N--CA 1.465 0.312 0 CA-C-O 120.596 0.236 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.9 161.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.741 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 3' ' ' VAL . 28.1 t70 -148.17 151.21 35.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -95.21 125.48 39.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.948 0.404 . . . . 0.0 110.663 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.5 m -132.25 167.35 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.17 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -108.49 136.7 47.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.679 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 5' ' ' VAL . 15.0 m -102.18 140.81 19.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.311 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.31 132.2 56.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.9 ptt180 . . . . . 0 CA--C 1.532 0.262 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.998 179.831 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -85.26 133.16 34.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.725 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.8 p -103.08 140.45 21.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.922 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -74.73 113.19 11.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.313 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.485 HG23 ' OG ' ' A' ' 13' ' ' SER . 30.0 m -118.75 138.05 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.249 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.76 115.0 20.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.406 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 59' ' ' VAL . 10.0 p -99.24 133.94 40.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.06 120.77 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.2 -55.82 0.69 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.468 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 163.39 22.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.587 0.232 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.66 -82.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.99 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -127.95 135.01 49.36 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.037 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.485 ' OG ' HG23 ' A' ' 5' ' ' VAL . 26.7 p -120.62 147.91 44.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.487 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.73 128.97 55.83 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.35 145.86 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB2' HH11 ' A' ' 28' ' ' ARG . . . -84.19 138.28 33.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.64 160.09 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.265 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 5.5 t70 -99.05 -22.84 15.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.004 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -24.99 65.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -62.2 -60.55 3.43 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.42 35.74 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.859 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -89.97 178.61 6.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.912 0.356 . . . . 0.0 111.312 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -40.14 83.58 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.56 81.54 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.621 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 21.0 t0 -59.86 -37.92 80.67 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.61 -40.56 72.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.54 0.209 . . . . 0.0 110.687 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 t -71.26 -50.68 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HB2' ' A' ' 16' ' ' ALA . 8.3 mmt85 -63.06 -35.67 81.01 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.557 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.1 26.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' HD13 ' A' ' 32' ' ' LEU . 8.7 t -85.74 22.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.592 0.234 . . . . 0.0 111.441 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.35 47.98 2.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 110.983 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.609 HD13 ' HB ' ' A' ' 30' ' ' VAL . 9.8 mp -116.09 38.05 3.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.959 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.15 121.52 71.42 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 120.727 0.298 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.34 -29.52 9.35 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 113.06 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -77.71 -42.62 33.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.097 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.09 70.49 0.4 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 111.402 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.45 155.61 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.489 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 t -85.32 138.32 32.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.7 m -110.36 129.73 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.456 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.8 139.99 45.61 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.72 135.11 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -47.75 122.06 4.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.815 0 O-C-N 124.414 1.071 . . . . 0.0 115.014 -178.532 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.6 0.238 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 161.84 22.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.786 0.327 . . . . 0.0 111.186 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.825 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 157.08 43.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -94.35 125.09 38.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.051 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.9 m -133.63 167.49 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.681 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 141.35 35.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 5' ' ' VAL . 16.2 m -116.54 141.32 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.794 0.33 . . . . 0.0 111.346 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mt -114.65 129.08 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.674 0.273 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -85.02 135.62 33.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.882 HG11 ' O ' ' A' ' 55' ' ' ASP . 11.8 t -102.34 140.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.47 118.65 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.511 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 57' ' ' VAL . 18.0 m -117.2 137.45 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.068 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.41 114.66 20.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 59' ' ' VAL . 16.1 t -87.75 134.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 t -57.31 120.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.89 -117.59 4.33 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.04 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -120.7 159.86 24.48 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.604 0.24 . . . . 0.0 111.251 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 69.49 145.71 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.016 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 135.03 54.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.408 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -118.58 163.35 16.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.7 144.12 44.39 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.032 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' A' ' 35' ' ' HIS . 11.8 p -120.13 139.63 46.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . . . -85.65 130.24 34.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.868 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.54 160.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.901 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.42 -21.36 15.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.895 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -34.91 50.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.514 0.197 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -68.56 -51.63 40.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.61 26.02 18.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.468 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.95 178.72 6.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.05 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.41 -32.82 67.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.467 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.76 70.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.651 0.262 . . . . 0.0 110.92 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.72 -40.53 95.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.753 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.18 -37.42 69.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.861 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.69 -51.2 48.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.979 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -36.27 79.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -28.44 61.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.71 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.587 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.7 t -93.55 21.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.672 0.272 . . . . 0.0 111.203 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 62.77 46.82 4.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 30' ' ' VAL . 1.2 mp -128.06 50.95 2.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.6 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.51 119.69 67.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.31 -27.35 2.87 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.388 . . . . 0.0 112.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 37' ' ' VAL . 10.4 p-80 -65.04 -43.39 92.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.96 45.52 8.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.985 0.421 . . . . 0.0 111.575 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 35' ' ' HIS . 18.6 m -126.88 160.52 35.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.91 122.99 44.44 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.722 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.9 m -82.0 135.17 25.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -103.96 145.27 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -101.68 126.07 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.17 120.0 12.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.771 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.947 179.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.47 0.176 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.24 162.18 39.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.882 ' O ' HG11 ' A' ' 3' ' ' VAL . 2.1 p30 -148.59 154.81 40.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -94.83 125.26 39.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.3 m -133.62 167.88 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.582 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.18 136.48 41.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.082 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.3 m -108.41 140.24 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.855 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 60' ' ' LEU . 3.2 pp -99.35 131.77 45.14 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.526 HH21 HG11 ' A' ' 7' ' ' VAL . 12.5 ttm180 . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.743 0.306 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -93.1 147.3 22.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.026 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 15' ' ' VAL . 12.7 m -112.12 139.6 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m -74.88 113.59 12.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 59' ' ' VAL . 27.7 m -117.03 136.29 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.443 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -81.65 114.7 20.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.761 HG22 ' CG2' ' A' ' 59' ' ' VAL . 8.7 t -89.03 133.29 31.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.636 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.65 120.4 33.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.546 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.09 -24.92 13.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.973 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.7 163.97 15.68 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 110.796 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -169.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.795 0.331 . . . . 0.0 111.709 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 131.2 45.38 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.35 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -133.1 162.99 30.26 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.043 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.16 140.23 39.45 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 3' ' ' VAL . 11.4 p -132.49 146.96 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 125.83 32.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.999 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 39' ' ' VAL . 6.9 m -116.32 161.63 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.909 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.3 -33.86 59.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -39.2 58.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.863 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 54' ' ' VAL . 1.3 t70 -48.01 -47.33 33.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.802 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.97 26.5 70.92 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.191 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.48 174.49 6.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.952 0.376 . . . . 0.0 111.143 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.86 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.313 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.42 -36.03 70.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.183 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 27.9 t0 -58.95 -39.33 81.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.892 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -65.43 -35.66 81.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.693 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.56 -51.34 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.067 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -63.28 -35.43 80.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.044 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.68 -25.05 37.75 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.82 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.5 t -85.72 23.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.93 48.28 2.39 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.247 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.1 mt -132.32 52.78 2.05 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.3 130.4 22.9 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.739 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.36 -32.93 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.615 2.21 . . . . 0.0 113.23 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.8 -43.0 23.24 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 48.37 67.45 0.85 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.345 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 59' ' ' VAL . 22.7 m -128.06 149.59 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.502 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -85.2 138.66 32.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 17' ' ' VAL . 31.5 m -99.31 131.62 46.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.296 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' LEU . 4.0 mm? -103.9 151.26 23.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.9 t -118.25 139.27 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.814 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -47.55 124.45 7.03 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.775 0 O-C-N 124.083 0.864 . . . . 0.0 114.356 -178.626 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.9 pt-20 . . . . . 0 N--CA 1.465 0.316 0 CA-C-O 120.534 0.207 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.451 HG12 ' OD2' ' A' ' 20' ' ' ASP . 35.9 m -106.43 161.86 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 149.97 34.54 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.853 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 129.77 42.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.345 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.612 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.6 m -135.23 167.15 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.394 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -105.39 136.29 45.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.487 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.761 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.9 m -101.82 136.52 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -100.3 113.01 25.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.267 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 . . . . . 0 CA--C 1.534 0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.651 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.584 ' HB2' HG21 ' A' ' 22' ' ' THR . 25.9 tpp . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.813 0.34 . . . . 0.0 111.305 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -89.32 149.36 23.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.738 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -101.82 140.01 21.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.424 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.51 113.54 11.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.312 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.6 m -117.43 137.27 51.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.672 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -82.46 115.24 21.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.679 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.83 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.0 t -90.01 134.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.56 120.38 30.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.419 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -22.15 17.91 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.042 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -118.64 163.71 16.41 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.771 0.285 . . . . 0.0 110.825 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.89 -168.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.467 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -99.69 122.84 43.3 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 121.046 0.45 . . . . 0.0 111.195 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.0 m -123.24 162.94 21.64 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.265 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -105.79 139.57 40.15 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.29 143.66 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.33 128.64 34.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.122 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 20' ' ' ASP . 28.8 m -116.18 161.11 15.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.92 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -85.73 -34.33 21.25 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.207 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.86 -31.02 64.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.223 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -54.02 -46.83 71.93 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.83 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.7 26.06 54.83 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.411 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.584 HG21 ' HB2' ' A' ' 1' ' ' MET . 0.6 OUTLIER -95.74 179.09 5.24 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -58.11 -34.22 69.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.171 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.97 -35.7 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.091 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -58.97 -42.72 90.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.78 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -58.76 -46.47 87.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.771 179.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.99 -50.44 79.59 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.002 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 33' ' ' SER . 0.0 OUTLIER -58.89 -37.37 76.42 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.18 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.54 -27.46 49.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.834 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 30' ' ' VAL . 7.1 t -94.26 23.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.289 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 t0 62.05 48.35 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.09 0.471 . . . . 0.0 111.033 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.479 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.3 OUTLIER -126.9 52.33 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.581 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.443 ' HB3' ' HG2' ' A' ' 28' ' ' ARG . 52.6 p -90.2 120.48 69.16 Favored Pre-proline 0 CA--C 1.53 0.178 0 CA-C-O 120.725 0.298 . . . . 0.0 110.599 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.64 -32.97 1.01 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.627 2.218 . . . . 0.0 112.916 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -79.62 -39.68 31.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.402 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 39.52 62.1 1.25 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 122.869 0.468 . . . . 0.0 111.883 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -123.77 153.72 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.402 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.68 137.17 33.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.583 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.593 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.2 m -105.34 134.87 45.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.845 0.355 . . . . 0.0 111.682 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 6.8 mp -100.33 147.21 26.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.663 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.822 HG12 ' HB2' ' A' ' 44' ' ' ARG . 2.0 t -101.72 117.81 47.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -64.87 120.25 12.19 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.301 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 32.79 36.54 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.009 -0.996 . . . . 0.0 114.739 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.822 ' HB2' HG12 ' A' ' 41' ' ' VAL . 16.6 mtt85 -132.61 120.51 16.74 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 117.151 0.475 . . . . 0.0 111.531 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.32 -40.18 0.67 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 112.771 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.0 m -134.04 103.59 11.77 Favored Pre-proline 0 C--O 1.233 0.233 0 CA-C-O 120.794 0.33 . . . . 0.0 111.306 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.55 -17.64 42.65 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.956 2.437 . . . . 0.0 112.685 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -59.35 -21.28 59.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.386 0.274 . . . . 0.0 111.48 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.47 -13.69 60.09 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.49 0.186 . . . . 0.0 111.247 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 mm100 -107.5 166.54 10.59 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.1 t -146.95 92.9 2.19 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 t -145.73 141.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.957 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -55.45 -46.08 76.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.082 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.551 HG12 ' OD2' ' A' ' 20' ' ' ASP . 33.3 m -124.16 161.86 26.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.112 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -149.22 153.97 38.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.3 ttm105 -95.38 124.96 39.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.875 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.7 m -134.83 166.63 27.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.415 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.5 mttt -104.46 136.03 44.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.54 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.83 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.2 m -106.69 141.23 22.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.842 0.354 . . . . 0.0 111.426 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.57 119.04 38.19 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.963 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -35.37 79.03 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.969 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 tp -149.28 110.97 4.52 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.76 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.518 HD13 ' N ' ' A' ' 66' ' ' GLY . 2.7 pp -67.72 156.9 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.537 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.01 -43.54 13.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.404 ' C ' HD13 ' A' ' 63' ' ' ILE . . . -124.81 -49.77 0.2 Allowed Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.651 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.518 ' N ' HD13 ' A' ' 63' ' ' ILE . . . . . . . . 0 C--O 1.25 1.136 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.555 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.69 0.281 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -84.91 146.71 27.13 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.028 0.442 . . . . 0.0 111.254 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.799 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.1 p -117.37 140.13 41.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.709 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -74.6 113.24 11.62 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 57' ' ' VAL . 20.1 m -118.7 136.43 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.36 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.431 ' HA ' HG23 ' A' ' 12' ' ' THR . 3.6 mt-10 -81.49 114.85 20.49 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.447 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG22 HG23 ' A' ' 59' ' ' VAL . 21.6 t -89.67 133.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.805 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.86 120.61 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.89 -57.42 5.01 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.449 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.76 163.51 26.06 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.679 0.276 . . . . 0.0 111.098 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -58.37 -172.65 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.521 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 6' ' ' GLU . 1.5 m -99.52 121.05 40.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.951 0.405 . . . . 0.0 111.035 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 42.5 t -120.96 161.71 21.14 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.055 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -99.55 140.83 33.17 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.735 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 HG23 ' A' ' 37' ' ' VAL . 10.1 p -128.24 150.75 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.082 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 124.67 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.869 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 m -115.93 164.99 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.707 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -88.53 -29.54 19.99 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.242 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.55 -37.61 63.03 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 53' ' ' GLU . 32.5 p30 -50.72 -30.39 13.74 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.54 25.62 75.4 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.983 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -103.07 179.14 4.36 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -57.02 -32.8 66.52 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.33 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.46 -36.96 69.65 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.207 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.74 -44.75 93.64 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.632 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.7 OUTLIER -57.2 -36.29 70.66 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.049 179.248 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.3 t -70.88 -51.08 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.888 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.17 -35.89 76.35 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.185 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.2 65.46 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.577 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 30' ' ' VAL . 12.8 t -94.53 20.37 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.276 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t70 63.36 47.85 3.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.991 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.97 49.63 1.95 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.871 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.1 p -93.28 120.43 66.69 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.632 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 14.1 Cg_exo -68.99 -32.95 20.69 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.705 2.27 . . . . 0.0 112.583 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.459 ' HB3' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -79.77 -42.77 23.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.377 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 56.17 55.23 6.96 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 121.082 0.468 . . . . 0.0 110.952 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.495 HG23 HG21 ' A' ' 15' ' ' VAL . 11.7 m -124.04 148.83 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.298 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 34.2 m -84.68 133.46 34.39 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 33.5 m -109.42 131.2 60.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.493 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -108.98 141.67 40.75 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.695 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.443 HG21 ' HD3' ' A' ' 47' ' ' PRO . 23.0 t -100.81 139.27 22.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -74.43 120.69 20.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.253 0.549 . . . . 0.0 109.643 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 106.94 -54.54 0.56 Allowed Glycine 0 N--CA 1.443 -0.884 0 CA-C-N 115.224 -0.898 . . . . 0.0 113.154 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.17 163.6 36.98 Favored Pre-proline 0 CA--C 1.531 0.234 0 CA-C-O 120.634 0.254 . . . . 0.0 111.266 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -63.34 -49.93 4.09 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.657 2.238 . . . . 0.0 112.589 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.5 m -136.92 152.61 74.39 Favored Pre-proline 0 C--O 1.232 0.157 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.923 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD3' HG21 ' A' ' 41' ' ' VAL . 38.5 Cg_exo -60.94 95.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.863 2.375 . . . . 0.0 112.239 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.06 -35.35 78.07 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.076 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -109.5 -18.23 13.57 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.711 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 59.61 54.27 4.6 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.069 0.461 . . . . 0.0 110.775 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 m -63.8 131.44 47.82 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.145 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.3 t 69.22 153.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.111 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 5.7 pt-20 -58.83 -48.43 81.33 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.86 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.5 m -117.83 162.17 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.863 0.363 . . . . 0.0 111.208 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.799 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.9 t70 -148.28 155.86 41.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.745 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.2 ttm105 -94.72 127.66 40.86 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.715 0.293 . . . . 0.0 110.347 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.2 m -131.64 167.23 26.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.903 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -102.78 140.75 36.65 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.682 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.779 HG23 HG22 ' A' ' 7' ' ' VAL . 3.8 m -118.49 141.94 35.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.196 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.12 115.29 29.76 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.79 -45.14 68.62 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.197 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 tp -175.99 98.99 0.07 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.622 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.2 tp -95.31 141.98 14.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.305 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -166.69 35.16 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.83 123.28 0.12 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.655 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.674 -179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 120.779 0.323 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -85.61 142.46 29.08 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.85 0.357 . . . . 0.0 111.212 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 55' ' ' ASP . 41.2 t -129.22 139.91 50.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.83 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -75.0 113.62 12.53 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.436 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 ' CG1' ' A' ' 59' ' ' VAL . 22.7 m -118.04 137.56 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.363 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.87 115.04 20.88 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.783 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.2 t -88.88 134.12 29.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.015 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.75 120.86 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.679 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.27 -57.19 5.04 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.397 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.56 163.57 26.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.721 0.296 . . . . 0.0 111.265 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -58.63 -170.24 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.48 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.2 m -99.73 122.53 42.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 111.014 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.5 m -121.34 162.56 20.11 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.083 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -100.47 138.44 37.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.911 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.94 HG11 HG21 ' A' ' 37' ' ' VAL . 27.3 m -131.5 150.56 34.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.339 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.58 127.02 33.84 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.819 0.342 . . . . 0.0 111.398 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 39' ' ' VAL . 3.4 m -121.94 139.55 48.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.608 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.5 -21.93 64.57 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.14 -35.16 47.6 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.59 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.16 -48.3 80.67 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.447 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.11 26.55 52.41 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.429 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.9 p -88.06 176.4 7.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 117.206 0.503 . . . . 0.0 111.46 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -60.44 -38.95 85.76 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.929 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.75 76.17 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.174 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.65 -37.18 83.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.205 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -55.78 -35.46 66.29 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.753 0.311 . . . . 0.0 110.543 179.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.2 t -67.26 -49.27 73.92 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.936 0.398 . . . . 0.0 110.831 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.9 -35.79 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.963 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.01 -24.9 41.8 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.854 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.828 ' HB ' HD12 ' A' ' 32' ' ' LEU . 11.3 t -87.45 23.58 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 120.721 0.296 . . . . 0.0 111.398 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 63.53 48.08 3.57 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.97 0.414 . . . . 0.0 111.045 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.828 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.6 mt -133.57 48.24 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 m -97.49 123.03 53.8 Favored Pre-proline 0 C--N 1.333 -0.136 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.934 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.28 -27.76 6.3 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.734 2.289 . . . . 0.0 112.718 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 -73.31 -43.07 61.55 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.326 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 46.55 60.05 3.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.189 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.94 HG21 HG11 ' A' ' 15' ' ' VAL . 16.0 m -124.19 148.93 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.376 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.98 137.27 33.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.457 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.737 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.9 m -107.33 129.8 60.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 111.634 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -117.45 138.22 51.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.593 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.717 HG21 ' HG3' ' A' ' 47' ' ' PRO . 4.6 t -101.82 135.5 38.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -62.94 120.56 11.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.858 0.361 . . . . 0.0 110.391 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 27.98 42.39 0.02 OUTLIER Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.068 -0.969 . . . . 0.0 114.891 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.55 ' HB2' HG12 ' A' ' 41' ' ' VAL . 18.2 mmt85 -132.37 128.6 21.22 Favored Pre-proline 0 C--O 1.233 0.22 0 CA-C-N 117.195 0.497 . . . . 0.0 111.375 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.41 -42.71 0.21 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.648 2.232 . . . . 0.0 113.077 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.74 96.66 25.99 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.716 0.293 . . . . 0.0 111.197 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.717 ' HG3' HG21 ' A' ' 41' ' ' VAL . 72.4 Cg_endo -75.95 -18.11 17.0 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.752 2.302 . . . . 0.0 112.806 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -60.86 -23.18 64.95 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.626 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -86.5 18.9 3.04 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 -104.03 158.23 16.56 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.901 0.381 . . . . 0.0 110.981 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.0 t -74.73 177.72 5.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.674 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.419 HG12 HG22 ' A' ' 54' ' ' VAL . 13.4 t 71.81 154.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.763 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -91.83 21.83 4.6 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.521 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG22 HG12 ' A' ' 52' ' ' VAL . 29.8 m -154.31 162.06 2.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-O 120.734 0.302 . . . . 0.0 111.108 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.867 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.4 OUTLIER -148.48 147.49 29.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.406 179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -94.76 125.37 39.37 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.829 0.347 . . . . 0.0 110.316 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.737 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.9 m -130.16 167.09 26.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.649 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.36 136.47 42.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.783 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -106.39 139.16 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.836 0.351 . . . . 0.0 111.549 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -117.3 121.22 40.53 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.909 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 tpt85 -133.94 -61.48 0.79 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.254 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.1 mp -96.26 113.52 25.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.105 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.437 ' O ' ' HB2' ' A' ' 64' ' ' LYS . 19.3 tt -79.57 150.65 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 63' ' ' ILE . 3.6 mtmp? 70.19 151.95 0.1 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.372 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 106.79 66.51 0.64 Allowed Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.469 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.302 -1.277 . . . . 0.0 112.549 -179.773 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -85.92 143.39 28.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.754 0.312 . . . . 0.0 110.783 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 15' ' ' VAL . 30.9 m -102.35 139.79 22.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.731 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.5 m -74.66 115.87 14.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.891 0.377 . . . . 0.0 110.237 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' CG1' HG23 ' A' ' 57' ' ' VAL . 17.7 m -115.57 137.33 49.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.183 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.28 117.27 21.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.538 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 59' ' ' VAL . 20.1 t -89.46 133.83 30.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.422 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.03 120.65 3.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.597 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.36 -117.13 4.59 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.081 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -120.8 159.93 24.43 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.544 0.211 . . . . 0.0 111.249 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 72.61 147.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.928 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.0 t -116.99 135.11 53.95 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.653 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.8 m -114.24 162.84 16.05 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.206 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -125.96 133.97 51.66 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.936 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.512 HG11 HG12 ' A' ' 39' ' ' VAL . 11.5 p -121.65 147.18 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.64 133.56 34.4 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 m -116.71 161.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.98 -38.32 32.44 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.786 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.63 -31.65 16.71 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.036 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -68.07 -51.54 45.45 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.89 25.73 31.23 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.158 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.09 179.18 6.71 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 111.098 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -57.46 -36.14 71.05 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.968 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.63 -36.61 74.36 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.95 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -60.84 -44.42 97.0 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.2 tp -59.61 -44.66 93.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.658 0.266 . . . . 0.0 110.933 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.45 -50.53 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.972 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -59.1 -36.77 75.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.288 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.82 -27.72 65.34 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.607 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.674 ' HB ' HD12 ' A' ' 32' ' ' LEU . 10.5 t -93.44 23.59 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.215 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 60.34 48.15 8.25 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.013 0.435 . . . . 0.0 111.083 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.674 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.54 44.88 2.89 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.776 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.5 t -83.82 120.3 74.86 Favored Pre-proline 0 C--O 1.233 0.21 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.696 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.51 -31.18 3.54 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.765 2.31 . . . . 0.0 112.801 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -77.05 -42.81 36.87 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.819 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 48.41 61.98 2.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.035 0.445 . . . . 0.0 111.233 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.3 m -123.56 146.1 29.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.267 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -85.72 119.57 26.2 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.846 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.59 ' HB ' HG21 ' A' ' 57' ' ' VAL . 31.6 m -88.89 134.76 27.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.458 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 7.4 mp -107.05 144.44 33.71 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.692 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 45' ' ' PRO . 13.7 t -101.59 139.38 22.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -66.13 121.64 15.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.309 0.575 . . . . 0.0 110.344 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.77 -71.7 2.92 Favored Glycine 0 N--CA 1.437 -1.27 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.42 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 61.3 mtt180 -131.96 145.94 59.57 Favored Pre-proline 0 N--CA 1.466 0.335 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 41' ' ' VAL . 71.8 Cg_endo -75.61 48.27 2.11 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.821 2.347 . . . . 0.0 113.183 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.5 t -151.3 114.33 3.08 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.427 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -70.11 57.17 1.61 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.897 2.398 . . . . 0.0 112.319 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -68.68 -35.59 77.41 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.223 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -18.87 55.01 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.69 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.41 174.1 0.14 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.877 0.37 . . . . 0.0 111.173 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -168.95 -167.92 0.8 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.15 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 16.8 m -71.02 -175.81 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.696 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -49.24 -36.74 21.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.274 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.6 m -109.06 163.83 6.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.485 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.41 150.35 34.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.851 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -95.33 126.11 40.42 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.2 m -134.74 167.08 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 1.6 mttt -103.43 138.4 40.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.6 m -112.77 139.3 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.868 0.366 . . . . 0.0 111.476 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.1 tp -108.22 119.61 39.98 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -73.52 -40.31 64.14 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.085 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.23 88.17 3.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.867 0.365 . . . . 0.0 110.964 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.494 HD13 ' C ' ' A' ' 66' ' ' GLY . 2.5 pp -81.96 157.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.187 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.45 102.52 4.98 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.048 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.03 48.98 4.19 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.703 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.494 ' C ' HD13 ' A' ' 63' ' ' ILE . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.392 -1.227 . . . . 0.0 112.551 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.693 0.283 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 3.2 m120 -87.0 143.4 27.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.815 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.3 p -102.04 140.16 21.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.678 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.7 m -75.0 115.2 14.35 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.58 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.491 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.5 m -115.97 137.4 49.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.116 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -81.49 114.83 20.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.555 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.658 HG22 ' CG2' ' A' ' 59' ' ' VAL . 23.1 t -88.69 133.93 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.633 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -57.37 120.69 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.673 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.28 -117.06 3.88 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.162 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.74 159.83 24.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.812 0.339 . . . . 0.0 111.175 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 68.61 162.32 0.21 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.857 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -126.6 135.11 50.8 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.605 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.437 ' O ' HG22 ' A' ' 5' ' ' VAL . 40.5 m -111.9 163.42 14.24 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.243 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 52.3 mt-10 -124.61 137.81 54.36 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.729 ' O ' HG12 ' A' ' 3' ' ' VAL . 9.3 p -125.53 143.96 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.86 131.61 34.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.839 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.77 133.3 63.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.671 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.98 -28.29 67.55 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.528 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.58 -33.87 61.0 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.276 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -60.55 -54.92 39.65 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.51 26.75 16.8 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.802 -0.713 . . . . 0.0 113.053 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.23 170.4 9.28 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.909 0.355 . . . . 0.0 111.524 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -62.62 -38.74 91.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.416 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.34 -38.55 74.29 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.32 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -64.73 -38.07 89.73 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.964 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 2.7 tp -57.61 -42.12 82.63 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.783 0.325 . . . . 0.0 110.569 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.2 t -65.55 -49.68 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.972 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 mmt-85 -60.22 -35.81 76.28 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.54 -25.14 64.28 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.644 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.0 t -90.93 23.32 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.648 0.261 . . . . 0.0 111.187 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.83 46.46 2.97 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.099 0.476 . . . . 0.0 111.167 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -124.36 34.43 5.03 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.956 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.3 p -91.22 120.58 68.44 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.499 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.05 -31.48 9.68 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.53 2.153 . . . . 0.0 112.484 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.481 ' NE2' HG23 ' A' ' 15' ' ' VAL . 8.7 p-80 -79.38 -41.61 27.39 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.33 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 43.97 73.43 0.15 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.135 0.493 . . . . 0.0 111.228 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.568 HG21 HG11 ' A' ' 59' ' ' VAL . 14.0 m -133.28 148.81 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.308 -179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.2 t -85.23 137.62 32.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.77 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.73 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.0 m -96.3 126.96 48.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.392 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mp -109.42 141.74 41.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.804 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.605 HG12 ' HB2' ' A' ' 44' ' ' ARG . 39.1 t -101.63 117.64 47.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 43' ' ' GLY . 8.3 t70 -63.73 120.49 11.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 16.56 54.62 0.01 OUTLIER Glycine 0 C--N 1.335 0.527 0 O-C-N 124.597 1.185 . . . . 0.0 115.002 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.605 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -132.05 120.38 17.24 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-O 120.53 0.205 . . . . 0.0 111.389 -179.512 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.67 53.51 4.16 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.018 2.478 . . . . 0.0 112.294 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 t 61.92 90.6 0.09 OUTLIER Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.03 94.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.113 2.542 . . . . 0.0 112.858 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.66 -29.79 70.4 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.118 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.31 18.26 5.33 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.643 ' HG2' HG22 ' A' ' 52' ' ' VAL . 3.3 tt0 -115.47 99.68 7.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.767 0.318 . . . . 0.0 110.725 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.74 34.82 1.79 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.992 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.643 HG22 ' HG2' ' A' ' 50' ' ' GLN . 34.5 m -80.28 178.17 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.377 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.4 -31.43 11.32 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.273 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.59 161.44 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.998 0.428 . . . . 0.0 111.531 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.815 ' O ' HG21 ' A' ' 3' ' ' VAL . 15.2 m-20 -142.63 157.22 44.91 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.574 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -94.74 125.46 39.41 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.879 0.371 . . . . 0.0 110.497 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' A' ' 39' ' ' VAL . 14.9 m -133.9 167.86 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.36 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.65 139.53 47.02 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.399 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.658 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.7 m -104.89 141.25 20.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.603 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.5 tp -105.22 135.84 45.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.907 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -73.83 0.22 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.237 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 19.2 tp -92.63 149.75 21.14 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.739 0.304 . . . . 0.0 111.115 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.611 HD13 ' N ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -158.64 143.89 7.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.288 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.611 ' N ' HD13 ' A' ' 63' ' ' ILE . 6.0 mttt -128.66 -48.5 1.26 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.981 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.02 -62.0 0.11 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.179 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.148 0 CA-C-O 118.607 -1.107 . . . . 0.0 113.07 -179.918 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.897 0.379 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -88.69 136.78 32.82 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.517 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 15' ' ' VAL . 23.2 m -102.35 139.69 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.026 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.4 m -74.88 117.58 16.89 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.345 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' CG1' HG23 ' A' ' 57' ' ' VAL . 14.4 m -118.03 137.51 51.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.022 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 114.67 20.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.035 0.445 . . . . 0.0 110.852 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 59' ' ' VAL . 27.1 t -86.13 133.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.69 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.08 120.6 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.88 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.92 -114.24 3.06 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.234 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 1.3 pm0 -121.03 158.97 26.64 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.773 0.32 . . . . 0.0 111.651 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 10' ' ' GLU . 5.0 mt-10 66.73 163.6 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.923 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 m -126.88 134.39 50.49 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.494 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 67.2 m -110.63 162.92 14.25 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.351 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.79 135.0 52.57 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.577 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.61 ' O ' HG22 ' A' ' 3' ' ' VAL . 16.4 t -130.04 149.23 33.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.875 0.369 . . . . 0.0 111.406 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.18 35.16 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.151 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.75 163.83 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.402 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -79.95 -14.85 58.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.546 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -54.15 -35.44 62.26 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.25 -44.97 20.69 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.73 -0.214 . . . . 0.0 110.976 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.33 27.02 34.36 Favored Glycine 0 C--N 1.336 0.548 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.618 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.78 175.68 7.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -57.15 -32.9 66.86 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.544 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.22 74.68 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.112 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -64.14 -40.92 97.2 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.032 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -56.99 -39.95 75.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.755 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.42 -51.01 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.984 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -35.9 77.87 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.092 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.77 -30.0 67.22 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.534 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.675 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.9 t -94.7 23.4 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.53 48.5 9.62 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.988 0.423 . . . . 0.0 111.26 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.675 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.8 OUTLIER -129.68 42.54 3.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.81 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.2 t -99.24 132.23 23.76 Favored Pre-proline 0 CA--C 1.529 0.139 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.61 -32.89 4.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.535 2.157 . . . . 0.0 112.59 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -80.21 -42.75 22.72 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 46.89 61.67 2.73 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.455 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.428 HG23 HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -126.04 146.0 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.212 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.72 134.97 33.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.046 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HB ' HG21 ' A' ' 57' ' ' VAL . 32.2 m -91.28 135.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.373 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.0 152.57 20.8 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.51 119.92 63.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.612 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -58.18 120.03 7.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.034 0.445 . . . . 0.0 110.357 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 33.97 32.86 0.02 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.801 -1.091 . . . . 0.0 114.76 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.81 148.32 69.02 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 117.289 0.544 . . . . 0.0 111.613 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' O ' HG13 ' A' ' 46' ' ' VAL . 57.8 Cg_endo -74.89 -48.09 0.19 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.429 2.086 . . . . 0.0 112.125 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 45' ' ' PRO . 1.0 OUTLIER -161.3 126.21 2.14 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 179.645 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -81.09 51.79 4.07 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.571 2.181 . . . . 0.0 112.702 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.57 -35.8 77.88 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.3 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.34 19.44 15.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.582 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -75.64 140.71 42.74 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.72 167.39 20.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.961 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.474 HG12 ' H ' ' A' ' 54' ' ' VAL . 22.1 t 74.04 135.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -37.67 70.76 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.213 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.474 ' H ' HG12 ' A' ' 52' ' ' VAL . 33.2 m -111.21 161.91 9.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.801 0.334 . . . . 0.0 110.904 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -146.09 156.97 43.82 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -95.32 126.33 40.56 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.897 0.379 . . . . 0.0 110.492 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.607 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.5 m -134.42 167.52 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.22 135.94 42.92 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.504 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 7' ' ' VAL . 5.4 m -117.14 140.49 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.952 0.406 . . . . 0.0 111.523 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -113.35 119.41 37.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.843 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -60.19 -33.2 71.88 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.053 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 60' ' ' LEU . 8.6 mt -116.51 146.12 42.83 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.917 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 tt -155.42 147.6 12.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.019 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.3 tttm 62.52 38.72 12.34 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.928 0.394 . . . . 0.0 110.839 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 108.41 -96.25 1.0 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.382 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.483 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttm . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 120.61 0.243 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 14' ' ' GLU . 8.2 m-80 -85.01 145.75 27.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.296 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.694 HG11 ' O ' ' A' ' 55' ' ' ASP . 31.6 t -127.96 139.66 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.62 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.95 113.51 12.34 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.964 0.411 . . . . 0.0 110.495 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.8 m -117.93 137.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.385 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -81.87 115.01 20.87 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.553 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.675 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.3 t -89.98 133.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.401 ' HB ' HD21 ' A' ' 62' ' ' LEU . 21.3 t -72.41 120.78 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.719 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.41 -56.98 5.04 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.443 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.58 163.64 26.08 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.618 0.246 . . . . 0.0 110.95 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -58.77 -174.98 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.407 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 m -99.63 131.69 45.45 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.836 0.35 . . . . 0.0 111.151 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.22 162.06 34.51 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 21.6 mt-10 -94.79 139.35 31.4 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.693 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.992 HG11 HG21 ' A' ' 37' ' ' VAL . 35.2 m -132.58 148.27 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.386 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.39 129.05 34.9 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.857 0.361 . . . . 0.0 111.204 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.922 HG12 HG11 ' A' ' 39' ' ' VAL . 4.1 m -116.76 150.67 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.814 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 25' ' ' ASP . 1.6 p30 -70.79 -20.67 62.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.044 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.2 -41.35 62.61 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.786 0.327 . . . . 0.0 111.015 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -54.78 -45.49 74.29 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.51 26.51 46.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.111 -0.566 . . . . 0.0 112.996 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.48 170.53 9.42 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.913 0.387 . . . . 0.0 111.465 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.38 -37.76 75.92 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.065 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . . . -56.56 -35.18 67.86 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.058 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 13.5 m-20 -68.5 -42.64 78.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.842 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -61.73 -43.52 98.7 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.584 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 24' ' ' ALA . 8.2 p -70.94 -39.87 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.258 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -66.9 -35.94 81.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.985 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.56 -25.03 23.54 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.889 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.0 t -89.31 23.35 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.706 0.289 . . . . 0.0 111.392 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.5 t0 62.84 48.28 4.14 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.034 0.445 . . . . 0.0 111.336 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.08 32.57 5.63 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.93 140.61 25.02 Favored Pre-proline 0 N--CA 1.462 0.157 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.064 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -73.64 -32.86 7.22 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.637 2.225 . . . . 0.0 112.462 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -78.66 -42.75 27.8 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.132 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 49.79 72.19 0.34 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.105 0.478 . . . . 0.0 111.024 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.992 HG21 HG11 ' A' ' 15' ' ' VAL . 17.8 m -123.74 146.85 28.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.343 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.38 137.85 35.73 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.746 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.922 HG11 HG12 ' A' ' 17' ' ' VAL . 29.8 m -86.84 131.7 34.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.12 147.46 37.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.223 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 44' ' ' ARG . 2.0 t -113.37 117.83 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.404 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 44' ' ' ARG . 10.6 t70 -56.04 120.09 6.91 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.335 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 24.44 43.47 0.01 OUTLIER Glycine 0 CA--C 1.525 0.693 0 O-C-N 124.447 1.092 . . . . 0.0 115.048 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.59 ' HB3' HG12 ' A' ' 41' ' ' VAL . 10.0 tpp180 -132.91 124.79 18.84 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.964 0.382 . . . . 0.0 111.153 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.87 -47.21 0.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.445 2.097 . . . . 0.0 112.091 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.483 HG23 ' HG2' ' A' ' 48' ' ' GLU . 12.0 m -155.88 153.6 26.18 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.605 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.03 74.98 0.34 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.98 2.453 . . . . 0.0 112.121 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.483 ' HG2' HG23 ' A' ' 46' ' ' VAL . 1.5 mt-10 -68.59 -22.2 64.47 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.593 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.66 5.73 30.69 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 66.22 96.74 0.05 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.027 0.441 . . . . 0.0 110.921 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.6 m -94.37 154.68 17.36 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.124 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 54' ' ' VAL . 27.6 m -70.08 -175.05 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.513 ' HG3' HG13 ' A' ' 54' ' ' VAL . 11.5 pt-20 -51.82 -42.62 62.66 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.357 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.513 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.6 m -111.39 162.31 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.047 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.694 ' O ' HG11 ' A' ' 3' ' ' VAL . 23.1 t70 -149.07 154.45 39.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.976 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 28.5 ttt-85 -94.95 125.2 39.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.912 0.387 . . . . 0.0 110.046 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.1 m -135.86 167.59 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.265 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -108.11 140.92 40.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.517 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.675 ' CG2' HG22 ' A' ' 7' ' ' VAL . 6.0 m -101.27 140.88 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -113.9 125.81 54.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.873 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 48.7 1.83 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.792 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 HD12 HG22 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -157.87 -48.97 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.221 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.469 HG22 HD12 ' A' ' 62' ' ' LEU . 14.0 tt -131.07 154.03 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.826 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 22.9 ttpt 62.05 37.68 14.57 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.957 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.23 145.9 19.34 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.391 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.401 -1.222 . . . . 0.0 112.427 179.872 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.689 0.28 . . . . 0.0 111.045 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.52 148.96 22.39 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.466 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -102.43 139.91 22.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.844 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.5 m -74.88 113.34 12.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.11 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.644 ' CG1' HG23 ' A' ' 57' ' ' VAL . 35.7 m -117.7 135.69 57.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.228 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.9 114.89 23.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.73 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.807 HG22 ' CG2' ' A' ' 59' ' ' VAL . 10.6 t -83.74 130.96 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.38 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.9 t -68.62 120.43 16.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.39 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 86.19 -57.41 4.77 Favored Glycine 0 C--N 1.334 0.427 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.161 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 163.53 26.07 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.683 0.278 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -58.55 -177.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.341 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -99.65 134.25 42.8 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.959 0.409 . . . . 0.0 111.07 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.4 m -137.19 160.45 38.98 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.228 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -92.34 137.39 32.41 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.924 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.671 HG21 HG23 ' A' ' 37' ' ' VAL . 9.1 p -130.77 145.69 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.163 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.48 125.83 32.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.719 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.727 ' CG1' HG11 ' A' ' 39' ' ' VAL . 9.2 m -119.76 161.42 19.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.672 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.94 -36.94 64.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.498 -0.773 . . . . 0.0 111.052 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -31.37 65.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.721 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.48 -48.05 72.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.85 26.06 63.37 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.606 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -100.62 178.89 4.59 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.015 0.408 . . . . 0.0 111.03 179.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -59.09 -34.63 72.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.076 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.99 -36.1 72.14 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.78 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -59.25 -38.7 80.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 tp -59.21 -45.22 91.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.686 0.279 . . . . 0.0 110.779 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.05 -47.73 59.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -35.97 81.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.673 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.12 53.51 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.731 ' HB ' HD12 ' A' ' 32' ' ' LEU . 7.4 t -90.57 23.48 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.988 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 59.29 48.36 10.31 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.009 0.433 . . . . 0.0 111.042 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.731 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.7 OUTLIER -127.12 45.24 2.75 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.71 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.6 t -84.65 129.11 58.36 Favored Pre-proline 0 C--O 1.232 0.178 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.81 -33.09 10.61 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.564 2.176 . . . . 0.0 112.423 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -79.95 -40.97 26.95 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.189 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.27 59.14 2.78 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.037 0.446 . . . . 0.0 111.15 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.671 HG23 HG21 ' A' ' 15' ' ' VAL . 5.6 m -126.44 146.01 33.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 m -86.13 123.3 31.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.727 HG11 ' CG1' ' A' ' 17' ' ' VAL . 32.6 m -91.52 127.65 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.38 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -116.76 133.28 56.2 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.171 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 57' ' ' VAL . 30.2 t -101.48 117.79 47.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 44' ' ' ARG . 13.4 t70 -56.23 120.66 7.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.902 -178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 3.78 61.11 0.0 OUTLIER Glycine 0 C--N 1.339 0.746 0 O-C-N 124.843 1.34 . . . . 0.0 115.679 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' ASP . 26.5 mtm180 -132.09 120.48 17.26 Favored Pre-proline 0 C--O 1.234 0.266 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 12.7 Cg_exo -68.81 -58.5 0.11 Allowed 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.921 2.414 . . . . 0.0 111.982 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.7 t -140.72 140.51 22.21 Favored Pre-proline 0 CA--C 1.531 0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.247 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -53.05 90.36 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.81 2.34 . . . . 0.0 112.794 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.8 -33.74 74.37 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.223 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.81 -18.85 58.15 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.599 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.05 158.82 0.13 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.056 0.455 . . . . 0.0 111.407 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -167.79 -172.8 1.95 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 54' ' ' VAL . 20.7 t -82.4 60.68 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.026 0.441 . . . . 0.0 110.272 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 55.81 23.86 6.83 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.436 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 52' ' ' VAL . 34.7 m -126.51 162.29 30.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.707 0.289 . . . . 0.0 111.34 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.94 154.69 39.77 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -95.56 129.93 42.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.354 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 ' HB ' ' A' ' 39' ' ' VAL . 4.2 m -135.23 167.32 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.261 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -113.37 138.2 50.4 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.477 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.807 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.7 m -103.1 138.4 27.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.312 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.46 117.17 33.31 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.176 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 ttt-85 -111.36 -47.06 3.22 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.066 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.98 157.85 17.05 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.079 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.1 tt -163.44 150.32 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.278 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -130.5 84.13 2.17 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -117.11 -84.77 1.07 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.635 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.186 -1.341 . . . . 0.0 112.953 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.457 0.17 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -86.16 148.96 25.44 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.822 0.344 . . . . 0.0 111.091 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 m -102.19 139.84 22.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.466 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.13 113.57 11.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.995 0.426 . . . . 0.0 110.286 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.986 HG21 HG13 ' A' ' 59' ' ' VAL . 2.1 p -114.39 135.12 55.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.268 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -85.5 114.94 22.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.408 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.849 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.7 t -85.93 133.64 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.813 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.5 t -77.33 120.41 27.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.46 -23.68 11.81 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.111 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -118.64 164.11 15.82 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.573 0.349 . . . . 0.0 110.826 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.91 -173.75 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.494 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -99.39 129.34 45.58 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.04 0.448 . . . . 0.0 111.341 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.8 m -126.29 163.09 23.99 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.22 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -104.9 137.67 42.31 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.903 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.89 146.04 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.04 124.38 31.01 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.228 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 m -126.53 157.89 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.277 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.59 -18.23 48.93 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.73 -41.02 73.27 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.556 0.217 . . . . 0.0 111.315 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -51.64 -35.94 44.06 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.792 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.31 26.07 69.11 Favored Glycine 0 C--N 1.335 0.516 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.588 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -93.34 166.75 12.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.215 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -60.95 -34.58 74.95 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.187 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.49 -35.44 70.22 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.278 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' HG2' ' A' ' 28' ' ' ARG . 13.9 m-20 -58.98 -38.12 78.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.993 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER -58.51 -34.25 70.74 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.622 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -70.45 -51.57 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.042 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 25' ' ' ASP . 1.4 ptm180 -65.18 -35.43 81.05 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.171 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.74 -25.32 39.97 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.6 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.2 t -87.48 23.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.615 0.245 . . . . 0.0 111.156 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 65.47 47.5 2.26 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.028 0.442 . . . . 0.0 111.123 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.6 HD12 ' HB ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -128.18 37.18 4.2 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.728 179.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 m -77.61 124.71 86.58 Favored Pre-proline 0 CA--C 1.529 0.14 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.866 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.77 -32.78 2.54 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.697 2.265 . . . . 0.0 112.913 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -42.9 32.89 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.2 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 50.02 72.1 0.35 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.035 0.445 . . . . 0.0 111.216 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.412 HG12 ' HE ' ' A' ' 61' ' ' ARG . 19.1 m -123.68 157.66 29.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.413 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 m -84.76 116.92 23.52 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.554 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -94.3 137.07 23.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.279 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.858 HD12 ' HB2' ' A' ' 58' ' ' LYS . 6.7 mt -81.99 157.81 24.09 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.582 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.45 139.68 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.304 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -47.58 130.33 13.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.718 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.93 -30.49 0.18 Allowed Glycine 0 CA--C 1.52 0.373 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.159 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -95.46 165.35 16.91 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.67 86.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.942 2.428 . . . . 0.0 112.734 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.0 t -149.8 137.09 11.32 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.755 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -86.51 37.1 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 112.624 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -68.5 -16.77 64.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.656 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.78 -7.83 56.15 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -120.14 99.34 6.54 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.69 0.281 . . . . 0.0 111.414 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.478 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -170.96 39.54 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.173 179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.654 HG12 ' HG3' ' A' ' 53' ' ' GLU . 54.6 t 62.49 -85.89 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.162 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.654 ' HG3' HG12 ' A' ' 52' ' ' VAL . 6.6 mt-10 -123.42 -10.16 7.98 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 51' ' ' SER . 34.2 m -106.08 171.57 1.93 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.693 0.282 . . . . 0.0 111.355 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -146.22 157.39 43.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.214 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 133.99 38.58 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.602 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.769 ' O ' HG23 ' A' ' 5' ' ' VAL . 6.3 m -129.47 167.38 24.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.858 ' HB2' HD12 ' A' ' 40' ' ' LEU . 23.0 mmtp -115.75 133.47 56.0 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.219 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.986 HG13 HG21 ' A' ' 5' ' ' VAL . 19.0 m -100.76 131.69 47.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.902 0.382 . . . . 0.0 111.307 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.4 111.24 23.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.819 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.412 ' HE ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -125.31 30.91 5.69 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.401 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.2 tp -173.71 150.01 1.67 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.809 0.337 . . . . 0.0 110.997 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.5 tt -160.0 151.99 5.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.95 -45.66 1.72 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.381 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 175.83 -46.09 0.12 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.211 -0.519 . . . . 0.0 112.518 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.409 -1.217 . . . . 0.0 112.541 -179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.647 0.26 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -84.9 146.61 27.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.048 0.451 . . . . 0.0 111.002 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 55' ' ' ASP . 11.0 p -134.24 140.02 46.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.907 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.81 113.41 12.06 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.104 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 57' ' ' VAL . 15.3 m -118.59 136.19 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.246 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -81.51 114.72 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.59 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.791 HG22 ' CG2' ' A' ' 59' ' ' VAL . 14.2 t -90.15 130.48 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.809 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.5 t -74.2 120.68 23.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.717 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.52 -51.37 3.0 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.395 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.96 163.39 14.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.658 0.266 . . . . 0.0 111.037 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -57.44 -177.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -99.62 127.02 45.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.193 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 48.2 t -131.12 162.64 29.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.267 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -92.89 137.77 32.07 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.821 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.836 HG11 HG21 ' A' ' 37' ' ' VAL . 24.4 m -129.87 150.47 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.202 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.49 126.85 33.65 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG12 HG11 ' A' ' 39' ' ' VAL . 7.2 m -116.51 160.7 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.765 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -84.71 -31.86 23.85 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.307 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.51 -31.63 24.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.078 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -51.92 -40.99 61.66 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.515 179.772 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.52 26.16 70.63 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.837 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -95.06 179.09 5.33 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.772 0.32 . . . . 0.0 111.155 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -57.13 -32.88 66.81 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.238 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.12 -35.6 67.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.366 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -58.48 -43.92 89.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.556 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -45.02 85.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.5 t -69.27 -45.65 78.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.879 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -35.88 73.23 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.028 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.73 34.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.637 ' HB ' HD13 ' A' ' 32' ' ' LEU . 9.4 t -91.26 23.0 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 120.675 0.274 . . . . 0.0 111.464 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t0 64.62 48.2 2.65 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.056 0.455 . . . . 0.0 110.85 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.637 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -119.22 48.9 1.41 Allowed 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.374 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.5 t -99.01 120.37 58.64 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.573 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -83.54 -33.02 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.571 2.181 . . . . 0.0 113.224 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -79.89 -42.66 23.7 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.264 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 50.42 66.37 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.076 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.836 HG21 HG11 ' A' ' 15' ' ' VAL . 26.2 m -123.81 151.31 28.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.346 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 121.33 33.85 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.628 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.656 HG11 HG12 ' A' ' 17' ' ' VAL . 16.8 m -90.92 132.47 35.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.358 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 4.3 mm? -102.17 134.93 44.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.184 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 44' ' ' ARG . 3.6 t -101.51 130.65 50.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 44' ' ' ARG . 19.7 p-10 -63.58 119.77 10.47 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.573 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 28.07 35.64 0.01 OUTLIER Glycine 0 CA--C 1.528 0.88 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.523 ' HB2' HG12 ' A' ' 41' ' ' VAL . 5.5 mmm180 -133.22 120.77 16.24 Favored Pre-proline 0 C--O 1.232 0.18 0 CA-C-N 117.684 0.742 . . . . 0.0 111.107 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -56.2 -54.85 3.41 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.34 2.026 . . . . 0.0 112.092 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -155.87 148.44 17.86 Favored Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.61 78.7 1.62 Allowed 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.826 2.351 . . . . 0.0 112.332 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -68.34 -35.41 77.73 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.02 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.71 -18.47 26.34 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.671 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 58.0 64.89 1.41 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.143 0.497 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.43 112.27 11.57 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.102 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 t 68.33 154.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.344 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.686 ' HG3' HG13 ' A' ' 54' ' ' VAL . 16.9 pt-20 -66.39 -44.1 84.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.686 HG13 ' HG3' ' A' ' 53' ' ' GLU . 29.9 m -108.0 161.96 6.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.895 0.379 . . . . 0.0 111.387 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.787 ' O ' HG21 ' A' ' 3' ' ' VAL . 23.9 t70 -147.92 154.11 39.93 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.667 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -94.93 125.94 39.93 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.833 0.349 . . . . 0.0 110.203 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.634 HG21 ' HB ' ' A' ' 39' ' ' VAL . 17.2 m -134.18 167.37 26.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -102.62 141.1 36.0 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.528 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.791 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.8 m -112.49 131.83 62.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.834 0.349 . . . . 0.0 111.318 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.06 122.38 44.53 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.83 -53.83 2.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.894 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.3 90.93 3.44 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.869 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.9 tp -82.42 145.63 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.186 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -135.22 154.82 51.46 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.031 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.38 -65.18 0.26 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.405 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.354 -1.248 . . . . 0.0 112.51 179.797 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HG21 ' A' ' 22' ' ' THR . 2.0 mpt? . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 120.602 0.239 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -92.67 146.98 23.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.172 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.745 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.5 t -121.76 139.57 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.931 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.21 113.42 12.55 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.288 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 57' ' ' VAL . 17.4 m -118.44 137.22 53.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.178 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -81.8 114.81 20.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.737 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 59' ' ' VAL . 5.5 t -86.86 133.23 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.66 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -67.72 120.66 15.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.638 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.82 -57.58 5.05 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.418 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -77.53 163.78 25.99 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 120.766 0.317 . . . . 0.0 111.035 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -58.22 -175.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.249 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 5' ' ' VAL . 60.1 m -99.64 130.44 45.86 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.928 0.394 . . . . 0.0 111.187 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -127.48 162.72 25.72 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -95.55 130.89 42.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.94 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.977 HG11 HG21 ' A' ' 37' ' ' VAL . 26.8 m -129.77 144.3 38.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.869 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB3' ' HE2' ' A' ' 35' ' ' HIS . . . -84.25 126.61 33.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.041 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 20' ' ' ASP . 26.8 m -117.11 161.98 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.135 0.493 . . . . 0.0 112.254 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.72 -41.94 78.34 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.335 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -50.69 -41.57 56.03 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.962 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' H ' HG23 ' A' ' 17' ' ' VAL . 1.6 t0 -47.19 -40.94 17.1 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 123.387 0.429 . . . . 0.0 111.582 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.94 26.38 69.14 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.931 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 1' ' ' MET . 0.0 OUTLIER -99.55 178.47 4.85 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.87 0.367 . . . . 0.0 111.111 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -32.75 66.49 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.219 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -35.82 70.18 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.17 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -63.42 -44.03 95.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.869 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 tp -59.68 -46.43 89.08 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.69 0.281 . . . . 0.0 110.8 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 32' ' ' LEU . 20.5 t -67.53 -44.88 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.667 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.52 -36.15 81.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.089 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.23 -26.87 42.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.848 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.84 23.33 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.562 0.22 . . . . 0.0 111.331 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.3 42.0 9.73 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.059 0.457 . . . . 0.0 110.964 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' HB2' HG12 ' A' ' 27' ' ' VAL . 3.5 mt -121.1 39.43 3.82 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.529 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.08 120.67 72.65 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.22 -33.15 7.57 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.505 2.136 . . . . 0.0 112.494 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.526 ' ND1' HG22 ' A' ' 37' ' ' VAL . 14.7 p80 -79.89 -42.07 24.92 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.096 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 51.67 70.26 0.57 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 111.602 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.977 HG21 HG11 ' A' ' 15' ' ' VAL . 26.9 m -135.68 147.29 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.414 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.18 136.97 32.73 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.796 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.667 ' HB ' HG21 ' A' ' 57' ' ' VAL . 25.2 m -93.34 133.96 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.399 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -108.83 148.01 31.23 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.216 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 44' ' ' ARG . 17.4 t -106.65 117.72 52.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -64.01 120.18 11.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.149 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 23.1 47.39 0.01 OUTLIER Glycine 0 CA--C 1.525 0.684 0 O-C-N 124.411 1.069 . . . . 0.0 114.786 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -132.81 121.03 16.81 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.874 0.337 . . . . 0.0 111.366 -179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.05 -51.8 6.15 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.528 2.152 . . . . 0.0 112.118 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 t -150.61 144.09 17.02 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.547 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.73 47.28 2.4 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.836 2.357 . . . . 0.0 112.469 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.59 -31.83 71.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.124 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -91.82 19.28 6.69 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.664 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -98.32 119.0 36.24 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.717 0.294 . . . . 0.0 111.059 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.1 m -120.29 33.71 5.49 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.987 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 54' ' ' VAL . 17.4 t -121.66 138.47 51.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.722 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.5 pm0 -57.77 -35.98 71.5 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.231 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.484 ' H ' HG12 ' A' ' 52' ' ' VAL . 8.7 t -110.65 161.66 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.659 0.266 . . . . 0.0 110.546 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.745 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 145.72 28.28 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.028 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -95.0 125.24 39.53 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.288 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.1 m -136.21 167.17 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.487 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -102.24 141.67 34.7 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.497 ' CG2' HG22 ' A' ' 7' ' ' VAL . 4.4 m -106.07 137.61 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 120.838 0.352 . . . . 0.0 111.098 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.75 128.49 56.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.174 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -95.08 -55.23 3.15 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.353 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 tp -92.06 102.45 14.99 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.867 0.365 . . . . 0.0 111.097 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 tp -101.43 146.21 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.281 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.83 114.71 14.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.746 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.65 131.01 7.89 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.558 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.348 -1.251 . . . . 0.0 112.518 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tpt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.86 0.362 . . . . 0.0 111.39 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -89.3 142.16 27.9 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.822 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.31 140.0 21.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.417 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.9 m -74.67 113.2 11.67 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.173 0.511 . . . . 0.0 110.485 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG23 ' A' ' 57' ' ' VAL . 31.9 m -118.87 137.6 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.378 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.15 114.95 21.03 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.34 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.781 HG22 ' CG2' ' A' ' 59' ' ' VAL . 21.6 t -88.66 133.98 29.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.419 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.7 m -58.22 120.62 4.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.696 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.6 -49.44 3.15 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.521 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -77.55 163.3 26.41 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.626 0.251 . . . . 0.0 110.972 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.41 -100.0 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -127.96 135.06 49.43 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.63 0.252 . . . . 0.0 111.349 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.6 t -132.07 162.89 29.7 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.245 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -123.47 138.54 54.56 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.27 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG21 HG23 ' A' ' 37' ' ' VAL . 11.4 p -131.98 147.88 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.257 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.736 ' HB3' ' HG3' ' A' ' 28' ' ' ARG . . . -84.38 125.79 32.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.148 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.17 161.05 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.47 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.6 -26.98 37.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.725 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -56.54 -34.87 67.46 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.599 0.238 . . . . 0.0 110.929 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.496 ' OD2' HG12 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -52.73 -61.09 2.51 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.991 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.63 26.18 57.11 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.709 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.73 178.91 5.16 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 111.141 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -57.17 -38.93 74.32 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.185 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.37 -36.15 82.76 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.932 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -60.38 -37.51 80.99 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.87 -41.73 78.52 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.809 0.338 . . . . 0.0 110.555 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.96 -50.71 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.013 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 16' ' ' ALA . 3.7 tmt_? -59.34 -36.16 75.18 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.213 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.06 -26.31 36.8 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.99 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 30' ' ' VAL . 8.4 t -92.14 23.46 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 120.702 0.287 . . . . 0.0 111.309 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.61 47.32 4.94 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.134 0.492 . . . . 0.0 111.454 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.01 33.16 4.99 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.8 120.27 68.81 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.863 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.82 -32.47 1.97 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.792 2.328 . . . . 0.0 112.951 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -69.93 -41.12 75.04 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.236 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 51.97 69.37 0.68 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.036 0.446 . . . . 0.0 111.176 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.414 HG23 HG21 ' A' ' 15' ' ' VAL . 23.4 m -124.02 145.8 30.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.239 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.8 m -96.77 119.43 35.22 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.831 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.2 m -84.18 131.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.519 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.1 mt -105.51 147.64 28.12 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.79 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' A' ' 44' ' ' ARG . 10.0 t -102.15 136.68 33.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.864 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.85 120.83 14.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.65 0.262 . . . . 0.0 110.333 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 26.24 47.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.191 -0.913 . . . . 0.0 114.625 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.585 ' HB2' HG12 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -132.31 120.36 16.97 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.943 0.371 . . . . 0.0 111.0 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.81 -61.03 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.752 2.301 . . . . 0.0 112.834 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.65 161.5 43.56 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.799 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -76.25 53.07 3.73 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.085 2.523 . . . . 0.0 112.44 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 -68.51 -32.94 73.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.498 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -90.96 19.69 5.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.872 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -54.05 94.45 0.01 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.83 159.7 39.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.75 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.6 t 72.21 146.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' HG13 ' A' ' 54' ' ' VAL . 17.2 pt-20 -59.1 -45.07 91.82 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.186 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.543 HG13 ' HG3' ' A' ' 53' ' ' GLU . 34.4 m -113.41 162.22 11.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 120.797 0.332 . . . . 0.0 111.214 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -147.97 152.3 37.25 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -97.13 125.12 41.4 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.41 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.505 HG21 ' HB ' ' A' ' 39' ' ' VAL . 10.4 m -136.26 167.13 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.15 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -110.64 128.71 55.8 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.829 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.781 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -100.86 141.62 17.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-O 120.975 0.417 . . . . 0.0 111.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 61' ' ' ARG . 4.3 tt -97.64 128.53 44.41 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.959 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -107.27 -56.39 2.21 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.791 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mp -101.36 -72.6 0.67 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.879 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.413 ' CA ' HD21 ' A' ' 60' ' ' LEU . 5.3 pt -147.05 171.76 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.259 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -171.06 93.97 0.18 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.6 -178.02 28.3 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.896 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.187 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.094 179.801 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.507 0.194 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -91.59 148.78 22.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.76 0.315 . . . . 0.0 110.648 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 15' ' ' VAL . 20.4 m -102.15 139.96 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.727 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 m -74.48 114.3 12.72 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.493 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' CG1' HG23 ' A' ' 57' ' ' VAL . 30.3 m -116.48 137.58 49.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.303 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 114.76 20.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' CG2' ' A' ' 59' ' ' VAL . 18.5 t -88.15 134.22 28.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.776 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -56.96 120.26 3.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.475 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.38 -118.14 4.19 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.246 -179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -120.73 159.04 26.19 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.623 0.249 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 70.19 155.19 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.066 -0.515 . . . . 0.0 112.05 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.1 m -116.23 134.9 54.4 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.393 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.442 ' HB2' HG21 ' A' ' 7' ' ' VAL . 25.6 t -108.51 161.98 14.56 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.298 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -126.01 131.93 52.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.051 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.621 ' O ' HG22 ' A' ' 3' ' ' VAL . 9.9 p -122.92 144.64 31.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.778 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.613 ' HB3' ' HD2' ' A' ' 28' ' ' ARG . . . -85.19 134.97 34.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.241 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.58 159.81 23.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.153 0.501 . . . . 0.0 111.88 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.85 -33.78 45.62 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.299 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -56.73 -35.82 69.0 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -55.18 -48.54 73.66 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.779 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.02 24.21 42.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.15 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.79 179.17 5.55 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.831 0.348 . . . . 0.0 111.064 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -57.31 -32.65 66.89 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.181 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.76 74.11 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.197 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -59.06 -44.4 91.83 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.559 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.96 -41.1 95.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.12 -50.08 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.879 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.613 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 1.1 mtp-105 -60.39 -36.05 77.17 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.359 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.11 -28.94 63.12 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.596 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 30' ' ' VAL . 10.7 t -95.58 23.15 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.717 0.294 . . . . 0.0 111.221 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 t70 59.27 46.94 12.14 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.026 0.441 . . . . 0.0 111.502 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.47 46.02 2.31 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.786 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.64 120.46 72.96 Favored Pre-proline 0 C--O 1.232 0.148 0 CA-C-O 120.598 0.237 . . . . 0.0 110.76 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.07 -33.17 2.17 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.674 2.25 . . . . 0.0 113.008 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.77 -42.75 23.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.461 0.172 . . . . 0.0 111.175 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 49.24 61.97 2.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.089 0.471 . . . . 0.0 111.173 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 m -123.51 146.08 29.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 m -85.49 132.21 34.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.883 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.561 ' HB ' HG21 ' A' ' 57' ' ' VAL . 24.7 m -93.71 131.42 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.61 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 3.9 mm? -107.29 147.71 29.9 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.282 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG12 ' CB ' ' A' ' 44' ' ' ARG . 16.5 t -106.19 117.79 52.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -64.86 120.12 11.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.933 0.397 . . . . 0.0 110.419 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 31.94 35.72 0.02 OUTLIER Glycine 0 CA--C 1.526 0.744 0 CA-C-N 114.827 -1.078 . . . . 0.0 115.153 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' CB ' HG12 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -133.07 143.94 50.62 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 117.349 0.574 . . . . 0.0 111.555 -179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.87 -47.53 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.417 2.078 . . . . 0.0 112.165 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HG2' ' A' ' 48' ' ' GLU . 3.2 m -154.15 110.11 2.46 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.953 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD3' HG11 ' A' ' 41' ' ' VAL . 89.9 Cg_endo -81.24 6.22 5.74 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.534 2.156 . . . . 0.0 113.1 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HG2' ' HB ' ' A' ' 46' ' ' VAL . 0.2 OUTLIER -63.8 -15.61 59.18 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.6 -10.92 59.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.56 150.54 31.3 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.835 0.35 . . . . 0.0 111.588 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.8 m -96.88 45.93 1.05 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 6.0 m -139.46 166.27 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.293 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -85.68 -37.48 19.37 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.3 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.6 m -105.96 161.63 5.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 120.712 0.292 . . . . 0.0 111.498 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.37 152.63 40.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.879 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.4 ttm180 -95.63 125.23 40.08 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.525 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.561 HG21 ' HB ' ' A' ' 39' ' ' VAL . 12.4 m -135.69 167.09 25.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.4 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 6.2 mmtt -107.65 140.11 41.17 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.888 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.729 ' CG2' HG22 ' A' ' 7' ' ' VAL . 3.9 m -102.2 136.12 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.783 0.325 . . . . 0.0 111.315 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.2 112.41 23.72 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ttp-105 -141.19 34.04 1.71 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 tp -171.26 98.72 0.2 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.6 tt -110.2 147.52 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.278 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -89.92 -54.15 4.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.988 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.44 123.41 0.7 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.25 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.269 0 CA-C-O 118.647 -1.085 . . . . 0.0 113.102 179.914 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.604 0.24 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -89.81 144.21 26.15 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.863 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 21.0 t -111.98 139.91 34.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -74.7 113.49 12.03 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.925 0.393 . . . . 0.0 110.182 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 m -113.98 135.55 53.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.398 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -81.71 114.65 20.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.562 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.828 HG22 ' CG2' ' A' ' 59' ' ' VAL . 6.3 t -89.27 133.9 30.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.393 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.9 t -78.03 120.45 28.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.756 0.312 . . . . 0.0 110.185 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.91 -45.09 2.32 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.53 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.41 164.01 12.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.458 0.303 . . . . 0.0 110.98 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.31 -176.13 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.933 0.397 . . . . 0.0 111.363 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.3 m -99.25 132.5 44.53 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.93 0.395 . . . . 0.0 111.03 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.3 p -134.69 163.01 30.73 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -94.91 138.12 33.08 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.217 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.483 HG21 HG23 ' A' ' 37' ' ' VAL . 11.1 p -131.33 147.61 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.191 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.22 127.85 34.2 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.009 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -117.65 160.6 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -76.05 -34.52 59.62 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.897 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -52.77 -35.56 56.65 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.794 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -57.29 -51.18 70.42 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.755 0.312 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.85 26.19 46.49 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.799 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -88.28 162.25 16.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.895 0.378 . . . . 0.0 111.265 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -57.57 -35.62 70.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.056 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.76 73.31 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.246 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -59.39 -37.31 77.66 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.373 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.23 -40.01 73.42 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.794 0.331 . . . . 0.0 110.577 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.9 t -71.07 -48.05 57.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.841 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -61.89 -35.7 79.12 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.27 -25.14 32.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 30' ' ' VAL . 7.1 t -88.8 23.31 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-O 120.6 0.238 . . . . 0.0 111.218 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 64.34 47.5 3.09 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.077 0.465 . . . . 0.0 111.052 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.466 HD13 ' HB ' ' A' ' 30' ' ' VAL . 6.6 mp -122.58 34.9 5.02 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.129 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 4.1 p -94.68 120.51 64.72 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.68 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 23.7 Cg_exo -64.04 -32.78 64.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.678 2.252 . . . . 0.0 112.56 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -43.04 23.12 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.341 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 48.53 67.2 0.89 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.069 0.462 . . . . 0.0 111.04 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.502 ' CG2' HG11 ' A' ' 59' ' ' VAL . 16.1 m -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.39 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.4 m -91.37 135.66 33.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.5 m -88.3 130.05 38.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.63 149.1 33.29 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.671 HG12 ' HB2' ' A' ' 44' ' ' ARG . 4.8 t -116.4 119.38 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.623 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 58' ' ' LYS . 17.8 t0 -52.47 120.59 5.77 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.687 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 42' ' ' ASP . . . 18.88 54.21 0.01 OUTLIER Glycine 0 CA--C 1.522 0.53 0 O-C-N 124.481 1.113 . . . . 0.0 114.904 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.671 ' HB2' HG12 ' A' ' 41' ' ' VAL . 26.6 mtt-85 -131.82 119.72 17.17 Favored Pre-proline 0 C--O 1.232 0.163 0 CA-C-N 116.759 0.279 . . . . 0.0 111.304 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -77.91 -45.81 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.664 2.242 . . . . 0.0 112.566 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.2 m -150.57 93.3 3.8 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -63.07 78.57 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.01 2.473 . . . . 0.0 112.588 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.58 -29.94 70.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.194 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.33 19.36 3.27 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.13 136.06 57.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.703 0.287 . . . . 0.0 111.149 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 t -129.85 158.81 38.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.433 HG12 ' H ' ' A' ' 54' ' ' VAL . 14.1 t 72.89 146.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.23 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.18 -34.68 68.73 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.995 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 52' ' ' VAL . 34.6 m -107.09 165.99 4.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.952 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 1.1 m-20 -145.99 154.9 42.41 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.925 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 ttm180 -94.64 125.45 39.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.966 0.412 . . . . 0.0 110.539 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.647 HG21 ' HB ' ' A' ' 39' ' ' VAL . 6.9 m -134.53 167.78 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.952 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.421 ' NZ ' ' HB2' ' A' ' 42' ' ' ASP . 6.7 ptpp? -109.72 139.9 44.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.687 0.28 . . . . 0.0 110.575 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.828 ' CG2' HG22 ' A' ' 7' ' ' VAL . 9.4 m -106.1 141.66 20.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 111.443 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.719 HD21 HG23 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -110.62 118.48 36.31 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.785 -179.802 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.9 mtt-85 -118.94 -58.29 1.96 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.198 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 mp -60.56 -66.89 0.46 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.974 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.719 HG23 HD21 ' A' ' 60' ' ' LEU . 19.0 tt -80.09 154.08 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.5 133.35 14.04 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 146.22 -36.24 1.3 Allowed Glycine 0 CA--C 1.521 0.444 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.883 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.489 -1.173 . . . . 0.0 112.575 179.807 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HA ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.3 p30 -89.41 147.9 23.78 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.896 0.379 . . . . 0.0 110.613 179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' A' ' 54' ' ' VAL . 27.6 m -102.35 139.95 22.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.507 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.43 113.42 11.64 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 57' ' ' VAL . 26.4 m -118.4 135.43 58.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.694 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.98 115.02 22.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.569 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.818 HG22 HG23 ' A' ' 59' ' ' VAL . 17.8 t -84.69 134.14 27.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.941 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -67.53 120.62 15.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.555 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.3 -55.55 5.03 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.431 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.35 163.93 25.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.358 0.263 . . . . 0.0 110.989 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.69 -167.16 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.94 0.4 . . . . 0.0 111.473 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.5 m -99.34 128.04 45.42 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.936 0.398 . . . . 0.0 111.243 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 m -126.65 162.82 24.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.063 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 2' ' ' ASN . 6.6 mp0 -105.69 145.26 31.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.435 HG21 ' CG2' ' A' ' 37' ' ' VAL . 7.4 p -130.97 147.06 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.168 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.38 123.64 30.43 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.691 0.281 . . . . 0.0 111.065 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.416 HG23 HG22 ' A' ' 3' ' ' VAL . 20.1 t -121.97 152.25 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.718 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -76.75 -44.77 31.77 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.301 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.51 -28.67 46.75 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 112.118 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' OD1' HG13 ' A' ' 54' ' ' VAL . 18.1 t70 -50.53 -29.53 10.81 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.7 25.95 61.75 Favored Glycine 0 C--N 1.338 0.68 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.732 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.419 ' OG1' ' HA ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -107.49 179.05 4.36 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.887 0.375 . . . . 0.0 111.294 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.34 -32.35 66.65 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.074 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.78 -35.67 66.53 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.946 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -58.76 -44.71 90.66 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.511 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -55.94 -44.06 78.01 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.975 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.3 t -70.53 -47.25 66.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.041 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -35.98 75.15 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.2 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.81 -27.42 63.12 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.648 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 30' ' ' VAL . 12.6 t -92.61 20.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.602 0.239 . . . . 0.0 111.275 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 65.76 45.12 2.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.2 88.57 2.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.1 t -115.81 120.5 35.66 Favored Pre-proline 0 C--O 1.234 0.271 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.821 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.96 -33.13 2.26 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.659 2.239 . . . . 0.0 112.8 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -79.54 -42.28 25.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.198 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 49.98 57.5 6.48 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.047 0.451 . . . . 0.0 111.216 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' CG2' HG21 ' A' ' 15' ' ' VAL . 10.6 m -123.62 152.17 28.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.125 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -84.75 134.17 34.34 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.695 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.52 ' HB ' HG21 ' A' ' 57' ' ' VAL . 27.4 m -105.88 132.18 53.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.918 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 58' ' ' LYS . 14.2 mt -101.55 151.52 21.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.25 139.35 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 44' ' ' ARG . 18.7 t70 -47.61 124.0 6.54 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -37.83 80.09 0.0 OUTLIER Glycine 0 C--N 1.339 0.74 0 O-C-N 124.204 0.94 . . . . 0.0 114.547 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 42' ' ' ASP . 5.7 mtm-85 -131.46 126.4 21.18 Favored Pre-proline 0 N--CA 1.464 0.225 0 CA-C-O 120.516 0.198 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.46 -41.69 0.56 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.659 2.239 . . . . 0.0 112.702 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 46' ' ' VAL . 12.8 m -141.1 108.41 6.3 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.497 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.63 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.942 2.428 . . . . 0.0 112.006 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -17.77 64.46 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.372 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.0 18.98 3.24 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.21 -169.65 0.19 Allowed 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.777 0.323 . . . . 0.0 111.271 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.5 m -122.71 165.1 17.09 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.055 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG12 ' HG2' ' A' ' 53' ' ' GLU . 10.6 t -129.81 159.39 41.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.214 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.635 ' HG3' HG23 ' A' ' 54' ' ' VAL . 1.5 pt-20 -47.59 -39.82 17.71 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.22 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 53' ' ' GLU . 3.3 t -124.13 161.36 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.419 179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -149.43 146.1 27.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.011 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -95.42 125.08 39.79 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.221 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' HB ' ' A' ' 39' ' ' VAL . 29.5 m -130.63 167.16 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.619 -179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' LEU . 2.1 mttt -104.22 140.24 38.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.57 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.818 HG23 HG22 ' A' ' 7' ' ' VAL . 2.3 m -113.01 140.93 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 120.727 0.299 . . . . 0.0 111.329 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.51 131.05 54.73 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.091 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.54 -51.28 2.91 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.019 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.1 mt -85.8 96.92 9.91 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.887 0.375 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 pp -88.93 164.26 2.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.286 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.18 133.24 17.21 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.2 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 57.11 0.02 OUTLIER Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.788 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.553 -1.137 . . . . 0.0 112.771 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.946 0.403 . . . . 0.0 111.586 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.455 ' CB ' ' HB3' ' A' ' 14' ' ' GLU . 18.6 m120 -89.12 138.16 31.67 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.496 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.783 HG11 ' O ' ' A' ' 55' ' ' ASP . 39.9 t -102.53 140.19 21.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.556 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.09 113.5 12.5 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.215 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 57' ' ' VAL . 27.9 m -117.74 137.48 51.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.489 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.96 114.8 21.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.741 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.651 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.4 t -88.32 134.36 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.977 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.1 t -77.22 120.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.482 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.93 -33.01 5.64 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.784 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -115.01 163.95 14.86 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.416 0.286 . . . . 0.0 110.757 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -169.83 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.44 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -99.68 132.87 44.74 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.057 0.455 . . . . 0.0 111.236 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.3 m -132.73 160.16 37.59 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.332 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 2' ' ' ASN . 3.1 mp0 -89.2 132.83 34.67 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.845 HG11 HG21 ' A' ' 37' ' ' VAL . 30.0 m -130.22 145.95 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.304 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.21 125.94 32.68 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.786 0.326 . . . . 0.0 111.361 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 3.3 m -119.0 137.76 51.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.941 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.21 -27.59 47.2 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.681 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.7 -40.81 63.31 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.715 0.293 . . . . 0.0 110.949 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.411 ' CG ' HG12 ' A' ' 54' ' ' VAL . 0.3 OUTLIER -49.24 -45.94 45.3 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.368 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.26 71.98 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.621 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.8 p -90.42 174.18 7.7 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.933 0.397 . . . . 0.0 111.362 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -57.44 -38.51 74.52 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.205 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.9 -37.1 78.45 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.407 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -59.35 -37.02 76.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.46 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -56.2 -42.71 77.6 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.28 -44.57 72.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.403 ' HG3' ' HB3' ' A' ' 33' ' ' SER . 10.6 ttp85 -59.57 -36.03 75.43 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.289 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.31 -25.07 58.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.918 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 30' ' ' VAL . 9.0 t -89.47 23.37 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.618 0.247 . . . . 0.0 111.255 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.8 t70 64.93 48.23 2.4 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.101 0.477 . . . . 0.0 111.033 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD13 ' HB ' ' A' ' 30' ' ' VAL . 4.7 mp -121.22 37.48 4.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -92.9 120.74 66.94 Favored Pre-proline 0 C--O 1.232 0.14 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.703 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 33' ' ' SER . 16.0 Cg_exo -67.68 -33.16 28.73 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.8 2.333 . . . . 0.0 112.54 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -79.57 -42.92 23.99 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.306 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 51.38 65.29 1.53 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.082 0.468 . . . . 0.0 111.13 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.845 HG21 HG11 ' A' ' 15' ' ' VAL . 3.4 m -125.48 145.99 31.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.518 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.5 m -88.03 136.6 32.9 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.648 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.749 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.0 m -98.82 134.64 36.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.44 140.36 48.77 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.807 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.6 t -101.77 137.56 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -66.61 120.16 12.97 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.904 0.383 . . . . 0.0 110.346 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 33.58 36.66 0.05 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-N 115.126 -0.943 . . . . 0.0 114.528 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.59 137.78 30.59 Favored Pre-proline 0 C--O 1.232 0.166 0 CA-C-N 117.179 0.489 . . . . 0.0 111.249 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.486 ' O ' HG13 ' A' ' 46' ' ' VAL . 50.4 Cg_endo -73.42 -52.18 0.15 Allowed 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.276 1.984 . . . . 0.0 112.263 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 45' ' ' PRO . 1.7 m -160.74 144.45 10.1 Favored Pre-proline 0 N--CA 1.466 0.359 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.891 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -85.77 43.51 1.18 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 112.678 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -68.3 -35.71 78.24 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.268 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -85.76 -16.95 37.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.552 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -64.0 147.76 51.29 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.731 0.301 . . . . 0.0 111.34 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.65 72.15 1.0 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.142 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.4 m -147.56 175.4 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -102.2 -35.11 9.0 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.411 HG12 ' CG ' ' A' ' 20' ' ' ASP . 25.6 m -130.89 161.85 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.806 0.336 . . . . 0.0 111.298 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.783 ' O ' HG11 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -149.27 156.67 42.47 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.678 179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -95.12 124.63 39.27 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.749 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.0 m -134.92 167.4 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.16 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.88 130.78 55.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.572 179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.651 ' CG2' HG22 ' A' ' 7' ' ' VAL . 16.6 m -103.3 141.74 18.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.7 mp -119.06 127.52 53.48 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.949 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -38.25 83.07 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.021 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mt -142.48 127.97 18.99 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.147 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.9 tt -140.86 143.04 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.436 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.4 mttt 66.24 109.34 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.375 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.5 57.56 0.11 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.734 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.258 -1.301 . . . . 0.0 112.704 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.751 0.31 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.55 146.01 24.41 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.071 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 55' ' ' ASP . 23.6 t -120.83 139.79 46.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.675 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m -75.01 114.94 14.08 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.979 0.419 . . . . 0.0 110.523 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 HG23 ' A' ' 57' ' ' VAL . 10.0 m -118.15 137.66 51.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.264 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -81.33 114.79 20.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.565 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -93.46 134.14 32.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.554 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.2 t -57.03 120.35 3.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.867 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.87 -118.36 3.43 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.183 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -120.93 152.88 37.96 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.719 0.295 . . . . 0.0 111.304 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 67.55 165.09 0.22 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.123 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.0 t -117.99 135.43 54.16 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.679 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.15 159.98 15.43 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.394 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -125.73 127.27 45.93 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.222 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.18 149.26 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.339 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -85.21 127.05 34.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.356 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' CG1' HG11 ' A' ' 39' ' ' VAL . 4.2 m -116.98 148.77 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.826 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.97 -23.38 67.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.758 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -54.24 -37.94 65.2 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.785 0.326 . . . . 0.0 110.808 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -57.97 -43.83 86.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.255 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.36 26.32 40.18 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.226 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.85 163.98 12.93 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.959 0.379 . . . . 0.0 111.036 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -60.08 -38.4 82.78 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.365 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -37.46 71.98 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.259 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.09 -41.86 98.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.931 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.06 -43.17 77.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.472 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.28 -44.33 94.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.664 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -35.89 82.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.068 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.89 -25.08 41.04 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.698 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.808 ' HB ' HD12 ' A' ' 32' ' ' LEU . 12.6 t -88.71 23.69 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 64.5 48.34 2.71 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 111.135 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.808 HD12 ' HB ' ' A' ' 30' ' ' VAL . 1.4 mt -130.65 44.81 2.91 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.712 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -99.18 136.53 20.47 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.01 -33.18 6.31 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.466 2.111 . . . . 0.0 112.529 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.13 -42.35 23.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.203 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 54.59 59.35 4.18 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.945 0.402 . . . . 0.0 111.242 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.0 m -124.4 146.32 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.268 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.8 t -90.49 138.48 31.52 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.02 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.801 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.5 m -96.59 132.0 42.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.516 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 140.21 45.34 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -101.67 135.49 38.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -65.96 120.46 13.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.734 0.302 . . . . 0.0 110.231 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 30.85 39.1 0.03 OUTLIER Glycine 0 CA--C 1.524 0.612 0 CA-C-N 115.189 -0.914 . . . . 0.0 114.57 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 133.95 24.22 Favored Pre-proline 0 C--O 1.233 0.223 0 CA-C-N 117.149 0.474 . . . . 0.0 111.644 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -75.35 -38.26 1.53 Allowed 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.426 2.084 . . . . 0.0 112.403 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.93 131.87 11.63 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.209 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -78.56 1.66 8.85 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.648 2.232 . . . . 0.0 113.12 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.8 -28.58 67.56 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.582 0.229 . . . . 0.0 111.357 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.84 19.36 4.84 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.596 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -106.0 155.02 19.8 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.788 0.327 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 t -92.4 167.87 11.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 54' ' ' VAL . 18.6 t 73.4 135.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -58.34 -36.19 73.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' H ' HG12 ' A' ' 52' ' ' VAL . 2.5 t -106.9 161.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.741 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.461 ' O ' HG11 ' A' ' 3' ' ' VAL . 28.1 t70 -148.17 151.21 35.16 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.716 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -95.21 125.48 39.88 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.948 0.404 . . . . 0.0 110.663 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 39' ' ' VAL . 15.5 m -132.25 167.35 26.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.17 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -108.49 136.7 47.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.679 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' CG1' HG21 ' A' ' 5' ' ' VAL . 15.0 m -102.18 140.81 19.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.311 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.31 132.2 56.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.939 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' A' ' 62' ' ' LEU . 18.9 ptt180 -66.94 -42.33 85.47 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.998 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 61' ' ' ARG . 1.8 mp -152.74 128.09 9.9 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.767 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.4 tp -155.36 145.67 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.402 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 157.9 18.09 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.293 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -170.67 86.15 0.08 OUTLIER Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.769 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.412 -1.216 . . . . 0.0 112.6 179.923 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.718 0.294 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -85.26 133.16 34.18 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.725 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.825 HG21 ' O ' ' A' ' 55' ' ' ASP . 12.8 p -103.08 140.45 21.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.922 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 m -74.73 113.19 11.72 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.313 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.485 HG23 ' OG ' ' A' ' 13' ' ' SER . 30.0 m -118.75 138.05 50.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.249 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -81.76 115.0 20.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.406 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 59' ' ' VAL . 10.0 p -99.24 133.94 40.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.087 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.06 120.77 9.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.2 -55.82 0.69 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.468 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.47 163.39 22.77 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.587 0.232 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -67.66 -82.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.99 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -127.95 135.01 49.36 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.037 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.485 ' OG ' HG23 ' A' ' 5' ' ' VAL . 26.7 p -120.62 147.91 44.6 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.487 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -116.73 128.97 55.83 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.096 -179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.9 p -132.35 145.86 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.982 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HB2' HH11 ' A' ' 28' ' ' ARG . . . -84.19 138.28 33.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.882 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 m -116.64 160.09 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.265 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.514 ' HA ' ' OD1' ' A' ' 25' ' ' ASP . 5.5 t70 -99.05 -22.84 15.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.004 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -24.99 65.18 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -62.2 -60.55 3.43 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.55 26.42 35.74 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.859 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -89.97 178.61 6.16 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.912 0.356 . . . . 0.0 111.312 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -40.14 83.58 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.888 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.91 -35.56 81.54 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.621 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 18' ' ' ASP . 21.0 t0 -59.86 -37.92 80.67 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.61 -40.56 72.26 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.54 0.209 . . . . 0.0 110.687 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.0 t -71.26 -50.68 39.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.131 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.44 HH11 ' HB2' ' A' ' 16' ' ' ALA . 8.3 mmt85 -63.06 -35.67 81.01 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.557 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.8 -25.1 26.0 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.609 ' HB ' HD13 ' A' ' 32' ' ' LEU . 8.7 t -85.74 22.19 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.592 0.234 . . . . 0.0 111.441 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.35 47.98 2.94 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.164 0.507 . . . . 0.0 110.983 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.609 HD13 ' HB ' ' A' ' 30' ' ' VAL . 9.8 mp -116.09 38.05 3.48 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.959 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.15 121.52 71.42 Favored Pre-proline 0 CA--C 1.529 0.171 0 CA-C-O 120.727 0.298 . . . . 0.0 110.7 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.34 -29.52 9.35 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.741 2.294 . . . . 0.0 113.06 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -77.71 -42.62 33.75 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.097 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 47.09 70.49 0.4 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.125 0.488 . . . . 0.0 111.402 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.7 m -127.45 155.61 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.489 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 6.8 t -85.32 138.32 32.38 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.655 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HB ' HG21 ' A' ' 57' ' ' VAL . 28.7 m -110.36 129.73 64.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.456 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.8 139.99 45.61 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.197 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.72 135.11 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.552 ' O ' ' N ' ' A' ' 44' ' ' ARG . 15.0 t0 -47.75 122.06 4.61 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -33.85 78.05 0.0 OUTLIER Glycine 0 CA--C 1.527 0.815 0 O-C-N 124.414 1.071 . . . . 0.0 115.014 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.552 ' N ' ' O ' ' A' ' 42' ' ' ASP . 0.2 OUTLIER -132.15 157.67 77.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 122.135 0.174 . . . . 0.0 111.052 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 44' ' ' ARG . 28.4 Cg_endo -62.52 155.15 59.91 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.407 2.072 . . . . 0.0 111.815 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.5 t -116.22 82.86 12.03 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.782 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 45' ' ' PRO . 24.6 Cg_exo -62.71 106.5 0.52 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.558 2.172 . . . . 0.0 111.742 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.91 -22.33 66.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.618 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -77.05 -18.15 58.28 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -129.2 154.86 46.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.806 0.336 . . . . 0.0 111.651 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.09 157.8 6.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.219 179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 m -116.01 174.75 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.854 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -73.7 -46.64 44.95 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.6 0.238 . . . . 0.0 110.985 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.15 161.84 22.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.786 0.327 . . . . 0.0 111.186 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.825 ' O ' HG21 ' A' ' 3' ' ' VAL . 0.7 OUTLIER -148.3 157.08 43.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.358 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -94.35 125.09 38.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.883 0.373 . . . . 0.0 110.051 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' A' ' 39' ' ' VAL . 13.9 m -133.63 167.49 26.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.681 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.35 141.35 35.32 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG1' HG21 ' A' ' 5' ' ' VAL . 16.2 m -116.54 141.32 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 120.794 0.33 . . . . 0.0 111.346 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mt -114.65 129.08 56.63 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.237 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -34.77 12.6 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.059 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.02 138.93 32.18 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.634 0.254 . . . . 0.0 110.983 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 pt -110.64 154.05 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.23 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 tttm -74.79 111.66 10.21 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.55 -149.67 19.57 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.556 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.553 -179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 120.674 0.273 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -85.02 135.62 33.94 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.882 HG11 ' O ' ' A' ' 55' ' ' ASP . 11.8 t -102.34 140.07 21.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.562 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -74.47 118.65 17.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.511 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 57' ' ' VAL . 18.0 m -117.2 137.45 51.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.068 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -81.41 114.66 20.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.561 HG22 ' CG2' ' A' ' 59' ' ' VAL . 16.1 t -87.75 134.34 28.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.64 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.2 t -57.31 120.52 3.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.809 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.89 -117.59 4.33 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.04 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -120.7 159.86 24.48 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.604 0.24 . . . . 0.0 111.251 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 69.49 145.71 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.016 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -118.87 135.03 54.78 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.408 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -118.58 163.35 16.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.098 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.7 144.12 44.39 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.032 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' A' ' 35' ' ' HIS . 11.8 p -120.13 139.63 46.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 35' ' ' HIS . . . -85.65 130.24 34.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.868 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.54 160.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.901 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -100.42 -21.36 15.41 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.895 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.42 -34.91 50.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.514 0.197 . . . . 0.0 111.51 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -68.56 -51.63 40.74 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.621 0.248 . . . . 0.0 110.913 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.61 26.02 18.86 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.468 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.95 178.72 6.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.886 0.374 . . . . 0.0 111.05 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -57.41 -32.82 67.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.467 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.42 -37.76 70.64 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.651 0.262 . . . . 0.0 110.92 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -64.72 -40.53 95.49 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.753 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.8 OUTLIER -56.18 -37.42 69.56 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.861 179.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.69 -51.2 48.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.979 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -36.27 79.43 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.207 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.83 -28.44 61.58 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.71 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.587 ' O ' HD12 ' A' ' 32' ' ' LEU . 10.7 t -93.55 21.92 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.672 0.272 . . . . 0.0 111.203 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 62.77 46.82 4.96 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.927 0.394 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.587 HD12 ' O ' ' A' ' 30' ' ' VAL . 1.2 mp -128.06 50.95 2.01 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.6 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.51 119.69 67.04 Favored Pre-proline 0 C--O 1.233 0.227 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.738 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.31 -27.35 2.87 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.881 2.388 . . . . 0.0 112.839 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.638 ' HB2' HG22 ' A' ' 37' ' ' VAL . 10.4 p-80 -65.04 -43.39 92.51 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.613 -179.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 44.96 45.52 8.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.985 0.421 . . . . 0.0 111.575 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.638 HG22 ' HB2' ' A' ' 35' ' ' HIS . 18.6 m -126.88 160.52 35.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.32 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.91 122.99 44.44 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.722 ' HB ' HG21 ' A' ' 57' ' ' VAL . 34.9 m -82.0 135.17 25.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.214 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.401 HD21 HD23 ' A' ' 60' ' ' LEU . 4.2 mm? -103.96 145.27 30.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -101.68 126.07 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.17 120.0 12.45 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.468 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 29.71 37.84 0.02 OUTLIER Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.087 -0.96 . . . . 0.0 114.947 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.77 138.04 31.07 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-N 117.231 0.516 . . . . 0.0 111.504 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.07 -44.0 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.431 2.087 . . . . 0.0 112.13 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG21 ' OE2' ' A' ' 48' ' ' GLU . 17.5 m -153.18 139.56 12.44 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.723 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -87.09 36.45 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.69 2.26 . . . . 0.0 112.823 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' OE2' HG21 ' A' ' 46' ' ' VAL . 39.6 mt-10 -68.75 -35.4 77.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.174 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -80.98 -17.92 48.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.548 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -62.92 136.36 57.8 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.665 0.269 . . . . 0.0 111.435 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 57.9 m -126.07 60.57 1.29 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.979 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 t -137.6 140.73 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -58.51 -44.51 89.49 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.246 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 35.7 m -131.24 162.18 39.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.101 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.882 ' O ' HG11 ' A' ' 3' ' ' VAL . 2.1 p30 -148.59 154.81 40.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.835 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -94.83 125.26 39.37 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.722 HG21 ' HB ' ' A' ' 39' ' ' VAL . 16.3 m -133.62 167.88 25.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.582 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.18 136.48 41.93 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.082 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.561 ' CG2' HG22 ' A' ' 7' ' ' VAL . 2.3 m -108.41 140.24 27.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-O 120.878 0.371 . . . . 0.0 111.855 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.535 HD22 ' HB2' ' A' ' 64' ' ' LYS . 3.2 pp -99.35 131.77 45.14 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.389 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.526 HH21 HG11 ' A' ' 7' ' ' VAL . 12.5 ttm180 -67.26 -59.76 3.16 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.68 -63.44 1.31 Allowed 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.711 0.291 . . . . 0.0 110.47 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 pp -145.31 174.97 2.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.955 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.535 ' HB2' HD22 ' A' ' 60' ' ' LEU . 0.8 OUTLIER -155.21 160.49 40.89 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.041 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.4 36.63 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.638 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.223 -1.321 . . . . 0.0 112.835 179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.743 0.306 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -93.1 147.3 22.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.026 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 15' ' ' VAL . 12.7 m -112.12 139.6 35.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.844 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.2 m -74.88 113.59 12.36 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.269 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.48 HG21 ' CG1' ' A' ' 59' ' ' VAL . 27.7 m -117.03 136.29 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.443 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -81.65 114.7 20.51 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.761 HG22 ' CG2' ' A' ' 59' ' ' VAL . 8.7 t -89.03 133.29 31.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.636 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 t -81.65 120.4 33.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.546 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.09 -24.92 13.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.973 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.7 163.97 15.68 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.652 0.381 . . . . 0.0 110.796 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.88 -169.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.795 0.331 . . . . 0.0 111.709 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.18 131.2 45.38 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.943 0.401 . . . . 0.0 111.35 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.5 m -133.1 162.99 30.26 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.043 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -106.16 140.23 39.45 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.535 ' O ' HG22 ' A' ' 3' ' ' VAL . 11.4 p -132.49 146.96 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.331 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -84.63 125.83 32.82 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.999 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.647 HG12 HG11 ' A' ' 39' ' ' VAL . 6.9 m -116.32 161.63 14.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.909 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.3 -33.86 59.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.96 -39.2 58.91 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.863 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD2' HG12 ' A' ' 54' ' ' VAL . 1.3 t70 -48.01 -47.33 33.36 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.802 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.97 26.5 70.92 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.191 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.48 174.49 6.43 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.952 0.376 . . . . 0.0 111.143 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -59.47 -34.86 73.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.313 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.42 -36.03 70.83 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.183 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 27.9 t0 -58.95 -39.33 81.34 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.892 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -65.43 -35.66 81.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.693 179.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.56 -51.34 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.067 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -63.28 -35.43 80.34 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.044 179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.68 -25.05 37.75 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.82 ' HB ' HD12 ' A' ' 32' ' ' LEU . 2.5 t -85.72 23.51 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.93 48.28 2.39 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.034 0.445 . . . . 0.0 111.247 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.82 HD12 ' HB ' ' A' ' 30' ' ' VAL . 2.1 mt -132.32 52.78 2.05 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.967 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.3 130.4 22.9 Favored Pre-proline 0 CA--C 1.529 0.135 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.739 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -81.36 -32.93 0.8 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.615 2.21 . . . . 0.0 113.23 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.8 -43.0 23.24 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 111.512 0.189 . . . . 0.0 111.512 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 48.37 67.45 0.85 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.345 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 59' ' ' VAL . 22.7 m -128.06 149.59 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.502 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 7.9 t -85.2 138.66 32.22 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.783 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.647 HG11 HG12 ' A' ' 17' ' ' VAL . 31.5 m -99.31 131.62 46.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.296 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 40' ' ' LEU . 4.0 mm? -103.9 151.26 23.35 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.054 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.9 t -118.25 139.27 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.814 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 44' ' ' ARG . 10.5 p-10 -47.55 124.45 7.03 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -36.57 80.91 0.0 OUTLIER Glycine 0 C--N 1.34 0.775 0 O-C-N 124.083 0.864 . . . . 0.0 114.356 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' A' ' 42' ' ' ASP . 37.2 ptt180 -125.99 144.49 48.89 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 120.649 0.261 . . . . 0.0 111.402 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.9 -39.38 2.38 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.818 2.346 . . . . 0.0 112.7 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.9 m -136.73 156.04 76.32 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.713 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.51 56.5 5.14 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.688 2.259 . . . . 0.0 112.627 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -68.55 -30.09 68.8 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -89.95 19.47 4.85 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.312 -0.403 . . . . 0.0 112.074 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.02 86.97 0.06 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.951 0.405 . . . . 0.0 110.65 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -142.53 160.46 40.24 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.898 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 54' ' ' VAL . 21.3 t 71.81 137.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.21 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.433 ' HG3' HG13 ' A' ' 54' ' ' VAL . 3.9 pt-20 -57.05 -38.51 73.33 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.974 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.484 ' H ' HG12 ' A' ' 52' ' ' VAL . 35.9 m -106.43 161.86 5.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.135 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 149.97 34.54 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.853 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 129.77 42.77 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.345 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.612 HG21 ' HB ' ' A' ' 39' ' ' VAL . 28.6 m -135.23 167.15 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.394 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.3 mmtt -105.39 136.29 45.22 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.487 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.761 ' CG2' HG22 ' A' ' 7' ' ' VAL . 5.9 m -101.82 136.52 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 111.173 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.609 HD22 HG23 ' A' ' 63' ' ' ILE . 1.5 tt -100.3 113.01 25.38 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.267 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -124.55 55.35 1.33 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.626 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.4 tp -149.05 34.61 0.74 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.951 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.609 HG23 HD22 ' A' ' 60' ' ' LEU . 2.3 pt -122.08 175.73 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.07 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.01 175.03 9.94 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.59 -32.08 6.87 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.792 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.54 -1.145 . . . . 0.0 112.669 -179.834 . . . . . . . . 0 0 . 1 stop_ save_